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ABSTRACT 
  
Caveolae are 50-100 nm invaginations in the plasma membrane of eukaryotes that 
are involved in a number of important cellular processes.  The integral membrane protein, 
caveolin-1, is a key architectural component within caveolae.  Despite the preeminent 
role that caveolin holds in maintaining functional caveolae, there is no three-dimensional 
structure available.  Part of understanding the three-dimensional structure of caveolin 
requires defining its depth within the biological membrane.  Only a hazy picture of 
caveolins topology exists, it is known that the global topology of the protein is such that 
the N- and C- termini reside on the cytoplasmic face of the membrane.  In this body of 
work, the topological disposition of the integral membrane protein caveolin-1 
reconstituted into model membrane systems is elucidated using biochemical and 
biophysical techniques.  Chapter 1 is provided to give adequate background needed to 
familiarize the reader with the body of knowledge pertaining to the caveolin protein, 
vehicles for studying membrane proteins, as well as biophysical techniques that are 
employed in the remaining chapters.  In Chapter 2, the characterization of a major 
methodological advancement using perfluorooctanoic acid-lipid mixtures to reconstitute 
protein into liposomes by detergent dialysis is presented.  This chapter tackled the 
challenge of natively refolding caveolin-1 from a highly-purified denatured state and may 
be useful for reconstitution studies in general.  In Chapter 3, a combined biophysical 
approach using fluorescence spectroscopy, nuclear magnetic resonance, and molecular 
dynamics simulations is taken to generate a model of caveolin-1 (residues 82-136) within 
a lipid bilayer.  These studies strongly suggested that caveolin contains a membrane 
embedded turn, an unusual motif in membrane proteins.  Chapter 4 deepens and supports 
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the model presented in Chapter 3 by employing cysteine scanning mutagenesis to 
examine the accessibility of the caveolin-1 scaffolding domain (residues 82-101), a 
region which is critical to the proteins function.  These studies pinpoint the caveolin 
scaffolding domain as being the region of the protein that first enters the bilayer and 
provide a clear rationale for how this region can interact with a diverse group of soluble 
and membrane bound ligands.  Chapter 5 examines the topological significance of two 
major factors thought to impact the caveolin-1 conformation and aqueous exposure, a 
highly conserved proline residue (P110) located within the putative intramembrane turn 
region and the inclusion of cholesterol.  Near and far ultraviolet circular dichroism 
measurements paired with single tryptophan mutant λmax and fluorescence quenching 
experiments provide insight into structural and accessibility changes that the P110A 
mutation and translocation of the protein into a cholesterol rich environment bring about.  
Chapter 6 details the synthesis of a novel lipid that contains an indole headgroup (indole-
PE) as well as its potential as a molecular ruler in fluorescence studies.  Importantly this 
probe draws light on the behavior of commonly employed tryptophan fluorescence 
quenching reagents and aids in the interpretation of tryptophan fluorescence quenching 
experiments performed on caveolin-1 single tryptophan mutants reconstituted into 
phospholipid bicelles. 
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Chapter 1.  Caveolae, Caveolin, and Lipid Environments for the 
Biophysical Characterization of Membrane Proteins 
 
Caveolae 
 The biological membrane has a number of roles within the cell; it provides 
protection of the cells interior from the harsh outer environment, gives the cell its 
identity, allows nutrient influx, waste secretion, compartmentalizes cellular organelles, 
and localizes specific homeostatic processes.  Caveolae (plural caveola) are 50-100 nm 
invaginations that are dispersed throught the plasma membrane of eukaryotic organisms, 
bulging inwards towards the cytoplasm.  These structures were first observed using 
electron microscopy in the 1950’s (Figure 1-1 A-C) 1,2.  
100 nm
50-100 nm
A
B C
 
Figure 1-1.  A) Transmission electron micrograph of caveola scattered across the surface 
of the plasma membrane (arrows). B)  Close up image of a single caveolae which are 50-
100 nm in diameter. C)  Cartoon showing the molecular constituents enriched in 
caveolae: Cholesterol, gangliosides, glycerophospholipids, sphingomyelin, and the 
membrane protein caveolin 24. 
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The Roles of Caveolae in the Cell
Since their initial discovery, caveolae have been observed in many cell types including 
adipocytes, endothelial cells, fibroblasts, and smooth muscle cells 1,3-5.  Furthermore, 
caveolae appear to be associated with the entire metazoan (vertebrate and invertebrate 
animal branch) branch of opisthokonta 6, highlighting the biological importance of these 
highly curved microdomains.  Such high levels of conservation is owed to the multitude 
of functions ascribed to caveolae, which include mechanoprotection, non-clatherin 
mediated endocytosis, and most notably, signal transduction (Figure 1-2) 7-10. 
 
Figure 1-2.  Diagram of a cell detailing the proposed functions attributed to caveolae. 
 
When a force is exerted upon a cellular membrane causing it to stretch, caveolae 
dissipate; therefore caveolae can act as a lipid reservoir, and this helps avoid mechanical 
rupture of the cell 11.  Once the force is removed, caveolae reform.  The flask-like shape 
of caveolae facilitates the endocytotic budding off from the membrane, and they can 
carry various biomolecules to other regions of the cell 12.  Furthermore, they have also 
been implicated in viral entry into cells through endocytosis 13-15.  Caveolae aid the cell 
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by acting as signaling hubs; specific examples of proteins which are thought to be 
regulated within caveolae include endothelial nitric oxide synthase, Src tyrosine kinases, 
H-ras, and G protein α-subunits 16-21.  A transmission electron micrograph of caveola 
along the cell surface is shown in figure 1-1A.  Figure 1-1B displays a close up image of 
a single caveolae 22-24.  Caveolae also have a unique lipid composition that differs from 
that of the plasma membrane (Figure 1-1C).  They are enriched in cholesterol (twice the 
amount in the bulk membrane) and sphingolipids - although recent studies have cast 
doubt on the latter from being significantly greater than what is found in the bulk plasma 
membrane 25,26.  Importantly, cholesterol is thought to be a stabilizing factor to caveolae 
by providing structural support.  Evidence of cholesterol providing structural support 
comes from studies where cells were treated with cholesterol depleting drugs resulted in 
caveolae that had a dramatically flattened morphology 27,28.  The most important and 
abundant protein in caveolae is the integral membrane protein caveolin.  Gene silencing 
studies have shown that when caveolin is not expressed, there is a complete 
disappearance of caveolae from the cell surface 16.  Additionally, expression of caveolin 
in cell lines and organisms that do not normally express the protein has been shown to 
induce the formation of caveolae 29,30.  These studies have implicated caveolin as an 
architect of caveolae morphology.  Despite the plethora of functions that are ascribed to 
caveolae, the exact molecular details of caveolin structure, oligomeric behavior, and 
topology have remained mysterious from a biophysical perspective. 
 
Caveolin 
 The gene encoding for caveolin is found in eukaryotic organisms ranging from C. 
elegans (roundworm) up to H. sapiens (humans) (Figure 1-3A, Table 1-1) 31,32.  
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Interestingly caveolae formation has not been observed in C. elegans, but has been 
confirmed for D. rerio (zebra fish) 33.  In humans, there are three isoforms of the protein 
that have been identified; caveolin-1, -2, and -3, each having a molecular weight of 
roughly 22 kDa (Figure 1-4, Table 1-2). 
 
Figure 1-3.  Sequence alignment for caveolin-1 across species.  Conserved hydrophobic, 
polar uncharged, negatively charged, and positively charged residues are shown in 
purple, green, red, and blue respectively. 
 
Species Nematode  Sea 
louse 
Ant Zebra 
fish 
Frog Chicken Chimp Human 
Nematode  100 21.6 22.9 25.4 22.3 22.8 26.1 26.1 
Sea louse 21.6 100 18.8 27.5 26.5 27.1 27.1 27.1 
Ant 22.9 18.8 100 27.4 23.8 25.6 25.6 25.6 
Zebra fish 25.4 27.5 27.4 100 68.5 72.9 72.9 72.9 
Frog 22.3 26.5 23.8 68.5 100 78.9 75 75 
Chicken 22.8 27.1 25.6 72.9 78.9 100 86.5 86.5 
Chimp 26.1 27.1 25.6 72.9 75 86.5 100 100 
Human  26.1 27.1 25.6 72.9 75 86.5 100 100 
Table 1-1.  Sequence identity as a percentage for caveolin-1 across species. 
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Figure 1-4.  Sequence alignment of caveolin isoforms from humans.  Conserved 
hydrophobic, polar uncharged, negatively charged, and positively charged residues are 
shown in purple, green, red, and blue respectively.  The “Identity” bar indicates the level 
of amino acid conservation where green and yellow regions indicate identical and similar 
respectively.  Transmembrane regions are indicated below the sequence of each isoform. 
 
 
 
 
Caveolin-1 is the most ubiquitously expressed of the isoforms and is found in many cell 
types.  It is present either as caveolin-1α (178 amino acid) or an N- terminally truncated 
caveolin-1β form (missing the first 33 amino acids) 34.  It is thrice palmitoylated at 
positions 133, 143, and 156, which has been shown to be unimportant for trafficking of 
Caveolin Isoform Caveolin-1 Caveolin-2 Caveolin-3 
Caveolin-1 100 33.1 62.9 
Caveolin-2 33.1 100 34 
Caveolin-3 62.9 34 100 
Table 1-2.  Sequence identity as a percentage across human 
isoforms. 
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the protein to the plasma membrane, downplaying any structural role for this post-
translational modification 35.  Caveolin-2 is often co-expressed with caveolin-1 and 
interestingly, (akin to C. elegans caveolin) cannot form caveolae on its own 36.  Caveolin-
3 has the ability to form caveolae on its own and is specifically found within skeletal 
muscles cells, smooth muscle cells, and cardiac myocytes 37-39. 
Caveolins homo- and hetero-oligomerize into Triton-X-114 resistant 200, 400, 
and 600 kDa complexes in vivo, and this oligomeric activity is postulated to provide 
structural stability to caveolae 40-42.  However, it is not clear how these complexes arise in 
vivo, and recent in vitro studies have suggested that caveolin-1 cannot homo-oligomerize 
in the absence of cellular components 43.  More recent examinations of the molecular 
components of the caveolar coat have revealed that caveolin homo- and hetero-oligomers 
are associated with another family of membrane proteins known as cavins, and that 
cavins are necessary for the formation of caveolae 44.  It has been shown using 
fluorescence correlation spectroscopy studies of fluorescent protein tagged caveolin and 
cavins that the four members of the cavin protein family (cavin1-4) associate with 
caveolin in a 1:4 stoichiometry.  It has been observed that different cell types express 
different complements of the cavin isoforms.  It is thought that the different complements 
of cavin-caveolin complexes may be in part responsible for the functional diversity of 
caveolae across cell types 45.  Studies on caveolin-1 have suggested that the protein binds 
cholesterol on a 1:1 molar ratio, however, the exact site of binding and the structural 
implications on caveolin are poorly characterized 19,46. 
 It cannot go without mention that caveolin misregulation and disfunction has been 
implicated in a number of human disease states.  This fact has largely been responsible in 
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generating vast interest in the caveolin proteins.  This list of diseases that caveolin has 
been implicated in is large, a non-exhaustive list includes: cancer, diabetes, 
cardiovascular disease, atherosclerosis, pulmonary fibrosis, and muscular degenerative 
diseases 47-56.  In terms of how misregulation of the caveolin protein is involved with 
disease, there appears to be tissue specificity.  For example, caveolin-1 up-regulation is 
associated with increased metastasis of prostate cancers 57.  On the other hand, caveolin 
knock-out mice showed increased tumor proliferation, pointing to a role of caveolin as a 
tumor suppressor 58,59.  Clearly, there is a delicate balance of caveolin expression levels 
required for proper cell function.  Very few specific mutations are associated with disease 
states; however, a prominent example is in breast cancer where there is a mutation of 
proline 132 to leucine in caveolin-1.  The molecular mechanism of how this mutation 
disrupts normal caveolin function has been uncovered, where improper oligomeric 
behavior (dimerization) results in the retention of the protein in the Golgi apparatus 
43,60,61.  An analogous mutation in caveolin-3, P104L, has also been shown to be 
associated with cardiomyapathies and results in poor myoblast function 62,63.  Therefore, 
proper structuring of caveolin is critical to many aspects of cellular homeostasis. 
 
Caveolin Structure 
 Caveolin-1 is typically divided up into four structural domains: The N-terminal 
domain, the scaffolding domain, the intramembrane domain, and the C-terminal domain 
(Figure 1-5).  Each of these domains is suggested to contribute to caveolin function in a 
variety of ways.  The domains will be discussed in the context of caveolin-1 as it is the 
subject of this dissertation. 
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Figure 1-5.  Domain map of caveolin-1.  Each domain is color coded and the degree to 
which the secondary structure is known is indicated. 
 
The soluble N-terminal domain (residues 1-81) is the most highly variant region 
of the protein across human isoforms and across species, differing in both its length and 
amino acid composition.  It has been implicated in various aspects of caveolin behavior 
such as enhancing cholesterol binding and being important to caveolin filament assembly 
64,65.  It has been shown to be unstructured by circular dichroism (CD) spectroscopy 65.  
Primary sequence analysis algorithms have also suggested the presence of a single 
amphipathic helix, which may interact with the membrane surface 66. 
The next domain in caveolin has been dubbed the caveolin scaffolding domain 
(CSD, residues 82-101).  This domain has been implicated in a number of caveolins 
proposed functions.  In particular, the CSD is thought to govern caveolins association 
with binding partners as it interacts with a number of cell signaling proteins (Src-like 
kinases, Ha-Ras, endothelial nitric-oxide synthase (eNOS), and G protein α-subunits), 
associates with cholesterol, and has been shown to be important for caveolin-1 
oligomeric behavior in vivo 16-21.  Early models of caveolin structure based on sequence 
analysis predicted this region to have an amphipathic α-helix stretching from residues 80-
92 in caveolin-1 66.  Helical character in this region has been supported by a number of 
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studies employing NMR and CD spectroscopy 67,68.  However, recent solid-state NMR 
studies suggest that the CSD may adopt β-strand character in the presence of cholesterol.  
Due to the exotic conditions of these experiments (very high concentrations of truncated 
caveolin-based peptides), it is not clear if the β-strand character is an artifact of irrelevant 
protein aggregation, or if it is indeed an effect of cholesterol on the protein 69. 
The C-terminus (residues 135-178) has a variety of purported functions that 
include membrane binding, signaling interactions, and mediating oligomeric behavior 40.  
It is also the region of the protein that contains two of the three sites of palmitoylation on 
caveolin-1; these post translational modifications may help anchor this portion of the 
protein to the membrane.  Little is known about the C-terminal domain in terms of the 
secondary structure; however, helix prediction software and NMR studies currently being 
undertaken in the Glover lab indicate that it may be composed of a long amphipathic α-
helix that rests on the surface of the membrane. 
The most highly conserved domain across isoforms and across species is the 
intramembrane domain (IMD residue 102-134 in caveolin-1).  This region was predicted 
to be composed of two transmembrane α-helices separated by a 3-4 residue break using 
primary sequence analysis algorithms 66.  Recent NMR spectroscopy experiments 
performed on the 96-136 region of caveolin-1 have supported this postulation and 
identified two α-helices, one stretching from residues 96-107 and the other stretching 
from residues 111-128.  These residues were separated by a three residue unstructured 
region consisting of a glycine (108), isoleucine (109), and proline (110).  Importantly, 
these studies have pinpointed the IMD as being the structural core of the protein 70.  The 
three residues that break the helices have unique character that seems to be critical for 
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maintaining a well structured protein and they may represent a turn 70.  Glycine and 
proline are commonly found in turns, due to their conformational freedom and rigidity 
respectively, therefore this hypothesis is very reasonable.  The IMD has been shown to be 
membrane embedded using a carbonate extraction method, which distinguishes surface 
associated membrane proteins from integral membrane proteins 71,72.  Analysis of the 
primary sequence using transmembrane prediction software indicates that caveolin-1 has 
an unusually long 33 amino acid stretch that is predicted to be membrane embedded 
because it is predominantly populated with aromatic and aliphatic amino acids (Figure 1-
6). 
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Figure 1-6.  Hydropathy plot generated using the primary sequence of caveolin-1.  The 
predicted 33 amino acid transmembrane sequence is indicated (red) and spans residues 
102-134. 
 
This differs from the length of most single spanning transmembrane helices which are 
20-25 amino acids in length. 
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Therefore, caveolin is too long to span the bilayer once but too short to span the 
bilayer multiple times.  Essentially, this sequence analysis inferred two models, one in 
which the long 33 amino acid stretch was highly tilted and traversed the bilayer as a 
single spanning α-helix, or one where the N- and C- termini rested on the same side of 
the membrane and would require a dramatic turn within the transmembrane sequence.  
The first study that examined the directionality of the termini used cell surface 
biotinylation probes and pointed to a single spanning α-helix with the N-terminus being 
cytoplasmic and the C-terminus resting outside of the cell 73.  Around the same time, a 
competing group performed studies that probed the location of the N- and C- termini 
using in vivo immuno-fluorescence.  The immuno-fluorescence study failed to see 
labeling of the caveolin protein using antibodies directed to either terminus unless the 
cells were permeabilized, suggesting that both termini are luminal 71.  This issue was 
finally resolved when the biotinylation experiment was revisited and it was determined 
that an impurity in the earlier study was giving a false positive 42.  In support of the 
immuno-fluorescence studies, and finally leading the field to a topological consensus, a 
study where a caveolin-1 construct with glycosylation epitopes at each of its termini was 
translated in vitro in the presence of dog pancreas microsomes was not glycosylated 
(Figure 1-7) 74. 
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Extracellular glycosylation machinery
Dog Pancreas Microsome  
Figure 1-7.  Early glycosylation epitope (asparagine/glycine/threonine) mapping study of 
caveolin-1 indicated that the N- and C- termini were inaccessible using an in vitro 
transcription/translation system.   
 
This meant that neither of the epitopes were accessible to extracellular glycosylation 
machinery, adding support for the termini having an intracellular location.  Combining 
sequence analysis and the aforementioned studies, along with the fact that the protein 
contains no soluble interruptions within its predicted transmembrane sequence, lead to 
the postulation that caveolin may contain an unusual intramembrane turn.  As mentioned 
above, the protein contains a triplet of amino acids at positions 108, 109, and 110 which 
have been shown to be critical to structuring the protein and are implicated as the turn 
region.  Other lines of evidence have suggested that the proline located at position 110 is 
critical to the orientation of caveolin-1 in the bilayer as well 75-77.  When considering that 
proline 110 is conserved across species and isoforms, it is clear that the position must 
play a biologically critical role.  This topic will be explored in later chapters of this work.  
Although the topology of caveolin in the cell has been characterized with respect to the 
location of its termini, many aspects of the topology remain uncharacterized.  For 
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instance, does caveolin automatically adopt the U-shaped topology in membranes, or is 
this conformation controlled by cellular insertion machinery?  Additionally, it is unclear 
where the transmembrane region enters and exits the membrane.  Also, the question as to 
the exposure of the turn region remains unanswered (membrane buried or aqueous 
exposed).  Besides these questions, the importance of specific amino acids within 
caveolins sequence in maintaining the unique topology remains to be an open question 
and one that should be addressed.  Answering these topological questions may help 
explain how this protein influences the curvature of lipid bilayers.  The core objective of 
this work is to draw light on these very pertinent topological ambiguities that surround 
caveolin (Figure 1-8). 
N
C
Intramembrane Turn?
Depth?
 
Figure 1-8.  Cartoon representation of the putative caveolin-1 topology detailing the 
controversy surrounding the protein’s disposition in the lipid bilayer.  Each domain is 
color coded: N-terminal (orange), scaffolding (green), intramembrane (red), and C-
terminal (blue).  Palmitoylation sites are shown in purple. 
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With the N- and C- termini residing on the same side, and no evidence of a 
soluble interruption, this rare motif may have functional consequences in terms of how 
the protein creates membrane curvature, and this idea is strongly supported by the high 
degree of sequence identity of the IMD between species.  Two possible mechanisms of 
how caveolins intramembrane region being inserted with the N- and C- termini on the 
same side could generate membrane curvature include: asymmetric insertion of the 
protein within the bilayer or asymmetric sequestration of cholesterol to one side of the 
membrane 78-80 (Figure 1-9).  Both are plausible models of how caveolin could cause 
negative membrane curvature, and integral membrane proteins containing hairpin turns 
(such as the reticulons) are found to help generate highly curved organelles such as the 
endoplasmic reticulum 81,82.   In the first model, caveolin inserts into the membrane and 
places more of its surface area within the inner leaflet of the membrane than the outer 
leaflet, acting like a wedge (Figure 1-9A).  This would displace more lipids in the inner 
leaflet than the outer and cause an asymmetric stretching effect.  Furthermore, 
oligomerization of caveolin into arrays would exacerbate this action, and could help 
explain the dramatic level of curvature observed in caveolae.  The second possibility 
plays upon the idea that caveolin-1 recruits and holds cholesterol.  Cholesterol has a 
small polar headgroup compared to its hydrophobic region, and this would displace more 
phospholipid tails in the inner leaflet if it were asymmetrically sequestered to it.  Similar 
to the effect of placing a majority of the proteins surface area within one leaflet, this 
would cause an asymmetric bending of the bilayer (Figure 1-9B).  Again, more caveolin 
molecules interacting through oligomerization behavior would result in more cholesterol 
within a confined space and this could enhance the membrane bending.  It is reasonable 
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to consider that the two mechanisms could work together in generating and stabilizing the 
high degree of curvature within a caveola. 
Protein Mediated Membrane 
Bending
Protein and Cholesterol Mediated 
Membrane Bending
A
B
 
Figure 1-9.  Two plausible mechanisms for membrane curvature generation by caveolin-
1. A)  Caveolin asymmetrically perturbs the inner leaflet more than the outer, acting as a 
wedge. B)  Caveolin sequesters cholesterol predominantly to the inner leaflet and disrupts 
the balance of lipids that have large hydrophobic cross sections.  Both mechanisms could 
be enhanced by oligomeric behavior.  Caveolin is represented as two cylinders in a 
wedge-like conformation.  Cholesterol is indicated with its hydroxyl headgroup (grey) 
and hydrophobic portion (blue). 
 
Membrane Proteins and Model Membranes Used in Biophysical Studies 
The biological membrane is comprised of bilayer forming phospholipids, sterols, 
and importantly, about 50% (w/w) of the cell membrane is made up of membrane 
proteins that are critical for survival.  Membrane proteins account for roughly 33% of the 
genome and about 50% or more of drug targets 83-85.  There are a number of different 
types of membrane proteins, and these include: membrane anchored proteins, peripheral 
membrane proteins, and integral membrane proteins.  Membrane anchored proteins are 
those that have been acylated or prenylated at one or more amino acids in their sequence, 
and this post-translational modification is responsible for holding the protein near the 
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membranes surface.  The nature of these modifications is thought to target soluble and 
membrane proteins to specific domains (i.e. caveolae) 86.  Peripheral membrane proteins 
are often associated with the surface of the membrane through electrostatic interactions of 
their charged groups with the polar head groups of the lipid bilayer.  Integral membrane 
proteins, such as caveolin, contain a high percentage of consecutive aliphatic or aromatic 
amino acids which make them extremely insoluble in the aqueous milieu and much more 
at home within the lipid bilayer.  By burying their hydrophobic portions in the bilayer, 
they can avoid the entropic penalty of ordered water surrounding their large non-polar 
surface area.  All of these types of membrane proteins require a lipid bilayer to properly 
study their structure and function because they are very hydrophobic and therefore, will 
often aggregate, precipitate, or adopt irrelevant conformations within purely aqueous 
environments 87-89.  Furthermore, the identity of the lipids is also critical to the proteins 
activity and fold in some cases 90.  The need for a hydrophobic environment for 
membrane proteins has made them very challenging to study and likely contributes to the 
lack of membrane protein structures compared to their soluble counterparts 85. 
 There is a large variety of different systems that can be used to mimic the natural 
plasma membrane environment that membrane proteins require for solubilization, proper 
structuring, and activity.  In this thesis work, three types of membrane mimetic systems 
are used and include: micelles, vesicles, and bicelles, all of which are commonly 
employed for biophysical studies in the field of membrane protein research (Figure 1-10) 
91-96.  Each of these mimics carries with it its own advantages and caveats. 
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Figure 1-10.  Cross sectional views of the three types of native bilayer mimics that are 
typically utilized in membrane protein structure and functional studies including micelles, 
vesicles, and bicelles. 
  
Micelles are aggregates of amphipathic surfactants, which in water place their 
hydrophobic moieties together to avoid the entropic penalty of structured water coverage 
creating an oil droplet that is surrounded by an ionic (sodium dodecylsulfate, lyso-
myristoylphosphatidylglycerol), zwitterionic (dodecylphosphocholine, Empigen BB®), or 
polar headgroup (octyl-β-D-glucoside, Triton-X-100) coating (Figure 1-11).  Micelle 
forming amphiphiles have a large headgroup size compared to their hydrophobic tail 
region and therefore have a cone-like molecular shape, which upon aggregation, allows 
them to support a high degree of curvature, giving the micelles a spherical, prolate, or 
oblate shape 97.  Micelles are typically a few nanometers in diameter.  They are dynamic 
D
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in nature, where a specific concentration of monomeric detergent is required to saturate 
the solution before they start forming aggregates; this parameter is called the critical 
micelle concentration (CMC).  Detergent micelles have been used almost exclusively in 
membrane protein structural determinations by both NMR and X-Ray crystallography, 
are typically used in membrane protein purification procedures, are easy to work with, 
and can support membrane protein function 98-101.  Additionally, the secondary structure 
of membrane proteins is usually preserved in micelles 102.  However, they have 
disadvantages in that they lack a bilayer, limiting them for topological studies examining 
protein depth and orientation.  Micelles also have a much more curved surface than the 
native bilayer; this aspect can have a negative effect on membrane protein conformation 
103.  They allow extensive water penetration, which could disrupt potentially important 
intra- or intermolecular interactions required for specific folding and activity 104.  They 
also cannot support biologically relevant quantities of cholesterol, a molecule which can 
be critical for the structure and function of some membrane proteins 105.  Small amounts 
of phospholipid can often be doped into micelles, and these structures are termed “mixed 
micelles” 106.  Often times, one must optimize the specific properties of chain length, 
headgroup size, and charge to find the most suitable detergent to uphold a specific 
membrane protein’s structure and function 107. 
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Figure 1-11: Various detergents commonly employed in the purification and study of 
membrane proteins. 
 
 Vesicles are spherical, static aggregates that are composed of bilayer forming 
amphipathic molecules with the ability to entrap solutes within their hollow interior.  A 
liposome is a type of vesicle composed of diacylglycerophospholipids, which have a 
glycerol backbone, a phosphate headgroup, and two acyl chains.  The phosphate 
headgroup is linked to the glycerol backbone via a phosphoester bond.  Headgroups on 
phospholipids vary in their charge and size.  In terms of the headgroups on phospholipids, 
eukaryotic organisms are composed of zwitterionic phosphatidylcholine, and 
phosphatidylethanolamine, and to a lesser extent negatively charged phosphatidylserine, 
phosphatidylglycerol, phosphatidylinositol, and phosphatidic acid.  The lipid chains are 
linked to the glycerol backbone via an ester bond.  The chains vary in their length and 
degree of unsaturation.  Typically the lipids in the biological membrane are 16-20 
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carbons in length and have 1 or more sites of unsaturation within their chain.  The 
identity of the headgroup, chain length, and degree of unsaturation contribute to a 
specific melting temperature (Tm) for lipid bilayers.  The Tm is used to describe the degree 
of order in the acyl chain region.  At low temperatures, the acyl chains are fully extended 
and this is called the gel or liquid ordered phase.  At high temperatures, the acyl chains 
are highly mobile and disordered, and this is called the fluid or liquid disordered phase.  
Physically the Tm represents the halfway point between these two states where half of the 
lipid population is ordered and half is disordered.  The Tm of bilayers is a very important 
parameter biologically as it allows embedded proteins to interact.  The fluidity of the 
bilayer can also be modulated by the addition of cholesterol which causes a broadening of 
the Tm (increase). 
The roughly equivalent surface area of the headgroup and chain regions allow 
phospholipids to pack together in a cylindrical fashion, limiting the amount of curvature 
that they can uphold.  Due to the hydrophobic effect, they form roughly planar bilayered 
structures that close to avoid exposure of the planar regions edges to water, and hence the 
spherical shape of the liposome.  Liposomes can have a single bilayer (unilamellar 
vesicles) or like an onion, multiple bilayers (multilamellar vesicles).  Single shelled 
liposomes are typically divided up into three classes depending on their size: small 
unilamellar vesicles (15-50 nm in diameter), large unilamellar vesicles (100-400 nm in 
diameter), and giant unilamellar vesicles (>500 nm).  Advantages to using vesicles 
include their near cell-like dimensions, which reduces curvature induced defects on 
reconstituted proteins, and an actual lipid bilayer.  They also have a distinct interior and 
exterior which can be useful in transport studies on channel forming proteins as well as 
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lysis/fusion assays of membrane proteins that require the release of entrapped solutes to 
observe their activity 108-110.  This property is also important for topological studies, to 
examine a reconstituted protein’s depth and orientation in membranes 111,112.  They can 
incorporate a wide variety of biologically relevant lipids, including cholesterol.  The 
downside to vesicles is that they are often quasi-stable when they are small, tending 
towards fusion.  They scatter significant amounts of light which can be burdensome in 
some spectroscopic techniques.  Additionally, liposomes have not been successfully 
employed for structural determinations of membrane proteins because their large size 
makes them hard to adapt to crystallization and NMR studies.  
 Bicelles are discoidal lipid aggregates that spontaneously form when long chain 
phospholipids (1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)) and short chain 
phospholipids/specific detergent molecules ((1,2-dihexanoyl-sn-glycero-3-
phosphocholine (DHPC), 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHePC), or 3-
[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO)) are 
mixed in aqueous solution  (Figure 1-12) 113,114. 
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Figure 1-12.  Chemical structure of bicelle forming species utilized throughout the 
course of this work. 
 
These structures are characterized by lipid segregation where long-chain phospholipids 
(DMPC and DPPC) form a planar bilayered region and the detergent molecules (DHPC, 
DHePC, and CHAPSO) create a curved rim region packed around the bilayer, shielding it 
from exposure to the aqueous environment.  Similar to micelles, the detergent is in 
exchange with the aqueous environment and there is a critical bicelle forming 
concentration, or CBC.  These structures typically range in size from 2.5 – 20 nm in 
length, and their size is tuned by a property know as q, which is the molar ratio of the 
long-chain lipid to the detergent 94,115,116.  With larger, q values, the length of the 
bilayered region increases, and the disks take on a larger diameter.  This is one way in 
which the tunable nature of bicelles makes them advantageous to use in structural studies.  
For example, a q = 1.0 has a planar bilayered region that is about 147 Å in diameter and 
can support membrane protein behaviors such as oligomerization 113.  Due to the dynamic 
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nature of the detergent, one must consider the overall lipid percentage in the sample.  For 
example, at low lipid percentage in solution, a much greater amount of detergent relative 
to the long chain phospholipid is in exchange, giving rise to a larger q than would be 
expected.  For this reason it is important to prepare bicelles with knowledge of their CBC 
and generate them according to their qeff, ([long chain phospholipid]/([long chain 
phospholipid]total-[long chain phospholipid]free)).  Bicelles can hold a variety of different 
phospholipids, have melting temperatures which are close to that of liposomes composed 
of pure phospholipids, and can contain biologically relevant amounts of cholesterol 
(albeit only at high temperatures) and therefore can mimic the native cellular 
environment nicely 117-121.  Their ability to hold longer chain lipids allows the modulation 
of bicelle thickness.  They can also be loaded with lipids that have negatively or 
positively charged headgroups allowing for modification of their surface charge.  
Additionally, they scatter very little light making them ideal for spectroscopic studies.  
Bicelles have a true bilayer and this allows for topological, functional, and structural 
determinations to be performed on proteins reconstituted into them 93,94,116,122-124.  They 
have disadvantages which include the fact that they cannot be used to determine 
membrane protein orientation, and proteins incorporated into them can be prone to “rim” 
effects (a micelle like environment), especially at low q values.  In most studies q values 
ranging from q= 0.3-3.0 are used, however, low q values are considered to be less 
biologically relevant due to the limited size of the bilayered region and increased 
detergent intermixing, making them more similar to a mixed micelle.  
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Biophysical Methods Used to Characterize Membrane Proteins 
 The characterization of membrane proteins requires not only the study of their 
secondary structure and three-dimensional folds, but also knowledge of their aggregation 
state and their degree of penetration into the bilayer.  The combinations of these 
parameters give an image of a membrane protein which can help explain how it 
functions, and in some cases, a better understanding of the protein can lead to new 
therapeutics or an understanding of disease mechanisms.  For instance, it is now known 
that many membrane receptors bind a variety of ligands through secondary, allosteric 
binding sites.  These secondary binding sites can be utilized to modulate receptor 
selectivity and activity which can bring about dramatic changes in how individuals 
respond to drugs which, without the use of allostery could result in drugs having many 
unintended side-effects 125.  The biophysical study of membrane proteins is critical to 
bring about new developments in the treatment of disease. 
 Although the secondary structure of proteins can be characterized by a number of 
techniques, in this body of work, the most common method used is circular dichroism.  
Circular dichroism examines how molecules absorb right and left handed circularly 
polarized light differentially, and is due to presence of chirality.  The peptide bond has 
slight double bond character and therefore contains a weak but broad n→π* transition 
around 220 nm and a somewhat stronger π→ π* transition at 190 nm.  Because the α-
helix motif in proteins is a chiral structure, it absorbs right and left handed polarized light 
very differently than the other major structural motifs in proteins (maxima at 190 nm and 
minima at 208 nm and 222 nm).  The β-sheet also has its own characteristic absorption 
profile (minimum at 217 nm) 126.  Furthermore, the α-helix and β-sheet give rise to 
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different spectral signatures than the random coil secondary structure (minimum at 204 
nm).  Many proteins contain a mixture of these different secondary structure motifs.  
With information of the proteins concentration and circular dichroism spectra, the 
contributions of different secondary structure motifs can be estimated using prediction 
algorithms and can yield specific information about how much α-helical, β-sheet, and 
random coil character a polypeptide contains. 
Circular dichroism can also yield qualitative information about the tertiary 
structure of proteins by examining the 260-320 nm region, and is referred to as the near 
ultraviolet (UV) CD 126.  The absorption of light in this region is due to the presence of 
tryptophan, tyrosine, and phenylalanine residues.  Each one of these residues gives rise to 
region specific peaks in a CD spectrum at 290-305 nm (primarily tryptophan), 275-282 
nm (primarily tyrosine), and 255-270 nm (phenylalanine).  These features can be 
considered as a “fingerprint” of the tertiary structure (due to the functional groups being 
held asymmetrically) and can be used to compare protein mutants, truncations, or lipid 
environments in terms of their structural impact.  However, this method is not advanced 
enough to give specific structural information one would obtain from solution NMR or 
X-ray crystallography.  Nonetheless, examination of the near UV spectra remains useful 
for comparisons sake. 
Another important method that can be employed to gain insight into the topology, 
dynamic behavior, membrane organization, and oligomeric behavior of a protein is 
fluorescence spectroscopy 127.  These studies require either the use of the naturally 
fluorescent amino acids (tryptophan, tyrosine, and phenylalanine), expression of 
fluorescent protein fusion constructs to the protein of interest (i.e. green fluorescent 
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protein), or the conjugation of a fluorescent molecule such as dansyl or fluorescein by 
covalent bond formation to the species of interest 128,129.  Fluorescence occurs when an 
electron within a chromaphore is excited by a particular wavelength of light.  This 
electron then relaxes back to its ground state after some time being excited, the average 
time a fluorophore spends in its excited state is known as the fluorescent lifetime (Figure 
1-13).  Rather than going through non-radiative decay, when a molecule fluoresces a 
photon is released, usually at a lower frequency than the photon that was absorbed (The 
frequency change is known as the “Stoke’s shift”).  With an environmentally sensitive 
fluorophore, the process can yield information about the micro-environment surrounding 
the molecule as fluorescence lifetimes are typically linked to dynamic processes that are 
occurring locally.  This is only true if the dynamic process occurs within the lifetime of 
the excited state (fluorescence lifetimes typically range from μsec-nsec, tryptophan 
fluorescence usually ranges from 0.1-8 ns) 127,130. 
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Figure 1-13.  Simplified Jablonski diagram.  Absorption of a photon by a fluorophore 
excites an electron from its ground state (S0) to the excited state (S1).  The excited 
electron then relaxes to the lowest vibrational state of S1 on a fast timescale.  The electron 
then falls back to its ground state giving off a photon of lower frequency. 
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Using the native fluorophore tryptophan for fluorescent studies of proteins has 
many advantages.  One particular advantage is that tryptophan can be selectively excited 
over the other fluorescent amino acids by irradiation using the 295 nm wavelength (the 
red edge of the tryptophan’s excitation spectrum).  In doing so, the emission spectrum 
will yield information specific to the environment surrounding the sequence location of 
tryptophan groups.  Another is that tryptophan is an environmentally sensitive 
fluorophore.  This is owed to the fact that there is large electron density redistribution in 
the asymmetric indole ring after the absorption of a photon that leads to a significant 
dipole moment compared to tryptophan in its ground state 131.  Once in the excited state, 
solvent-solute, or solute-solute interactions can occur that change the emission peak 
shape or emission maximum.  These spectral properties are easily recorded using a 
fluorometer and can be determined by fitting the spectrum of the protein to a log-normal 
equation (equation 1-1): 
ܫ(λ) = ܫ0݁ݔ݌ ቈ ݈݊2݈݊2ߩ ݈݊2 ቆ1 + (ߣ − ߣ݉ܽݔ )(ߩ2 − 1)ߩГ ቇ቉ 
 
where I0 is the intensity observed at the wavelength of maximum intensity (λmax), Г is the 
peak width at I0/2 (peak shape), and ρ is the asymmetry of the peak 132,133. 
The λmax of tryptophan ranges from 308-360 nm depending on the environment.  
For instance, upon the dipole reorientation of tryptophan, the organization of solvent 
molecules around tryptophan in its excited state may be perturbed and causes a shift in 
the λmax of the protein.  Generally, factors that contribute shifts are described by the 
modified Lippert equation (equation 1-2): 
∆ݒ ≈  |∆ߤ|2 ቈ2(− 1)2 + 1 − 2(݊2 − 1)2݊2 + 1 ቉ ܨ ߬ܨ ߬ + ܴ ߬  
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This equation relates the spectral shift in wave numbers (∆ν) between the excited and 
ground state to changes in the dipole moment (∆μ), the dielectric constant of the medium 
(), the time of dipole relaxation of the tryptophan (TR) in comparison to the lifetime of 
fluorescence (TF).  In the most simplistic sense when it comes to interpreting the location 
of tryptophan groups within membranes, the dielectric constant is a major factor.  For a 
tryptophan buried in the membrane (small ), the stokes shift would be less than that for a 
tryptophan buried in the aqueous environment (large ).  However, due to the complexity 
of interactions that can occur within protein microenvironments, and the typical scenario 
where a protein contains more than one tryptophan, the degree of spectral shift alone 
must be interpreted carefully alongside orthogonal techniques. 
When considering proteins containing only one tryptophan residue, the emission 
spectra typically fall into three categories 134-136.  The most red shifted spectra, having 
λmax values ranging from 346-350 nm (Class III) are considered to be aqueous exposed.  
The most blue-shifted spectra, having λmax values ranging from 330 -333 nm (Class I) are 
considered to be buried deeply within the tertiary structure of a protein or a lipid bilayer.  
In between these two classes, a tryptophan group with an emission that ranges from 340-
344 nm (Class II) would be considered to be located at interfaces such as the one between 
the aqueous environment and the hydrophobic core of the membrane.  These classes are a 
result of many investigations into the location of tryptophan’s within both soluble and 
membrane proteins, where the majority of cases contain species within these discrete 
states of fluorescent emission.  By no means do these narrow definitions capture the full 
range of emission spectra possible, as hybrids of classes, which reflect conformational 
flexibility, phase, and oligomeric distributions, can be observed.  The shape of the peak is 
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also important, where Г can give information about the heterogeneity of the distribution 
of fluorophores 133.  For instance, if two different proteins each have a single tryptophan 
with the same λmax but different Г values, the protein with a larger Г could be in multiple 
conformations, or showing other dynamic behaviors. 
 Another method employing fluorescence spectroscopy utilizes the ability of 
particular substances to quench fluorescence.  A number of species can quench 
tryptophan including acrylamide, cobalt, and iodide.  The mechanism of fluorescence 
quenching is not entirely understood, but for halogens such as iodide, it is thought that 
intersystem crossing to an excited triplet state is promoted by spin-orbit coupling of the 
excited fluorophore and the halogen.  In the triplet state, the emission from the 
fluorophore becomes slow and may be quenched by other processes 127.  Quenching can 
be dynamic or static in nature.  Dynamic quenching results from diffusion mediated 
collision between the fluorophore, whereas static quenching is a result in the formation of 
a complex with the fluorophore.  Methods of telling the two apart from one another 
include performing quenching experiments at various temperatures and looking at the 
trend.  With static quenching, complex formation is typically less favored at higher 
temperatures and the amount of quenching decreases whereas collisional quenching is 
enhanced due to the increased rate of collisions.  Collisional quenching is described by 
either the Stern-Volmer equation for quenching or the modified Stern-Volmer equation.  
Upon successive additions of quencher, tryptophan fluorescence is quenched at different 
efficiencies depending on its chemical environment.  This technique is used for 
tryptophan groups which are buried within the core of a folded protein, as well as those 
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which are buried within a biological membrane 137.  The Stern-Volmer equation (equation 
3) takes the form: 
ܫ0
ܫ
= 1 + ܵܭ ܸ[ܳ] 
 
where I0 and I are the initial fluorescence and fluorescence after addition of quencher 
respectively, KSV is the Stern-Volmer quenching constant of the entire population of the 
fluorophores (KSV is the concentration in which 50% of the total fluorescence intensity is 
quenched, and is the product of the bimolecular quenching kq constant and the lifetime of 
the fluorophore in the absence of the quencher, τ0), and [Q] is the concentration of 
quencher.  However, if the plot is not perfectly linear and deviates towards the x-axis, 
then this is indicative of there being an accessible and buried fraction of fluorophores.  
Stern-Volmer quenching curves generated from the quenching data can also be fit to a 
double reciprocal plot (Modified Stern-Volmer plot, equation 1-4) that assumes a buried 
and accessible population to give: 
ܫ0
ܫ0 − ܫ = 1݂ܽ ܭܽ [ܳ] + 1݂ܽ  
 
where I0 and I are the initial fluorescence and fluorescence after addition of quencher 
respectively, Ka is the Stern-Volmer quenching constant of the accessible fraction (Ka is 
the concentration in which 50% of the fluorescence intensity of the accessible fraction is 
quenched), fa is the fraction of the initial fluorescence that is accessible to the quencher, 
and [Q] is the concentration of quencher.  The fa value is useful and can be used much 
like λmax to interpret the location of tryptophan residues, where more highly exposed 
tryptophan residues will have fa values approaching 1 and tryptophans deeply embedded 
within a hydrophobic matrix such as the lipid bilayer will have fa values that approach 0.  
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However, fa values can have a large degree of error associated with them as the 
measurement extrapolates to an infinite quencher concentration (the y-intercept 
represents quenching at an infinite quencher concentration, as [Q]→∞,	the	ϐirst	term	in	equation 1-4 becomes ~0), far away from the practical concentrations used within 
experiments.  Nonetheless, the fa value can be more useful than KSV when comparing 
different constructs, as it does not require knowledge of the fluorescence lifetime for 
interpretation. 
 Another useful fluorescence technique which is used to give information about 
the conformational freedom of a fluorophore is fluorescence anisotropy.  When a 
fluorophore is excited with polarized light, the emission can also be polarized 127.  The 
amount of the emission that maintains polarization is described by its anisotropy (r).  
Anisotropies greater than zero are observed if some of the population of the fluorophores 
have their absorption transition moments oriented along the electric vector of the incident 
light.  If the molecules are randomly oriented, then there is no preferential excitation due 
to the polarized light and anisotropies close to zero are observed.  Anisotropy can be 
determined by a comparison of the measured intensity of emitted light from a sample 
which has been excited by vertically and horizontally polarized light (with respect to the 
z-axis).  Anisotropy is given by the equation (equation 1-5): 
ݎ = ܸܫ ܸ − ܩܸܫ ܪ
ܸܫ ܸ − 2ܩܸܫ ܪ  
 
where IVV and IVH are the emitted intensities of the fluorophore with the excitation 
polarizer oriented vertically and the emission polarizer oriented vertically or horizontally 
respectively, and G is the G-factor which is the ratio of sensitivities for vertically and 
horizontally polarized light (defined as IHV/IVV). 
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 Finally, fluorescence resonance energy transfer (FRET) can also be used to give 
information about fluorophores in solution.  In this technique, an initially excited donor 
molecule (D) is excited using incident light and gives off an emission.  If this emission 
spectrum overlaps with another fluorophore’s excitation spectrum, the second 
fluorophore can then be an acceptor (A) and will undergo an emission.  The transfer of 
energy that causes the acceptors emission is a photonless event and is highly dependent 
on the distance between the two species (there is an R6 dependence on the efficiency of 
this transition event).  Most FRET events are 50% efficient in the 20-60 Å range making 
this technique a useful molecular ruler for macromolecular distance measurements 127.  
The efficiency of an energy transfer event is measured using the fluorescence intensity of 
the donor in absence and presence of the acceptor and is described by the following 
equation (equation 1-6): 
ܧ = 1 − ܨܦܣ
ܨܦ
 
 
Where FDA and FD are the fluorescence intensity of the donor in the presence and absence 
of the acceptor, respectively.  If one has knowledge of the R0 value for a given donor 
acceptor pair, an estimate of distance can be made from the following equation (equation 
1-7): 
ܧ = ܴ06
ܴ06 + ݎ6 
 
Where E is the FRET efficiency, R0 is the radius of 50% transfer efficiency and r is the 
distance (reliable only within 2R0). 
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Chapter 2.  Development of Perfluorooctanoic Acid as a Tool for Vesicle 
Formation and Caveolin-1 Topology Analysis 
 
ABSTRACT 
 
The study of membrane proteins has become a major research interest because 
they have a central role in maintaining proper cellular function and also have potential as 
targets in the treatment of disease states.  A major challenge in working with recombinant 
membrane proteins is their reconstitution into a biologically relevant lipid bilayer 
environment where they achieve a refolded state and are functionally active.  The 
detergent dialysis technique, which utilizes mixtures of egg phosphatidylcholine with 
protein dissolved in cholate or octylglucoside, is often used to incorporate membrane 
proteins into lipid vesicles.  Although useful, these lipid-detergent systems are not able to 
reconstitute highly pure, insoluble membrane proteins such as caveolin-1.  The failure of 
these commonly used detergents in reconstituting caveolin-1 warranted the use of novel 
lipid-detergent mixtures.  The removal of perfluorooctanoic acid (PFOA) from mixtures 
of phosphatidylcholine and PFOA results in the formation of small unilamellar vesicles 
with a hydrodynamic radius of approximately 11 nm.  The presence of vesicles was 
confirmed by gel filtration, dynamic light scattering, and glucose entrapment.  Increasing 
the amount of sodium chloride in the dialysate leads to the formation of larger vesicles 
with a hydrodynamic radii ranging from 12-70 nm.  Moreover, cholesterol can be 
incorporated into the vesicles (up to 40% by mol).  Using this method, various caveolin-1 
constructs can be effectively reconstituted into vesicles.  Evidence of incorporation of the 
caveolin-1 protein into vesicles with or without cholesterol was shown by gel filtration 
followed by Western blot analysis.  Sodium carbonate extraction methodologies showed 
 36 
 
that the reconstituted protein was embedded within the bilayer.  Consistent with caveolin 
being a non-pore forming peptide, a real time entrapment study showed that the 
permeability of entrapped solutes was not markedly enhanced by the incorporation of the 
protein into vesicles.  A limited proteolysis assay to examine the topology of 
reconstituted caveolin-1 was developed and showed a mixed topology where 60 % of 
reconstituted caveolin-1 was present as a single spanning membrane helix and 30% of the 
protein was present with a native topology with the N- and C- termini on the same side of 
the membrane. 
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INTRODUCTION 
 
The cell membrane is composed of a phospholipid bilayer that is enriched with 
membrane proteins.  Biological membranes typically contain approximately 50% protein 
content by weight.  Membrane proteins have a myriad of cellular functions including 
selective transport, catalysis, and signal transduction.  They also play a role in the 
structure and architecture of cellular membranes 138.  The utility of membrane proteins 
has not gone unnoticed by organisms, where approximately 33% of most genomes 
encode for these proteins 31.  Membrane proteins are difficult to characterize in terms of 
their structure and function due to obstacles in expression and solubility.  For this reason, 
unique approaches must be taken to study these highly insoluble proteins. 
Detailed characterization of membrane protein structure and function in vitro 
requires reconstitution of the protein into phospholipid environments that mimic the 
native bilayer.  Unilamellar vesicles are often used to meet these ends because they have 
a single bilayer shell and can be constructed using mixtures of natural lipids such as egg 
yolk phosphatidylcholine (EYPC) 139.  Vesicles are static and hollow giving them a 
distinct interior and exterior that is similar to the cell, making them ideal for the 
topological characterization of reconstituted membrane proteins.  Additionally, vesicles 
are amenable to the incorporation of biologically relevant amounts of cholesterol which 
may be important for maintaining the structure of some membrane proteins 140. 
Detergents can be used to solubilize membrane proteins and lipids, and their 
subsequent dialysis results in the formation of unilamellar vesicles.  In many cases, β-D-
octylglucoside, or sodium cholate are the detergents of choice in vesicle formation for 
membrane protein reconstitution, as they are mild and non-denaturing 96,141.  Although β-
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D-octylglucoside and sodium cholate are useful for the solubilization of membrane 
proteins that already exist in lipid-protein complexes, or membrane proteins which have 
amphipathic characteristics, these mild detergent are not powerful enough to solubilize 
extremely hydrophobic membrane proteins such as caveolin-1, the principle protein 
component of cholesterol rich membrane invaginations known as caveolae.  
Perfluorooctanoic acid (PFOA) is an octanoic acid analogue where the aliphatic 
hydrocarbons have been replaced by fluorine atoms (Figure 2.1).  PFOA has been shown 
to be effective for the solubilization of various membrane proteins 142.  In addition, 
fluorous surfactants have also been shown to be an effective aid in refolding experiments 
using soluble proteins 143,144.  For these reasons, PFOA was investigated in its use as a 
detergent that could both solubilize caveolin-1 and facilitate its reconstitution into 
vesicles.  Advantageously, the adoption of the native fold of caveolin-1 can be evaluated 
by probing the location of its termini; the natively folded protein would maintain the 
hallmark feature of the protein where the N- and C- termini are coincident to the same 
side of the membrane.  Therefore, caveolin serves as an excellent test case for the 
development of the PFOA dialysis method as a way of refolding membrane proteins. 
 
 
Figure 2-1.  Chemical structure of PFOA. 
 
In this chapter, PFOA is shown to be a detergent that can produce vesicles by the 
dialysis of EYPC-PFOA mixtures.  The vesicles were formed in the presence of sodium 
chloride and cholesterol, and the effect of these solutes on vesicle size was examined by 
gel filtration and dynamic light scattering (DLS).  It was found that the addition of 
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sodium chloride allows for size tuning of the vesicles (11-77 nm) and that cholesterol can 
be incorporated into vesicles at physiologically relevant concentrations.  Static light 
scattering (SLS) was used to show that the vesicles were hollow spheres.  Additionally 
the vesicles have the ability to entrap solutes in the absence and presence of caveolin.  It 
was demonstrated that a caveolin-1 construct containing the complete membrane 
interacting domain (residues 62-178), a portion which has been shown to dictate many of 
the protein’s critical functions in vivo, can be reconstituted into lipid vesicles using PFOA 
145.  Upon PFOA mediated reconstitution, caveolin-1 behaved as an integral membrane 
protein when evaluated using the method of carbonate extraction.  The addition of the 
protein was shown to cause a slight increase in the leakage rate of entrapped contents, 
consistent with a modest degree of bilayer disruption.  A limited proteolysis method 
revealed a mixture of topologies upon reconstitution, with the majority of the protein 
(~60%) being in a misfolded, transmembrane orientation with the N- terminus located on 
the interior of the vesicle and the C-terminus located on the exterior and the remainder of 
the population was fully exposed to cleavage by the protease.  Although this attempt to 
refold the protein was met with limited success, the results indicate that that a complex 
set of biological conditions are likely critical to forming caveolins hallmark topology.  
Nonetheless, the detergent dialysis approach using PFOA-lipid-protein mixtures will 
serve as a general method for the reconstitution of membrane proteins into lipid vesicles. 
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MATERIALS AND METHODS 
 
Vesicle Formation 
 
Typically, 50 mg of EYPC (Avanti Polar Lipids, Alabaster, AL) dissolved in 
chloroform was dried down to a film under a stream of nitrogen with gentle heating at 
37°C in a 10 mL glass vial.  Next, a buffer containing 300 mM PFOA (Oakwood 
Products, West Columbia, SC), 10 mM Tris-HCl pH 8.0 was added to the EYPC to 
achieve a final lipid concentration of 20 mM.  The mixture was then sonicated until it 
became transparent.  For samples containing cholesterol, cholesterol (Avanti Polar 
Lipids, Alabaster, AL) was added at 5, 20, and 40 mol % while maintaining the final 
concentration of EYPC and cholesterol at 20 mM.  The resulting solution was then added 
to a 10 kD MWCO slide-a-lyzer G2 dialysis cassette (Thermo scientific, Rockford, IL.), 
and was dialyzed against 2 L of 10 mM Tris-HCl pH 8.0 with various concentrations of 
NaCl added which did not exceed 150 mM.  The mixture was dialyzed for three days 
with buffer exchanges every 24 hours to ensure complete removal of PFOA. 
 
Protein Expression, Purification, and Mutagenesis 
 
 For these studies, the gene encoding for a biologically relevant caveolin-1 
construct containing residues 62-178 flanked by double antibody epitopes (HSV and 
FLAG) on both the N- and C- termini was purchased from Genscript Corporation 
(Piscataway, NJ) (HSVFLAGCav162-178) 145.  The primary sequence is indicated in Appendix 
2-1.  The underlined portion denotes residues 62-178 of caveolin-1.  A few conservative 
mutations were made to the native protein sequence and are indicated by bolding.  Three 
sites of palmitoylation, at positions 133, 143, and 156, which are not essential to 
caveolin-1 trafficking to the membrane were mutated to serine to avoid disruptive and 
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biologically irrelevant disulfide bonding 35.  Additionally, a non-conserved methionine at 
position 111 was mutated to leucine based on sequence homology to caveolin-3 in order 
to facilitate separation of the protein from the TrpLE protein used to direct protein 
expression into inclusion bodies.  The protein was cloned into according to the 
methodologies described in Diefenderfer et al 146,147.  Specifically, the protein was cloned 
into a pET24a between BamHI and EcoRI restriction sites, downstream from a gene 
encoding for the Trp leader protein (cloned between NdeI and BamHI). 
Truncated versions of HSVFLAGCav162-178 were generated to create a ladder for use 
in sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) experiments 
that reflected the molecular weight shifts of our construct after treatment with 
enterokinase.  All mutant constructs were prepared using the Quik change site-directed 
mutagenesis kit (Agilent Technologies, Santa Clara, CA).  To mimic the N-terminal 
cleavage of the protein by enterokinase, a methionine residue was placed immediately 
after the N-terminal FLAG site, therefore, the HSV-FLAG portion would be removed 
during the protein preparation by CNBr cleavage (see Diefenderfer et al).  To mimic the 
C-terminal cleavage of the protein by enterokinase, a stop codon was inserted 
immediately after the second FLAG cleavage site.  Doubly truncated Cav162-178 was 
generated using a combination of the two mutations above.  Primers were designed using 
the free web-based primerX program (Bioinformatics.org).  Primer sequences are 
indicated in Appendix 2-2.  The PCR conditions utilized to generate mutant constructs 
are described in Appendix 2-3.  Following PCR, 1 μL of DpnI (New England Biolabs, 
Ipswich, MA) was added to the reaction test tube and the reaction was incubated at room 
temperature overnight.  This allowed digestion of methylated DNA, ridding the reaction 
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mixture of the template.  Transformation of the mutant plasmid was accomplished as 
described in Appendix 2-4 by adding 1 μL of reaction mixture to 50 μL ultra-competent 
XL-1 Blue E. coli cells.  All constructs were confirmed to be correct by DNA 
sequencing. 
The plasmid was transformed into BL21DE3 cells for expression of the protein as 
described in Appendix 2-4.  The protein was expressed using the auto-induction protocol 
described by Studier et al 147.  Briefly, cells were grown from a glycerol (15%) freezer 
stock in MDG media (Appendix 2-5) for 16-24 hours.  After this time period, a 1:1000 
dilution of the culture was made into 1L ZYM-5052 media (Appendix 2-5).  The growths 
were harvested by centrifugation at 5000 x g for 30 minutes at 4°C after the exponential 
growth phase (typically 10-16 hours, denoted by the leveling out of the optical density at 
600 nm for the culture). 
Purification of HSVFLAGCav162-178 to homogeneity was carried out akin to 
Diefenderfer et al with slight modification.  The cell pellet was first washed using 0.9% 
(w/v) saline solution at a volume that was 20% of the original culture volume.  Next, the 
pellet was taken up into 400 mL of a buffer composed of 20% (w/v) sucrose dissolved in 
10 mM Tris-HCl, pH 8.0.  The pellet was homogenized using sonication for 15 minutes 
at 4℃.  The lysate was then centrifuged at 27,500 x g for 2 hours at 25℃.  The pellet was 
then taken up into 400 mL of 1% (v/v) Triton-X-100 and the sonication/centrifugation steps were repeated.  The next step was a modification to the method by 
Diefenderfer et al, in place of three 400 mL Tris-HCl washes after spinning down triton-
X-100 insoluble Trp-Leader HSVFLAGCav162-178 inclusion body pellets, a single 400 mL 
wash using a buffer containing 40% isopropyl alcohol, 50 mM Tris-HCl wash was 
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utilized.  The pellet was sonicated into this buffer at a duty cycle of 40 % and an output 
of 5 for 15 minutes at 4°C with rapid stirring.  The inclusion bodies were then re-pelleted 
by centrifugation at 27,500 x g for 2 hours at 4°C.  The pellet was then subjected to 
cyanogen bromide cleavage (0.2 g CNBr) to remove the Trp leader fusion partner and 
was subsequently isolated using reverse phase high performance liquid chromatography 
(HPLC).  The chromatographic conditions were 80% water/20% acetic acid going to 80% 
n-butyl alcohol/20% acetic acid at a 1%/minute gradient using a Phenomenex (Torrance, 
CA) C4 Jupiter column with a 15 μm particle size.  The resultant peak was dried down 
using a SpeedVac® concentrator.  The resulting film was dissolved in 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP) at a concentration of 0.5 mg/mL and was lyophilized 
overnight.  Aliquots were stored at -20°C until use.  All protein concentrations were 
determined using a micro BCA assay kit (Thermo scientific, Rockford, IL).  The identity 
of the protein was confirmed using matrix assisted laser desorption-ionization time of 
flight mass spectrometry (MALDI-TOF). 
 
Reconstitution of HSVFLAGCav162-178 into Phospholipid Vesicles 
Lyophilized HSVFLAGCav162-178, was dissolved in 300 mM PFOA, 10 mM Tris-
HCl pH 8.0 to a concentration of 1 mg/mL.  The appropriate volume of the 1 mg/mL 
HSVFLAGCav162-178 stock was added to the lipid-detergent solution (discussed in the section 
above) so that the HSVFLAGCav162-178 to lipid ratio was 1:6000.  All other steps were 
carried out as described above.  For experiments containing HSVFLAGCav162-178, 0-150 mM 
NaCl was included in the dialysis buffer. 
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Gel Filtration Experiments 
For gel filtration experiments, a 3 mL preparation of vesicles was concentrated 
down to 600 μL using an Amicon ultrafiltration unit (10 kD MWCO) (Thermo scientific, 
Rockford, IL.).  Next, the sample was passed through a Versapore 5 μM syringe filter to 
remove any large particulates.  The sample was injected onto a Sepharose 4B column 
equilibrated with 10 mM Tris-HCl pH 8.0, 150 mM NaCl.  The elution of vesicles was 
monitored using a refractive index detector. 
 
Sodium Carbonate Extraction 
After forming the HSVFLAGCav162-178 containing vesicles, a 600 μL sample was 
diluted to 1.75 mL using ice cold 100 mM Na2CO3 pH 11.5.  The vesicles were then 
incubated on ice for 30 minutes.  After this time period, the sample was spun 193,911 x g 
at 4 °C for 2 hours with a Beckman L8-55M ultracentrifuge using a Beckman SW 55 Ti 
rotor.  The pelleted lipid was then washed with 1.75 mL ice cold water and was 
centrifuged at 193,911 x g at 4 °C for an additional 10 minutes.  The sample was then re-
suspended into 10 mM Tris-HCl pH 8.0.  A small amount of this stock was then diluted 
to an expected Cav162-178 concentration of 10 μg/mL using SDS loading buffer, assuming 
that all the protein would be associated with the pellet.  The sample was analyzed by 
SDS-PAGE followed by Western blotting, as described in proceeding sections to detect 
the presence of HSVFLAGCav162-178. 
 
Entrapment Assays 
Vesicles were prepared as described previously except 90 mg/mL glucose with 
either 100 mM NaCl for non-protein containing vesicles, or 50 mM NaCl for 
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HSVFLAGCav162-178 containing vesicles, was included in the dialysis buffer.  The last 
dialysis exchange was performed at 4°C.  After dialysis, the external buffer was 
exchanged quickly using a 2 mL Zeba® spin (Thermo Fisher, Rockford, IL) desalting 
column equilibrated with 10 mM Tris-HCl pH 8.0, 150 mM NaCl.  Next, a 180 μL 
aliquot of vesicles was lysed using Triton-X-100 added to a final concentration of 1.0%.  
After 30 minutes, the glucose content was measured using a standard enzymatic glucose 
assay.  A vesicle free solution containing 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 90 
mg/mL glucose was used as a control.  The amount of phospholipid in the sample was 
determined by the method of Stewart 148. 
Leakage over time was examined qualitatively by the entrapment of glucose-6-
phosphate which cannot permeate the bilayer passively (glucose can).  Vesicles were 
formed as described above except 1.3 mg/mL glucose-6-phosphate (Alfa Aesar, Ward 
Hill, MA) with either 100 mM NaCl for non-protein containing vesicles, or 50 mM NaCl 
for HSVFLAGCav162-178 containing vesicles, was included in the dialysis buffer.  After 
dialysis the external buffer was exchanged quickly using a 500 μL Zeba® spin desalting 
column equilibrated with 10 mM Tris-HCl pH 8.0, 150 mM NaCl.  This step was 
repeated to ensure complete removal of the sugar.  Next, 70 μL of a standard glucose-6-
phosphate assay mixture was added to the 30 μL of the vesicle preparation giving a final 
concentration of the following reagents, 1 mM MgCl2, 25 μM NADP+ (Sigma Aldrich, 
St. Louis, MO), 500 μM 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
terazolium (Dojindo Molecular Technologies, Rockville, MD), 7 μM 1-Methoxy-5-
methylphenazinium methyl sulfate (Sigma Aldrich, St. Louis, MO), 200 mU/mL glucose-
6-phosphate dehydrogenase (Sigma Aldrich, St. Louis, MO), 40 mM Tris-HCl pH 8.5 149.  
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The absorbance at 440 nm was monitored versus time for 400 minutes.  The contents 
were then released by lysis of the vesicles using Triton-x-100 added to a final 
concentration of 1%.  The absorbance was then monitored for an additional time period, 
to obtain the signal for the completely processed vesicular contents.  
 
Dynamic/Static Light Scattering Experiments 
DLS and SLS experiments were employed to estimate vesicle size and shape.  For 
these experiments, 100 μL of vesicles were diluted into 2.5 mL of distilled water in a 
glass scintillation vial.  Three or more measurements were obtained for each sample, and 
the results were averaged.  All experiments were carried out at 25°C.  For these 
experiments the viscosity and refractive index were assumed to be that of water, having 
values of 0.8900 cP and 1.332 respectively. 
For these experiments a Brookhaven Instruments LLS spectrometer equipped 
with a solid state laser operating at 532 nm was used.  The scattered light from the sample 
was detected at 90°.  Size information was obtained using a 9000AT multi-channel 
correlator.  The field correlation function was analyzed to determine the translational 
diffusion constant by the constrained regularized CONTIN method to yield the 
hydrodynamic radius (Rh) from the Stokes-Einstein equation (Equation 2-1): 
ܴℎ = ݇T6D 
 
Where k is the Boltzmann’s constant, T is the temperature,  is viscosity of the solvent, 
and D is the diffusion constant. 
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For static light scattering experiments, a commercial ALV/CGS3 goniometer 
dynamic light scattering system equipped with solid state HeNe Laser operating at 632.8 
nm was used.  The Rh was determined at angles ranging from 50-135° at 5° increments 
using 3 × 10s measurements.  Three lipid concentrations were analyzed from a 
preparation of vesicles that had 100 mM NaCl in the dialysis buffer (400, 200, and 100 
μg/mL total lipid).  Measurements were repeated three times at each concentration of 
lipid utilized.  The refractive index and viscosity were taken to be that of water and the 
d/dc (change in RI as a function of concentration) was assumed to be 0.16.  ALVSTAT 
software was utilized to generate a Zimm plot 150 in order to obtain the radius of gyration 
(Rg) from extrapolation of the Kc/R versus q2 line to a concentration of zero using the 
following equation (Equation 2-2): 
 
where K is an optical constant, c is the mass concentration of particles scattering in 
solution, Mw is an estimate of the particles molecular weight, and R is the normalized 
scattering ratio. 
 
Western Blot Analysis 
HSVFLAGCav162-178-containing vesicles were diluted to a protein concentration of 
10 μg/mL using Lamelli loading buffer.  The sample was centrifuged at 20,000 x g for 3 
minutes, followed by heating at 100 °C for 3 minutes.  The protein was resolved on a 
15% acrylamide gel for 20 minutes at 100 V and then 150 V for an additional 80 minutes.  
Protein bands were transferred to a 0.2 μm nitrocellulose blot paper and washes were 
ܭܿ
ܴ
= 1
ܯݓ(1 − 13ܴ2݃ݍ2) + 2ܣ2ܿ 
 48 
 
performed according to well established protocols.  Alkaline phosphatase conjugated 
anti-FLAG (Sigma, St. Louis, MO) was used as the primary antibody for detection of the 
protein bands.  The protein bands were visualized by development with the NBT-BCIP 
colorimetric reagent.  Images were collected using the Biorad Gel Doc XR+ and band 
densities were analyzed using Biorad’s Image Labs software (Biorad, Hercules, CA). 
 
Protease Protection Assay 
HSVFLAGCav162-178-containing vesicle solutions were diluted to a protein 
concentration of 10 μg/mL using 10 mM Tris-HCl pH 8.0, 50 mM NaCl.  50 μL of the 
diluted sample was treated with 2 ng of enterokinase light chain.  The reaction was left to 
proceed for 5 hours at room temperature.  The enterokinase cleavage reaction was 
terminated by the addition of 100 mM phenylmethylsulfonyl fluoride to 1 mM for a five 
minute incubation period.  The samples were then subjected to Western blot analysis 
described in the previous section. 
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RESULTS AND DISCUSSION 
 
Characterization of Vesicle Formation using Gel Filtration Chromatography, 
Dynamic/Static Light Scattering, and Entrapment of Solutes 
The detergent dialysis technique has been successfully employed to reconstitute 
membrane proteins into vesicles.  Membrane proteins are typically solubilized using 
detergents such as octylglucoside, deoxycholate, and Triton X-100 which are amenable to 
the detergent dialysis method 151.  Unfortunately, the detergents commonly used to 
solubilize membrane proteins for reconstitution aren’t powerful enough to completely 
solubilize and de-aggregate the caveolin-1 transmembrane domain.  Highly pure, de-
lipidated Cav162-178 is soluble into 300 mM PFOA at concentrations up to 3 mg/mL.  
Moreover, PFOA can readily solubilize lipids.  Advantageously, PFOA has a high CMC 
(~10-30, buffer dependent) so it is easily dialyzable and has been shown to have a 
reasonable dialysis half-life of 10 hours 142.  For these reasons PFOA was chosen as a 
detergent that could be employed as an alternative to those typically used in membrane 
protein reconstitution studies. 
When forming vesicles, the preparations were not visibly turbid unless sodium 
chloride was included in the outer buffer or cholesterol/protein was added to the mixture.  
Upon centrifugation at 20,000 x g of the vesicles formed in only 10 mM Tris-HCl, no 
lipid precipitated out of solution after three days of dialysis.  This indicated that the lipid 
was in solution, but the particles formed were too small to scatter significant amounts of 
light.  On the other hand, when as little as 25 mM sodium chloride was included in the 
buffer, the vesicles showed turbidity after two days of dialysis.  At concentrations 200 
mM or above, significant precipitation of the lipid was observed resulting in low vesicle 
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yields, and therefore examinations of species formed at high ionic strength was not 
carried out. 
To examine differences in the size and homogeneity of vesicles upon the addition 
of NaCl, cholesterol, and protein, gel filtration and dynamic light scattering experiments 
were carried out.  The chromatograms generated for vesicles formed with NaCl, 
cholesterol, and HSVFLAGCav162-178 are shown in Figure 2-2.  All traces showed Gaussian 
distributions in the particle sizes indicating that the vesicle formation process is well 
controlled and results in homogeneous species.  However, as vesicle preparations 
increased in size, more aggregated material was observed to elute at the void indicating 
that additives can cause some inhomogeneity in the formation dynamics. 
Elution volumes decreased as the NaCl concentration included in the vesicle 
formation buffer increased, indicating an increase in the size of the vesicles formed 
(Figure 2-2 A).  Interestingly, the elution volume showed a sigmoidal relationship with 
respect to the concentration of NaCl that the vesicles were formed in (Figure 2-3).  This 
indicates that the size of vesicles formed largely depends on the ionic strength of the 
medium.  Above 100 mM NaCl the vesicles all eluted at the void volume and separation 
of the well defined vesicles from any large aggregates formed was not possible using 
Sepharose 4B. 
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Figure 2-2.  A)  Refractive index traces of vesicles formed in the presence of 0 mM (–), 
25 mM (○), 37.5 mM (□), 50 mM (◊), 75 mM (×), and 100 mM (+) of NaCl.  B)  
Refractive index traces of vesicles formed with a PC:Cholesterol ratio of 80:20 (–) and a 
PC:Cholesterol ratio of 60:40 (×).  C)  Refractive index trace of vesicles formed in the 
presence of HSVFLAGCav162-178.  This preparation included 50 mM NaCl and had a protein 
to lipid ratio of 1:6000.  Void volumes denoted by an arrow. 
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Figure 2-3.  Elution volume as a function of NaCl concentration that was maintained 
during vesicle formation. 
 
The addition of cholesterol at 20 and 40 mol % resulted in more precipitate that 
had to be removed by centrifugation before injection of the sample onto the sepharose 4B 
column.  The addition of cholesterol also decreased the elution volume of vesicles 
prepared, suggesting that the sterol increases the size of the vesicles (Figure 2-2 B).  The 
addition of cholesterol also broadened the peaks indicating a wider distribution of vesicle 
sizes.  The amount of material eluting at the void volume was insignificant for the 
addition of 20% by mol cholesterol but increased somewhat for 40% by mol cholesterol.  
However, the voided material and the well-defined vesicular population were still 
resolved. 
There appeared to be a limit to the amount of protein that could be included in the 
lipid-detergent mixture during the dialysis without resulting in significant precipitation of 
lipid and protein, and it was found that a 1:6000 ratio of protein to lipid was required to 
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yield homogenous preparations of vesicles.  The addition of HSVFLAGCav162-178 at a 1:6000 
protein to lipid ratio decreased the elution volume of the vesicle peak when compared to 
vesicles that were formed in the absence of HSVFLAGCav162-178 formed in the presence of 
50 mM sodium chloride (Figure 2-2 C).  Inclusion of the protein also resulted in a 
somewhat broader elution profile, indicating that the protein alters the heterogeneity of 
the vesicle preparation.  This result is consistent with a size increase of the vesicles which 
is likely a consequence of Cav162-178 changing the vesicle formation dynamics.  Species 
eluting at the void were insignificant when compared to the major peak, indicating that 
the vesicle formation process is well controlled at the specified ratio. 
Size determinations of the approximate hydrodynamic radius of vesicles came 
from DLS measurements (Figure 2-4 and Table 2-1).  The vesicle size trends using DLS 
were consistent with elution volumes from gel filtration experiments where larger sizes 
were always correlated with lessened elution volumes.  It was observed that the smallest 
species (0 mM NaCl added), which formed vesicles of about 11 nm in radius, were 
unstable and after several days the appearance of a large 230 nm aggregate was detected 
by DLS.  The fusion of these species may be a consequence of limited space to pack the 
large EYPC headgroups within a highly curved sphere and would result in a large amount 
of curvature strain, which would be relieved by aggregation of the small particles into 
larger vesicles.  This type of behavior is commonly observed for small unilamellar 
vesicles (less than 30 nm in diameter) which fuse to form larger more stable vesicles133.  
Anomalous binding of membrane proteins to the bilayer surface as opposed to integration 
into the hydrophobic core has been reported during reconstitution procedures using 
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vesicles of this size 152.  Due to the instability of these particles, they were not 
characterized further in terms of their ability to entrap solutes. 
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Figure 2-4.  Data obtained using dynamic light scattering for vesicles formed in the 
presence of 100 mM NaCl. A)  Regularized correlation function derived from 
fluctuations in scattered light as a function of the measurement time. B)  Count rate 
obtained by two correlators show tiny undulations in the scattered intensity hitting the 
detectors indicative of a single population of small species. C)  Residuals of the 
regularized correlation function fit that was used to derive the diffusion constant for 
utilization in the Stoke’s-Einstein equation. D)  Histogram of particle sizes from fitting of 
the correlation function and obtainment of the diffusion constant showing a very narrow 
distribution.   
 
All other vesicle preparations showed that a single population of vesicles was formed.  In 
contrast to vesicles formed without sodium chloride, the addition of 50-100 mM sodium 
chloride generated vesicles that were stable for one week at 4°C with very little change in 
size (Figure 2-5).  The effect of NaCl on vesicle size is very interesting and may be 
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related to changes in the rate of detergent removal.  It has been shown that vesicle sizes 
that result from the detergent dialysis method are related to the rate of detergent removal, 
where fast rates of removal result in small, monodisperse species 153.  Therefore, NaCl 
may result in slower PFOA removal, possibly by lowering the CMC of the detergent due 
to screening ionic repulsion of the negatively charged headgroup 154.  In agreement with 
gel filtration data, the size of the vesicles increased in a sigmoidal fashion (Figure 2-5). 
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Figure 2-5.  The size of vesicles obtained by DLS experiments show a sigmoidal trend 
for both protein lacking (solid line) and protein containing (dashed line) vesicles.  The 
inset shows that the size of the vesicles formed in the presence of 100 mM NaCl are 
stable over a period of 1 week. 
 
Advantageously, the addition of salt allowed for fine tuning of vesicle size, which could 
be used to examine curvature dependence on membrane protein activity/reconstitution 
behavior and in the case of fluorescence experiments, or to produce smaller vesicles 
which scatter less light. 
A static light scattering experiment was employed on vesicles formed in the 
presence of 100 mM NaCl.  This technique can give information about the radius of 
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gyration (Rg) and the molecular weight of a molecule diffusing in solution.  These 
parameters are derived from variations in the scattered intensity of particles in solution as 
a function of the measurement angle and concentration.  The combination of the Rg and 
Rh can be used to give shape information (sphere, rods, disks, worm-like structures) 
(Figure 2-6).  The vesicles formed using the PFOA method did not vary in size upon 
changing the angle of detection significantly, supporting a spherical structure.  This 
technique can also tell the difference between a hard sphere (non-vesicular) and a hollow 
sphere (vesicle) by using a Zimm plot to determine the radius of gyration and comparing 
it to the radius of hydration.  Extrapolation to lipid concentration of zero yields a line 
with a slope that can be used to derive the Rg.  For a hard sphere Rg/Rh=0.77 whereas for 
a hollow sphere Rg~Rh.   For the vesicle preparation tested, the Rh was determined to be 
27.01  0.30 nm and the Rg was determined to be 25.42  1.53 nm yielding a ratio of the 
two values close to 1 (~0.94) supporting the existence of hollow spheres. 
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Figure 2-6.  A)  The Rh was invariant as a function of the scattering angle, providing 
evidence for the existence of a spherical particle. B)  A Zimm plot generated using a 
static light scattering experiment for different vesicle concentrations allows for 
extrapolation of the Rg, proving the vesicles are hollow spheres. 
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In agreement with gel filtration data, cholesterol is shown to increase the 
hydrodynamic radius of the vesicles (Table 2-1).  Doubling of the cholesterol content 
from 20% by mol to 40% by mol accounted for a roughly 10 nm growth in the size of the 
vesicles.  These vesicles are close in size to those that have been observed for PC-
cholesterol mixtures when prepared by sonication at the same mol % 155.  Importantly this 
method can incorporate cholesterol into vesicles at concentrations relevant to caveolae 26. 
When vesicles with reconstituted HSVFLAGCav162-178 were prepared at different 
NaCl concentrations they were on average larger than those formed in the absence of 
protein.  Generally, HSVFLAGCav162-178 vesicles were 5-10 nm larger (about 6 nm on 
average) than their purely lipid counterparts (Figure 2-5 and Table 2-1). 
[NaCl] 
mM 
Caveolin (-) 
Rh (nm) 
Caveolin (+) 
Rh (nm) 
Cholesterol 
(mol %) 
Rh (nm) 
0 11.39 ± 0.14 14.91 ± 0.10 20 12.41 ± 1.60 
25 12.52 ± 0.28 17.11 ± 0.36 40 22.93 ± 2.20 
37.5 14.48 ± 1.70 -  
50 19.81 ± 0.84 26.75 ± 0.68 
75 23.54 ± 0.68 28.22 ± 1.0 
100 28.28 ± 1.70 32.89 ± 0.66 
150 29.30 ± 2.0 38.79 ± 0.89 
Table 2-1.  Table of vesicle sizes obtained using DLS. 
 
Considering that a 7 nm size increase occurs when comparing vesicles formed using 50 
mM NaCl in the presence or absence of caveolin, it is clear that the integration of the 
protein must profoundly change the vesicle formation dynamics.  This is especially 
remarkable when considering that there are only about 4 HSVFLAGCav162-178 molecules per 
vesicle using a 1:6000 protein to lipid ratio.  For instance when glucose, which is highly 
polar and would not likely interact with the lipids and detergents, was included in the 
formation buffer at a 500 mM concentration, there was no change in vesicle elution time 
compared to when it was absent.  This supports the idea that HSVFLAGCav162-178 was 
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integrated into the volume of the bilayer and was not simply entrapped.  Interestingly, the 
addition of protein alters the sigmoidal behavior observed for non-protein containing 
vesicles where there is a less steep transition going from small unilamellar vesicles to 
large unilamellar vesicles and the curve doesn’t seem to level off clearly by the final 
point tested.  It is possible that the protein’s presence results in alterations in the 
formation dynamics of the vesicles.  The final size of vesicle formed by detergent dialysis 
is related to the size of the mixed micelle that is present just prior to the onset of 
solubilization (in this case, onset of vesicle formation) 153.  Therefore, the protein could 
alter the size of the mixed micelle just prior to vesicle formation.  For subsequent studies, 
vesicles containing protein were formed in the presence of 50 mM NaCl because these 
vesicles were consistent with the size of a caveola (50-100 nm diameter), making the 
vesicles an ideal mimic in terms of the curvature that caveolin-1 would experience in the 
native membrane.  In addition, these vesicles were stable over long periods of time if kept 
at 4°C. 
One important property that defines vesicles versus other bilayer mimics is that 
they have a distinct interior and exterior, and this makes them ideal for topology assays 
that assess the orientation of proteins reconstituted into them.  To assess if the vesicles 
were static and hollow, a classic glucose entrapment experiment was performed to show 
that polar solutes present during the formation process can be encapsulated inside the 
vesicles.  First, the internal volume of the vesicles was calculated by the method of 
Huang and Mason using the Rh obtained from DLS experiments 156.  This analysis 
assumes a 4.5 nm thickness of the bilayer and surface area of 0.70 nm2 for each lipid.  A 
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calibration plot was generated based on this theoretical treatment and was used to link 
glucose entrapment to the size of the vesicles (Figure 2-7). 
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Figure 2-7.  Entrapped volume of vesicles as a function of their size.  This plot was used 
to obtain theoretical amounts of glucose that would be entrapped by EYPC vesicles in the 
size range generated for the studies performed. 
 
Using the internal volume entrapment parameter it is possible to assess if the vesicles are 
static by measuring the mass of glucose entrapped per mass of lipid and comparing it to 
an expected value based on a given vesicle size and loaded glucose concentration.  For 
this experiment, vesicles formed in the presence of 100 mM NaCl for pure lipid vesicles 
or 50 mM NaCl for HSVFLAGCav162-178 vesicles (1:6000 protein to lipid ratio) were used 
since vesicles of approximately the same size are formed using both methods.  Based on 
theoretical calculations, the entrapped volume for non-protein loaded vesicles was 0.155 
μg glucose/μg lipid.  The actual entrapped volume was determined to be 0.133 μg 
glucose/μg lipid.  The two values are with 14% of each other, indicating that the vesicles 
are static and hollow, in agreement with the SLS studies.  This is also evidence of 
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unilamellar vesicle preparations as multilamellar vesicles entrap much less than the 
theoretical value based on a sphere with only a single bilayer.  For the protein loaded 
vesicles, the entrapped volume was found to be 0.116 μg glucose/μg lipid.  This agreed 
well with the theoretical value of 0.140 μg glucose/μg lipid.  The two values are within 
17% of each other, indicating that the HSVFLAGCav162-178 does not significantly alter the 
encapsulation properties of the vesicles formed.  As mentioned the inclusion of glucose in 
the formation buffer had no effect on the size of the vesicles formed.  Furthermore, the 
closeness of the experimental value to the theoretical value supports the accuracy of DLS 
measurements.  Although glucose entrapment proves that the vesicles are hollow and 
likely unilamellar, it does not give data on the integrity of the vesicles over time. 
To evaluate the permeability of the vesicles as a measure of stability over time, 
glucose-6-phospate, which cannot pass through bilayers due to its -2 charge, was 
entrapped in vesicles with and without HSVFLAGCav162-178.  Un-entrapped material was 
removed using desalting resin and then glucose-6-phosphate dehydrogenase was added to 
the exterior of the vesicles.  This enzyme is large and will not be able to access entrapped 
glucose and will thereby only process glucose-6-phophate that leaks through the vesicles.  
Once the glucose-6-phosphate dehydrogenase processes the glucose-6-phosphate by 
oxidizing the anomeric carbon, NADP+ is reduced to NADPH which then reduces 2-(4-
Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-terazolium and produces a 
yellow colored formazan 157.  After roughly 400 minutes at room temperature the vesicles 
were lysed with Triton-X-100 detergent to assess the total levels of glucose-6-phosphate 
entrapped.  Figure 2-8 shows the entrapment study result.  It was observed that over time 
there is very slow leakage rate in both protein containing and non-protein containing 
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vesicles.  There was a slight difference with the protein containing vesicles being 
somewhat more permeable (roughly 4 fold) than those prepared in the absence of the 
protein (Figure 2-8 inset).  After the addition of detergent, there was a large increase in 
the signal as the substrate became available to glucose-6-phosphate dehydrogenase 
confirming that glucose-6-phosphate was entrapped.  It is surprising that the permeability 
would be altered by the addition of HSVFLAGCav162-178 to the vesicles given that it is not a 
pore forming peptide.  Reports of leakage of entrapped vesicle contents from the 
reconstitution of transmembrane proteins such as mellitin do exist, although the 
mechanism is still unclear.  Nonetheless, it is likely that the vesicles are intact and 
contents on the interior would not be accessible to larger species, such as enzymes. 
A
44
0 
nm
(t)
A
44
0n
m
(fi
na
l)
Time (minutes)
0 100 200 300 400 500
0
0.067
0.133
0.200
A
44
0 
nm
(t)
A
44
0n
m
(f
in
al
)
0 100 200 300 400 500
0
0.2
0.4
0.6
0.8
1.0
100 mM NaCl Vesicles
HSVFLAGCav162-178 Vesicles
 
Figure 2-8.  Glucose-6-Phosphate is entrapped within the vesicles over a time period of 
~400 minutes.  The contents are released by the addition of the mild detergent Triton-X-
100 proving that the vesicles are static.  The inset shows a small difference in the natural 
leakage rate between protein lacking and protein containing samples. 
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Reconstitution and Topological Evaluation of HSVFLAGCav162-178 
After first determining that HSVFLAGCav162-178 was associated with the vesicle 
containing faction eluting from the gel filtration column by Western blotting, the amount 
of protein reconstituted into various cholesterol containing vesicles was examined (Figure 
2-9).  This method shows that HSVFLAGCav162-178 co-elutes with the vesicle containing 
fraction (the weak band above the intense band is a small amount of dimer which was 
frequently observed during SDS-PAGE analysis, Figure 2-9A).  Therefore, 
HSVFLAGCav162-178 is incorporated into the vesicles using the PFOA method.  Interestingly, 
HSVFLAGCav162-178 runs higher than the expected molecular weight of 18.2 kD (Figure 2-
9A lane 2).  This phenomenon has been reported as a property of hairpin structured 
membrane proteins due to anomalous detergent binding 158.  Next, the amount of 
HSVFLAGCav162-178 incorporated into cholesterol containing vesicles (lanes 3 and 4) was 
compared relative to the amount of HSVFLAGCav162-178 incorporated into non-cholesterol 
containing vesicles (lane 2) and yielded values of 1.0, 0.91, and 1.11 for 0, 5, and 20% 
cholesterol respectively.  This analysis was undertaken because caveolin putatively binds 
cholesterol in the 94-101 region and an earlier study where caveolin was reconstituted 
into vesicles found that the protein required cholesterol to achieve significant amounts of 
reconstituted protein 19,159,160.  This analysis determined that there was no difference in 
HSVFLAGCav162-178 incorporation into the vesicles due to cholesterol.  Therefore, it appears 
that caveolin does not strictly require cholesterol to partition into membranes.  However, 
it cannot be discounted that the facile reconstitution of HSVFLAGCav162-178 into vesicles 
may be enhance by the presence of the protease cleavage sites engineered to the ends of 
the protein that were required for a topological evaluation. 
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To better understand if the HSVFLAGCav162-178 protein used in these studies was 
behaving as an integral membrane protein and not just as a peripherally bound or a 
vesicle entrapped species, a sodium carbonate extraction method was utilized 161.  This 
method uses sodium carbonate at pH 11.5 to linearize the vesicles into membrane sheets 
as well as to break up electrostatic interactions between peripherally bound proteins and 
the membrane surface.  The membrane sheets are then collected by ultracentrifugation, 
and if a membrane protein is incorporated into the bilayer it will be localized to the pellet.  
Figure 2-9B shows the result of this study.  Lane 1 and 2 represent pre- and post- 
carbonate extraction samples of the same vesicle preparation loaded to the same final 
protein concentration (10 μg/mL).  Analysis of these species by densitometry shows that 
there is very little difference in intensity of the bands found at 18.2 kD having relative 
intensities that are within 30% of one another, providing evidence that the HSVFLAGCav162-
178 construct used in these studies is behaving as an integral membrane protein and is not 
superficially absorbed to the vesicles surface due to electrostatic interactions. 
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Figure 2-9.  A)  Western blot analysis of caveolin-1 reconstituted into vesicles of varied 
cholesterol composition.  Lane 1 is a molecular weight ladder.  Lane 2, 3, and 4 represent 
reconstitution of HSVFLAGCav162-178 into vesicles with a lipid composition of 0, 5, and 20% 
cholesterol by mol respectively.  Each lane was quantified relative to the HSVFLAGCav162-
178 band in lane 2 using densitometry.  B)  Western blot analysis of pre and post carbonate 
extraction of caveolin-1 from vesicles indicating that caveolin-1 is integrated into the 
hydrophobic matrix of the vesicles.  Bands were quantified relative to the amount of 
HSVFLAGCav162-178 in lane 1 by densitometry. 
 
A protease protection assay was used to determine if the protein had been 
integrated into vesicles in a native ‘horseshoe’ orientation.  Two enterokinase restriction 
sites were placed on each flank of the transmembrane region, that if solvent accessible, 
would be cleaved by the protease.  It is unlikely that enterokinase would be able to cross 
bilayers due to its large size (26 kD) and soluble nature, therefore it was an excellent way 
to probe exposure of the HSVFLAGCav162-178 termini upon reconstitution.  Furthermore, the 
prior result showing that glucose-6-phosphate dehydrogenase (67 kD) cannot process the 
majority of entrapped glucose-6-phosphate until vesicle permeabilization by detergent 
adds support to the notion that enterokinase would not be able to access the interior of the 
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vesicles.  Preceding the N-terminal FLAG site and after the C-terminal FLAG site, are 
HSV antibody recognition epitopes, which were added to enhance molecular weight 
changes upon enterokinase cleavage (Figure 2-10). 
Caveolin-1  62-178 FLAGFLAG HSVHSV
Enterokinase Enterokinase
18.2 kD
16.6 kD 15.9 kD
14.4 kD
 
Figure 2-10.  Graphic representation of the limited proteolysis assay principle performed 
on HSVFLAGCav162-178.  The bar diagram on top shows the construct layout with different 
cleavage possibilities and their expected molecular weight shifts shown below. 
 
Using this construct, four cleavage products were possible, each indicating a different 
topological orientation within the vesicles.  The four predicted molecular weights upon 
enterokinase treatment are 18.2 kD (uncleaved), 16.6 kD (C- terminal only cleavage), 
15.9 kD (N- terminal only cleavage), and 14.4 kD (both termini cleaved).  Two 
possibilities correspond to caveolin-1’s natively folded orientation (18.2 kD and 14.4 kD) 
and two possibilities correspond to a non-biologically relevant transmembrane orientation 
(16.6 kD and 15.9 kD).  The result of the cleavage reaction performed on HSVFLAGCav162-
178 reconstituted into vesicles formed using the PFOA detergent dialysis technique is 
shown in Figure 2-11.  The molecular weight markers generated from making truncations 
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of HSVFLAGCav162-178 (Figure 2-11 lane 1) are run side by side with the enterokinase 
treated and untreated vesicles (Figure 2-11 lanes 2 and 3).  Clearly, the four possibilities 
can be resolved using SDS-PAGE.  The cleavage pattern after five hours of allowing the 
vesicles to interact with enterokinase is shown in lane 3 and resulted in the appearance of 
two major bands.  These cleavage products correspond to the fully cleaved product (14.4 
kD) as well as the C-terminally cleaved product (16.6 kD).  Using densitometry to 
compare relative amounts of the cleavage product to the uncleaved parent band showed 
that although a fraction HSVFLAGCav162-178 is integrated with both N- and C- termini facing 
the exterior of the vesicle (32  5%, n=3), most of the protein is present in a misfolded 
(Ninterior, Cexterior) transmembrane orientation (60  2% , n=3, Figure 2-11, lane 3). 
18.2 kDa
16.6 kDa
15.9 kDa
14.4 kDa
1 2 3
1.00 0.60
0.35
 
Figure 2-11.  Typical results of limited proteolysis assay performed on HSVFLAGCav162-178.  
Lane 1 shows a home-made molecular weight marker that is used to track the cleavage 
pattern (all four possibilities).  Lane 2 shows HSVFLAGCav162-178 prior to the addition of 
enterokinase.  Lane 3 shows the post enterokinase cleavage product which resulted in the 
appearance of two major bands.  The cleavage products are quantified relative to the 
parent band in lane 2 by densitometry. 
 
 67 
 
It is worth mentioning that changes in the ionic strength of the formation buffer (leading 
to a size change in the vesicles) did not have an effect on the observed cleavage pattern, 
downplaying any significance of vesicle curvature.  The result from the cleavage study is 
surprising for two reasons: One is that the transmembrane conformation would require a 
significant tilt of the protein to provide hydrophobic coverage of the intramembrane 
domain and the other is that the protein seems to preferentially orient with the C-terminus 
on the exterior or with both termini facing the exterior indicating specific topologies were 
preferred.  It would be expected that if the protein weren’t refolded properly, a mixture of 
all four topologies would be observed, however, this was not the case.  This leads to the 
interesting idea that there is an equilibrium between the native topology and the 
transmembrane topology which would be controlled biologically.  It also leads to the 
possibility that the natively folded population positions its termini on the side of less 
curvature through a biophysical mechanism as only small amounts of uncleaved species 
were observed (usually below the detection limit of the assay).  It is possible that the tags 
at the termini or the N-terminal truncation alter the proteins topological behavior.  It has 
been demonstrated that residues flanking the transmembrane region of caveolin have lead 
to differences in its membrane orientation when translated in the presence of dog 
pancreas microsomes.  Specifically, it was found that a full length caveolin construct with 
glycosylation epitopes at its termini could be not be glycosylated at either termini 
(Ncytoplasmic, Ccytoplasmic), in line with the study discussed in chapter 1.  However, a 
construct in which N-terminal residues 1-95 were removed could be glycosylated at the 
N-terminus (Nluminal, Ccytoplasmic), and the removal of C-terminal residues 140-178 resulted 
in a construct that could be glycosylated at its C-terminus (Ncytoplasmic, Cluminal) 76.  Finally, 
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in a construct where the removal of all portions of the protein except the intramembrane 
domain (construct: 96-139), a mixture of topologies was observed.  Removal of the 
termini changes the net charge of the wild-type caveolin molecule.  In the HSVFLAGCav162-
178 construct, both termini have a negative net charge yielding a possible parallel between 
our studies and the aforementioned study where a fine balance of charged residues may 
be required to uphold caveolins specific membrane orientation.  Therefore the construct 
used in these studies may not necessarily capture the true nature of the native caveolin-1 
given that the addition of a single residue flanking a transmembrane sequence has been 
shown to alter its topology 162. 
Another possibility exists that although the insertion of our polypeptide into the 
bilayer is controlled thermodynamically by lipid-protein interactions (therefore correct 
hydrophobic coverage is obtained, as evidenced by carbonate extraction), a specific 
orientation is controlled biologically by the cellular machinery which inserts membrane 
proteins into the lipid bilayer (such as the Sec61 translocon complex) 163.  Interestingly, 
the Sec61 translocon often places termini of transmembrane sequences that are preceded 
by positively charged residues on the cytoplasmic side of the membrane, and the caveolin 
TMD is flanked by a lysine at position 96 and a lysine at position 136 164.  Nonetheless it 
is still very interesting to consider that caveolin-1 may orient with a preference outside of 
a biological system but more studies will be needed to determine what drives this 
preference. 
It is also known that refolding proteins using fluorous surfactants, such as PFOA, 
results in the formation of non-native α-helices 143.  These non-native helices could be 
stable after the detergent has left resulting in the improperly folded transmembrane 
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orientation.  Therefore, it is possible that PFOA is too harsh or too exotic to result in 
properly folded material.  Clearly, other approaches will need to be explored to natively 
fold caveolin-1 in vitro. 
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CONCLUSIONS 
In this chapter, a method of forming lipid vesicles by detergent dialysis of PFOA-
EYPC mixtures was demonstrated.  This expands upon the limited number of detergents 
that have properties that facilitate membrane protein reconstitution into vesicles by 
detergent dialysis (high CMS and can solubilize membrane proteins at high 
concentrations).  Important properties of the vesicles were confirmed including the size, 
shape, homogeneity, and the ability to entrap solutes included in the formation buffer.  It 
was found that NaCl can be used to control the size of the vesicles formed and that 
cholesterol can be incorporated into the vesicles in biologically relevant quantities.  A 
novel assay for examining the permeability of the polar solute glucose-6-phosphate was 
demonstrated and could be useful for studies examining the effects of proteins, 
detergents, or small molecules on the integrity of vesicles.  The reconstitution of a 
functional construct of the integral membrane protein caveolin-1 was proven by co-
elution with vesicles on a gel filtration column.  Caveolin-1 was shown to be 
reconstituted into the bilayer as an integral membrane protein by the carbonate extraction 
method.  Interestingly the HSVFLAGCav162-178 construct used in the studies was found to 
increase vesicle size and permeability slightly.  A limited proteolysis assay was presented 
and it was shown that the majority (60 %) of the protein adopted a non-native fold, 
possibly due to alterations to the constructs termini, detergent mediated formation of non-
native α-helices, or the need for a protein chaperone to mediate the insertion.  The 
remaining population was found to have both termini exposed, indicating that a small 
fraction could be refolded in a directional fashion.  The methodologies presented here 
may be useful for reconstituting extremely hydrophobic membrane proteins that have 
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limited solubility in commonly used detergents used for vesicles formation by detergent 
dialysis.   
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Appendix 2-1.  Sequence of Protein Constructs Utilized 
 
Construct Protein Sequence 
HSVFLAGCav162-178  
Full Length 
QPELAPEDPEDDYKDDDDKDVV
KIDFEDVIAEPEGTHSFDGIWK
ASFTTFTVTKYWYRLLSALFGI
PLALIWGIYFAILSFLHIWAVV
PSIKSFLIEIQSISRVYSIYVH
TVSDPLFEAVGKIFSNVRINLQ
KEIDYKDDDDKDGIQPELAPED
PED 
 
HSVFLAGMinsCav162-178 
N-Terminal Cleavage 
QPELAPEDPEDDYKDDDDKMDV
VKIDFEDVIAEPEGTHSFDGIW
KASFTTFTVTKYWYRLLSALFG
IPLALIWGIYFAILSFLHIWAV
VPSIKSFLIEIQSISRVYSIYV
HTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPE
DPED 
 
HSVFLAGCav162-178Stopins 
C-Terminal Cleavage 
QPELAPEDPEDDYKDDDDKDVV
KIDFEDVIAEPEGTHSFDGIWK
ASFTTFTVTKYWYRLLSALFGI
PLALIWGIYFAILSFLHIWAVV
PSIKSFLIEIQSISRVYSIYVH
TVSDPLFEAVGKIFSNVRINLQ
KEIDYKDDDDK 
 
HSVFLAGMinsCav162-
178Stopins 
N/C-Terminal Cleavage 
QPELAPEDPEDDYKDDDDKMDV
VKIDFEDVIAEPEGTHSFDGIW
KASFTTFTVTKYWYRLLSALFG
IPLALIWGIYFAILSFLHIWAV
VPSIKSFLIEIQSISRVYSIYV
HTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDK 
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Appendix 2-2.  Mutagenesis primers utilized 
 
Construct Primer Sequence 
HSVFLAGMinsCav162-178 
N-Terminal 
Cleavage 
5’-
CAAAGACGACGACGACAAAATGGACGTTGTT
AAAATCGACTTC-3’ 
 
HSVFLAGCav162-178Stopins 
C-Terminal 
Cleavage 
5’-
CGACGACGACAAAGACTAAATCCAGCCGGAA
CTGG-3’ 
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Appendix 2-3.  PCR Cycling Conditions 
 
Reaction Component Volume 
Sterile ddH2O 13.3 μL 
10X Pfu Turbo Buffer 2.5 μL 
10X 9N° Ligase Buffer 2.5 μL 
DMSO 0.2 μL 
dNTPS (25 mM) 2.5 μL 
Template DNA (30 ng/μL) 1.0 μL 
Forward (5’-3’) Quikchange primer (10 μM) 1.0 μL 
Pfu Turbo Polymerase 1.0 μL 
9N° Ligase 1.0 μL 
 
PCR Cycling Conditions   
Number of 
Cycles 
Temperature Time 
1 95°C 30 seconds 
30    Step1 95°C 30 seconds 
        Step2 55°C 1 minute 
        Step3 68°C 6 minutes 
Storage 4°C ∞ 
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Appendix 2-4.  Transformation Protocols 
 
General Transformation Protocol XL-1 Blue/BL21DE3 E. coli  
 
1. Pre-chill a culture tube and thaw 50 μL of cells on ice 
2. Add cells and DNA to the culture tube according to the following table: 
 
Application Cell Type Amount DNA 
Standard Transformation XL-Blue/BL21DE3 
(Subcloning Grade) 
1μL of 20 ng/μL plasmid 
DNA 
Mutagenesis XL-Blue                   
(Ultra-competent) 
1μL of post PCR 
reaction/post DpnI 
treated mixture 
Ligation XL-Blue          
(Subcloning Grade) 
1μL of post ligation 
mixture 
 
3. Incubate reaction mixture on ice for 30 minutes. 
4. Heat shock the cells at 42°C for 90 seconds. 
5. Place the culture back on ice for two minutes. 
6. Add 300 μL of SOC media to the culture. 
7. Incubate at 37°C for 1 hour with shaking at 250 rpm. 
8. Plate various dilutions on LB (XL-1 Blue) or MDAG (BL21DE3) agar plates 
supplemented with the appropriate antibiotic and allow to grow over night. 
9. Pick a single colony for desired downstream application. 
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Appendix 2-5.  Starter and Media Recipes 
 
MDG Starter Recipe 
(5 mL) 
 MDAG Starter 
Recipe (5 mL) 
 
Reagent Volume Reagent Volume 
ddH2O 4.8 mL ddH2O 4.7 mL 
1M MgSO4 10 μL 1M MgSO4 10 μL 
1000× Trace Metals 1 μL 1000× Trace Metals 1 μL 
25% (w/v) Aspartate 50 μL 25% (w/v) Aspartate 20 μL 
40% (w/v) Glucose 62.5 μL 40% (w/v) Glucose 43.8 μL 
50×M 100 μL 50× M 100 μL 
17 Amino Acids None 17 Amino Acids 100 μL 
40 mg/mL Methionine None 40 mg/mL Methionine 40 μL 
1000 × Kanamycin 5 μL 1000 ×  Kanamycin 5 μL 
 
 
ZYM-5052 Recipe (2L)  
Reagent Amount 
ddH2O 1916 mL 
NZ Amine 20 grams 
Yeast Extract 10 grams 
1M MgSO4 4 mL 
1000X Trace Metals 400 μL 
50×M 40 mL 
50×5052 40 mL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 77 
 
Appendix 2-6.  Auto-Induction Growth Protocol 
 
1. Add either a fresh colony or a crystal from a 15% glycerol cell stock to 1-5 mL of 
MDG supplemented with antibiotic and shake on a platform shaker at 250 rpm at 
37℃ for 16-20 hours. 
2. Dilute starter culture into ZYM-5052 at a 1:1000 culture to ZYM-5052 ratio and 
shake on a platform shaker at 250 rpm at 37℃ for 10-14 hours. 
3. Harvest by centrifugation at 5000 x g for 30 minutes at 4℃. 
4. Wash pellets with 0.9 % (w/v) NaCl at 1/5 the original culture volume. 
5. Centrifuge 5000 x g for 30 minutes at 4℃. 
6. Cell pellets can be stored short term (days) at -20℃ or long term (months) at -
80℃ before protein preparation. 
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Chapter 3.  Does Caveolin-1 Contain a Membrane Embedded Turn? 
 
ABSTRACT 
Caveolin-1 is critical in many cellular functions that are localized within caveolae.  
It is thought that caveolin induces membrane curvature and drives the formation of 
caveolae, although the mechanism remains elusive.  However, caveolins unique topology 
could be key in understanding the structural role that leads to its bilayer bending 
predilection.  The membrane interacting portion of caveolin-1 is comprised of two α-
helical segments, (H1 and H2) connected by a three-residue unstructured break with both 
N- and C-termini exposed to the cytoplasm.  A U-shaped configuration is assumed based 
on its inaccessibility to extracellular matrix probes, however, both the structure and exact 
topology of caveolin within a bilayer remains elusive.  This chapter aims to characterize 
the structure, depth, and conformation of the core membrane interacting region of 
caveolin-1 residues 82-136 (Cav182-136) in a DMPC bilayer using NMR, fluorescence 
emission measurements, and molecular dynamics simulations.  The secondary structure 
of Cav182–136 from NMR chemical shift index analysis serves as a guideline for 
generating initial structural models for molecular dynamics simulations (MD).  Fifty 
independent molecular dynamics simulations (100 ns each) were performed to identify 
the favorable conformation and orientation of Cav182-136 in the bilayer.  A representative 
configuration was chosen from these multiple simulations and was simulated for 1 μs to 
further explore the stability and dynamics of Cav182-136.  The results of the simulations 
agreed strongly with tryptophan fluorescence measurements (i.e., Cav182–136 insertion 
depth in the bilayer).  These data work together to corroborate that Cav182–136 inserts in 
the membrane with a U-shaped conformation, and that the angle between H1 and H2 is 
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dynamic and ranges from 35 - 69°.  The overall tilt of the Cav182–136 molecule was found 
to be 27  6°, and it was observed that H1 and H2 tilt differentially to provide lipid 
coverage of their hydrophobic segments.  Additionally, the simulations also reveal that 
specific faces of H1 and H2 prefer to interact with each other and with lipid molecules 
and these interactions may help stabilize the membrane-embedded U-shaped 
conformation. 
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INTRODUCTION 
 
Despite great gains in the characterization of the secondary structure of caveolin, 
there are still major questions in terms of its exact membrane topology which need to be 
addressed in order to better understand the proteins tertiary structure in the context of the 
lipid bilayer.  One major question that has brought controversy is what is the structure 
and orientation of caveolin-1 in a bilayer?  Another is the question of the existence of 
specific intramolecular caveolin helix-helix or intermolecular caveolin-lipid interactions 
that would help dictate caveolin structure and orientation.  This chapter tackles these 
provocative and critical questions using molecular dynamics (MD) simulations guided 
and supported by NMR and tryptophan fluorescence emission data.  NMR experiments 
were performed to determine the secondary structure of a caveolin-1 construct consisting 
of the CSD and IMD (residues 82–136: Cav182–136).  NMR experiments employing 
chemical shift index analysis indicates that residues A87–F107 form helix 1 (H1) and 
L111–A129 form helix 2 (H2) which are separated by a three residue break spanning 
from G108 to P110.  This data provided a template for starting conformations in 
molecular dynamics simulations.  The short simulations were employed to sample a large 
conformational space by generating 50 × 100 ns trajectories of Cav182–136 embedded in a 
lipid bilayer with various starting angles between H1 and H2, different initial H1 and H2 
interfaces, and different initial insertion depths.  Next, a simulation that best represented 
the averaged parameters from the short simulations was utilized for an extended 
conformational evolution over a 1 μs time period to further explore dynamics, stability, 
and protein-lipid interactions. 
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The simulation results provide evidence that a U-shaped conformation for Cav182–
136 embedded in the lipid bilayer is stable over the course of the simulations.  The tilt of 
the overall Cav182–136 molecule was determined to be 27  6°, revealing a nearly vertical 
disposition for the protein.  The angle between the two helices was dynamic but 
maintained an average of 53  5°.  Interestingly, side-chain interactions between the two 
helices near the three residue break were evident and may be at play in helping the 
protein maintain its conformation.  Depth measurements revealed that the turn residues 
were buried within the hydrophobic core of the membrane.  The depth was corroborated 
with tryptophan fluorescence experiments examining the Stoke’s shift data obtained for 
Cav182–136 single tryptophan mutants.  Simulations examining the interaction between 
Cav182–136 and lipids showed that residues in both leaflets of the bilayer can interact with 
lipid headgroups via water mediated hydrogen-bonding.  These interactions likely play an 
important role in the topological and conformational preferences of caveolin-1 within the 
bilayer.  Overall, this chapter helps provide a better understanding of caveolin-1 structure 
and behavior within the lipid bilayer. 
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MATERIALS AND METHODS 
 
NMR spectroscopy 
Isotopically labeled Cav182–136 and Cav182–136(W85F, W98F, W115F, W128F) 
were prepared according to protocols described by Lee et al 70.  Lyophilized Cav182–136 
constructs were dissolved into a buffer containing 100 mM 1-myristoyl-2-hydroxy-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (sodium salt) (LMPG, Avanti Polar Lipids, 
Alabaster, AL), 100 mM NaCl, 20 mM phosphate at pH 7, and 10% D2O for a final 
protein concentration of ~1.0 mM.  This mixture was vortexed vigorously until a clear 
homogeneous solution resulted.  The sample was then passed through a 0.2-μm 
regenerated cellulose spin filter.  NMR spectra were acquired at 310 K using a 600 MHz 
Avance II spectrometer (Bruker, Billerica, MA) equipped with a cryoprobe.  For analysis 
and backbone assignments, the following transverse relaxation optimized spectroscopy 
based 165 pulse sequences were utilized: HSQC 166, HNCA 167, HNCACB 168, HN(CO)CA 
169, and HNCO 170.  The spectra were processed using NMRPIPE and SPARKY software 
171,172.  For the generation of the chemical shift index plot, the observed Cα chemical 
shifts were subtracted from their corresponding random coil chemical shifts as described 
by Wishart and Sykes 173.  To aid in backbone assignments, specific amino-acid labeling 
was employed (Gly, Phe, Tyr, Leu, Ile, and Val). 
 
Single Tryptophan Mutant Cloning, Expression, and Reconstitution into Bicelles 
Cav182–136 was cloned, expressed, and purified according to protocols described in 
Chapter 2 146.  Cav182–136 contains four tryptophan residues: W85, W98, W115, and 
W128.  Single tryptophan mutant constructs were prepared using the Quick-change site-
directed mutagenesis kit (Agilent, Santa Clara, CA).  In each mutant, one of the four 
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native tryptophan residues was retained and the other three were mutated to 
phenylalanine.  Primers were designed using the free web-based primerX program 
(Bioinformatics.org).  See Appendix 2-3 for PCR reaction and cycling conditions.  A 
TROSY-HSQC spectrum was obtained for the most dramatic mutant (Cav182–136(W85F, 
W98F, W115F, W128F)) to confirm that these mutations were not significantly altering 
the structure of the native Cav182–136. 
Cav182–136 was reconstituted into 4% (w/w) lipid, q= 0.5 DMPC/CHAPSO (1,2 
dimyristoylphosphatidylcholine (Avanti Polar Lipids, Alabaster, AL)/3-[(3-
cholamidopropyl)dimethylammonio]-2-hydroxy-1-propane sulfonate) (Anatrace, 
Maumee, OH) bicelles at a protein concentration of 30 μM.  To achieve this, Cav182–136 
was first reconstituted into DMPC vesicles by dissolving the protein and lipid to 30 μM 
and 20 mM, respectively, in a buffer containing 300 mM PFOA and 20 mM Tris-HCl pH 
8.0.  This solution was then dialyzed (three 24-h exchanges) against 1 L buffer (20 mM 
Tris-HCl pH 8.0 and 50 mM NaCl).  The vesicle containing solution was centrifuged at 
10,000 x g for 20 minutes at room temperature.  The supernatant collected and 
centrifuged at 366,613 x g for 2 h at 4°C to pellet the vesicles.  The pelleted vesicles were 
then converted into 4% (w/w) lipid, q = 0.5 bicelles by adding ice-cold buffer components 
(2.704 mL 20 mM phosphate pH 7.0 and 296 μL 25% (w/w) CHAPSO) and slowly 
mixing on ice over the course of 30–60 minutes.  The bicelles were then centrifuged at 
10,000 x g for 20 minutes at room temperature to remove protein and lipid aggregates 
that may have formed during the reconstitution process.  The supernatant was used for 
fluorescence measurements. 
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Determination of λmax for Single Tryptophan Mutants 
Three separately prepared samples were used to determine λmax for each single 
tryptophan mutant.  Bicelles were used because they scatter very little light, and contain a 
planar DMPC bilayer, which closely mimics the environment employed in the 
simulations 116.  Fluorescence emission spectra were acquired using a 1 × 1 cm quartz 
cuvette held at 310 K with an Eclipse fluorometer (Agilent, Santa Clara, CA).  The 
excitation wavelength used was 295 nm to avoid unwanted tyrosine excitation 127.  Both 
the excitation and emission slit widths were set to 5 nm. The emission spectra were 
measured from 315 to 500 nm with a scan speed of 1 nm/s and 0.5 nm data point 
increments.  Four scans were averaged for each construct.  A blank solution containing 
only bicelles was used to subtract background fluorescence.  The λmax values were 
obtained by fitting the spectra to a log-normal distribution using Igor Pro 6.22A software 
(Wavemetrics, Portland, OR) 133. 
 
Building a Structural Model for In Silico Analysis of Caveolin-1 
The characterization of the structure and dynamics of Cav182-136 on a quantitative 
level required that a model be generated that describes parameters which define its 
intramolecular fold and topological disposition with respect to the bilayer.  To define the 
intramolecular fold of Cav182-136 with respect to the bilayer, four parameters are needed: 
the angle between the two helical axes of H1 and H2 (), the angle of rotation for H1 (ρ1) 
and H2 (ρ2), and the distance between a pair of residues that are in close contact (Resij, 
the residues are on different helices).  To define the rotation, two vectors in the plane 
perpendicular to the helical axis of rotation are used.  One of these vectors is the fifth Cα 
from the N-terminus of the helix, the other is one drawn connecting the centers of the two 
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helices, both of which are in structured spots that do not have conformational floppiness 
that would cause difficulties in interpreting the data to arise (Figure 3-1).   
 A description of the topology requires four additional parameters: the Cav182-136 
tilt angle (φ), which is the angle between the molecular plane of caveolin and the 
membrane normal, the individual helical tilts of H1 (α) and H2 (β) in the Cav182-136 
molecular plane (the least squares plane through all of the Cα atoms which define helices 
H1 and H2), and the insertion depth of the protein in the bilayer (ZCOM), which is defined 
as the center of mass of the Z position (distance from the bilayer center in Å) of residues 
at the break (G108-P110).  Although it may not be clear, the individual tilt angles of the 
helices are necessary for an unambiguous description of the Cav182-136 fold in the bilayer.  
This is because the helices sometimes deviate from the molecular plane of caveolin in the 
simulations, however, the two individual tilt angles are a good approximation of  when 
the two helices are within the same plane (α-β ). 
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Figure 3-1.  A)  Parameters used to define the intramolecular fold of Cav182–136 and B)  
Parameters used to define the orientation of the Cav182–136 molecule with respect to the 
lipid bilayer.  Spheres show the approximate location of residues of interest in terms of 
their burial within the bilayer. 
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Multiple 100 ns and 1 μs caveolin-1 simulations in DMPC bilayers 
A Cav182–136 model was first generated using the IC BUILD command in 
CHARMM 174.  Based on the secondary structure assignments from the chemical shift 
index plot, residues A87–F107 (H1) and L111–A129 (H2) were modeled as ideal α-
helices with their Φ- and Ψ- angles assigned to -57.8° and -47°, respectively; the other 
residues were modeled with their Φ - and Ψ- angles in the CHARMM residue topology 
file.  The Φ- and Ψ- angles of G108 were varied randomly to generate initial structures of 
Cav182–136 with different angles between the helical axes of H1 and H2 ().  These 
structures were then placed into five categories (initial=45°, 55°, 65°, 75°, and 85°), with 
10 replicas in each set, all of which have  within  5° of initial.  Prior to inserting 
caveolin models into the bilayer, the protein was oriented so that its principle axis (the 
vector sum of the axis of H1 and H2) coincided with the membrane normal (Z).  As there 
is no concrete depth measurement in existence for caveolin, the insertion depth of the 
model in each replica system was initially positioned along the Z axis by randomly 
placing the break residues’ centers of mass (COM) between -5 Å and 5 Å; by definition 
Z=0 corresponds to the bilayer center. 
After the generation of these initial models, each one was embedded in a DMPC 
bilayer, solvated by 0.15 M KCl.  The system was composed of ~52,000 atoms and had a 
size of 75 × 75 × 90 Å3.  Every system was individually constructed using the 
MEMBRANE BUILDER module 175,176 in CHARMM-GUI 177.  Each short simulation 
was ascribed a reference code in the form of cav1_P_Q, with P and Q corresponding to 
the value of initial and the replica index (cav1_45_5 corresponds to the fifth replica with 
initial=45°).  Each system was allowed to equilibrate for 225 ps to allow initially 
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uncorrelated system components to relax.  After this short time period, 100 ns second 
simulations were performed for each of the 50 systems.  For the first 50 ns of each 
simulation the dihedral restraints of H1 and H2 backbone atoms were not allowed to float 
in order to maintain their secondary structure according to the chemical shift index 
analysis.  This was designated as an equilibrium time period and was not utilized in the 
final trajectory analysis.  For the final 50 ns, these restraints were taken away and the 
system was allowed to explore the conformational preferences of Cav182-136. 
All calculations were performed with the constant particle number, pressure, and 
temperature (NPT) ensemble 178 using CHARMM 174.  The temperature was maintained 
at 310 K using Nosé-Hoover temperature control 179,180 and the extended system 
algorithm was employed to maintain a pressure of 1 atm along the membrane normal 178.  
The C27 all-atom force field 181 with a modified version of dihedral cross-term correction 
182 was used for the protein.  In addition to the protein force field, the C36 lipid force 
field 183 was used for DMPC and the TIP3P water model 184 was employed for water 
molecules.  A time step of 2 fs was enabled with the SHAKE algorithm 185.  Because of 
the U-shaped conformation of caveolin-1 and potential changes in the protein cross-
sectional area in both lipid leaflets during the simulation, the P21image transformation 186 
was applied to allow the variation in the number of lipids at the top and bottom leaflets 
during the simulation.  The non-bonded and dynamics options were kept the same as in 
the MEMBRANE BUILDER input; the van der Waals interactions were smoothly 
switched off at 10–12 Å by a force-switching function 187 and the electrostatic 
interactions were calculated using the particle-mesh Ewald method 188 with a mesh size 
 88 
 
of ~1 Å for fast Fourier transformation, κ=0.34 Å-1, and a sixth-order B-spline 
interpolation. 
After allowing Cav182–136 to explore conformational and structural preferences in 
a DMPC bilayer using the multiple 100 ns simulations, the distribution of final structural 
parameters (, φ, α, β, ρ1, ρ2, Z) for each set was analyzed to ascertain the most probable 
values.  A snapshot from one of the short simulations, cav1_65_3 at 85 ns had structural 
parameters that met the criteria of being a near mimic of the most probable values from 
the 50 simulations.  This system was employed for a 1-μs simulation using ANTON, a 
supercomputer designed for long timescale MD simulations.  As prior, a constant particle 
number, volume, and temperature (NVT) ensemble was employed with the Nosé-Hoover 
temperature coupling scheme (310 K).   
The lengths of all bonds involving hydrogen atoms were constrained using M-
SHAKE 189.  The cutoff of the van der Waals and short-range electrostatic interactions 
was set to 10.06 Å.  Long-range electrostatic interactions were evaluated with the k-space 
Gaussian split Ewald method 190 and a 64 × 64 × 64 mesh.  The integration time step was 
2 fs.  The r-RESPA integration method 191 was employed and long-range electrostatics 
were evaluated every 6 fs. 
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RESULTS AND DISCUSSION 
 
Probing the secondary structure of Cav182–136 
A combination of HSQC, HNCA, HNCACB, HNCO, and HN(CO)CA 
experiments, in conjunction with selective amino-acid labeling, were employed to give 
definitive backbone assignments for Cav182–136.  The HSQC obtained for Cav182–136 
revealed excellent chemical shift dispersion, which was indicative of a well structured 
protein, adding strength to using the secondary structure assignments obtained as a 
starting point for in silico analysis.  Using the aforementioned methods, nearly all of the 
backbone residues (96%) were assigned and all of the Cα values were obtained.  Figure 
3-2 shows a chemical shift index plot of Cav182–136.  Consistently positive stretches of 
∆Cα values indicate that residues 87–107 (H1) and 111–129 (H2) are α-helical 172.  In 
line with NMR studies on a shorter construct, (residues 96-136), there is a break between 
the two helices at residues 108–110, which most likely is the site of a turn between the 
helices, that returns the polypeptide chain to the same side of the membrane 70.  Regions 
flanking the helix-break-helix structural core (residues 82–86 and 130–136) show a 
random pattern of ∆Cα values which is indicative of unstructured or dynamic regions of 
the protein.  Importantly, TALOS+ which requires much more data input (Cα, Cβ, CO, 
N, and NH) is in agreement with the secondary structure assignment given to Cav182–136, 
confirming that the scaffolding domain and intramembrane domain have a helix-break-
helix motif 192.  This expands upon what is known about caveolin-1 secondary structure 
in this region as it is in contrast to the model put forth by Parton et al. 66, which is based 
on primary sequence analysis, and predicts three distinct helical regions for residues 82–
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136 (i.e., 81–92, 97–107, and 112–128).  Therefore, it appears that Cav182-136 is 
composed of two helices that are roughly equal in length. 
D GI WKA SF TTF TV TKY WF YRL LS ALF GI PLA LI WGI YF AIL SF LHI WA VVP SI KS
∆
C

Helix 1 (H1)
+
-
Helix 2 (H2)
CSD IMD  
Figure 3-2.  Chemical shift index plot of Cav182–136.  The secondary structure is that of a 
helix-break-helix motif as consecutive positive ∆Cα values are indicative of α-helical 
structure, consecutive negative values are consistent with β-strand structure, and mixtures 
are dynamic regions. 
 
Defining the Cav182–136 Intramolecular Fold in a Lipid Bilayer 
The most distinct structural feature of caveolin-1 is its unusual U-shaped 
conformation shown by in vivo studies, where the N- and C- termini rest on the same side 
of the membrane and there is no portion of the protein accessible to extracellular probes 
71,74.  The current topological model places the portion of the protein that makes this 
dramatic turn to the same face of the bilayer from which it entered within the 
hydrophobic core of the bilayer.  Combining this with the NMR studies, it is clear that 
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this U-shaped model is made up of a helix-break-helix motif, likely implicating residues 
108-110 as the turn residues.  Even with this information in hand, it is unclear how the 
helices would be separated – for instance, is caveolin forming a tight hairpin 
conformation or does the protein adopt a wide angle in which the protein is linear and 
rests on the surface of the inner leaflet?  The angle between these helices also will likely 
play a large role in determining which residues pack together and their packing may give 
information in how a specific angle is stabilized by H1-H2 contacts. 
Simulations were set up to examine this question in depth and help determine 
which angle between the two helices is energetically favorable.  Simulation sets ranged 
with initial H1-H2 angles from 45-85° that were allowed to move into stable 
conformations over the timescale of the simulation.  Figure 3-3 shows the distribution of 
 for all simulations.  It was found that U-shaped conformation is stable in 98% of the 
short simulations having <90°.  Over the course of the longer simulation, the protein had 
a final= 53  5° which lent additional support to the stability of the U-shaped motif.  This 
indicates that, within the timescale explored by the simulation, the U-shape conformation 
is stable within the bilayer.  Significantly, this result shows that the protein is not linear 
and likely does not lay on the surface of the bilayer, which appears to be very 
unfavorable.  This finding is in-line with carbonate extraction studies which have shown 
caveolin-1 as an integral membrane protein 71,72.  This important piece of data will aid 
further refining the proposed mechanism of caveolin induced membrane curvature.  
Interestingly this finding may eliminate a BAR-domain type mechanism which requires 
the protein to lay on the surface of the bilayer acting as a scaffold that stabilizes 
membrane curvature 80,193. 
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Figure 3-3.  Population distributions of  in all systems.  Colors distinguish different 
simulation sets: cav1_45 (red); cav1_55 (green); cav1_65 (blue); cav1_75 (magenta); 
cav1_85 (cyan).  Additionally, the 1 μs simulation is indicated (orange) along with the 
average of all the 100 ns systems (black). 
 
Interestingly, the Cav182-136 molecule displayed a dynamic fluctuation in its  
value in the 1 μs simulation where  ranged from 35-69°.  This fluctuation happened on a 
time scale in the tens of nanoseconds and was usually accompanied by the diffusion of 
lipids between the two helices.  Lipid headgroup or tail intercalation between the two 
helices was observed the majority of the time, and their presence often persisted over the 
course of the entire simulation.  The appearance of lipids between H1 and H2 limited the 
protein from sampling angles below 30°, as angles beneath this limit were coincident 
with absence of lipids between the two helices.  Therefore, caveolin-lipid interactions are 
critical to the proteins maintenance of a specific fold in the bilayer. 
Aside from lipid interactions, specific H1-H2 interactions could be at play in 
determining the fold of Cav182-136.  Therefore, it was pertinent to determine if there were 
specific packing interactions between the faces of H1-H2 that could help explain the 
adoption of a  value that holds Cav182-136 in its U-shape.  The rotation angle (ρ1, ρ2) that 
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was varied randomly in the beginning of each simulation, the terminal position after the 
simulations is shown in Figure 3-4 as a cross plot. 
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Figure 3-4.  The average two dimensional rotation angle distribution for H1 (1) and H2 
(2) shown as a contour map.  Level of the contours are indicated going from low (black) 
to high (red) probability.  The one-dimensional distributions of each individual helix are 
shown with each different simulation set distinguished by different colors with cav1_45 
(red); cav1_55 (green); cav1_65 (blue); cav1_75 (magenta); cav1_85 (cyan).  
Additionally, the 1 μs simulation is indicated (orange) along with the average of all the 
100 ns systems (black). 
 
Although the values were initially randomized, they clearly collapsed upon a favorable 
orientation by the end of the short and 1 μs simulations of ρ1=337°, ρ2=115° and of 
ρ1=331°, ρ2=124° respectively.  The closeness between long and short simulations in 
terms of their ρ1, ρ2 pair values, indicates that the helical contacts form quickly, therefore 
they are likely very stable and are not highly promiscuous.  Specific interactions that 
were observed were van der Waals packing interactions near the turn as the helices come 
close together (Figure 3-5).  Specifically, these packing interactions were between A105 
and L106 of H1, I109 of the break, and I114 of H2.  This result helps explain both the 
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biological conservation of a β-branched amino acid at position 109 across species and 
caveolin isoforms (Figures 1-3 and 1-4), and NMR structural studies that showed only β-
branched amino acids are tolerated at this position for proper structuring.  I109 is likely 
very important in mediating interactions between the two helices 70.  Diverging from the 
turn region, hydrogen bonding interactions between R101 and Y118 to lipid headgroups 
were observed.  For R101 this interaction was electrostatic whereas for Y118 the 
interaction was due to hydrogen bonding.  The positively charged amino acid at position 
101 also represents a strongly conserved site among species and isoforms.  Therefore, the 
combination of these interactions may be crucial in generating and holding the U-shaped 
conformation.  It appears that short distance hydrophobic interactions are important at the 
point of the turn but longer distance hydrogen bonding interactions become dominant at 
the ends of the helices.  Interestingly, in a short simulation in which the U-shape was not 
maintained, these interactions were not present, strengthening the case for a specific 
packing interface between H1 and H2. 
A B
 
Figure 3-5.  A)  Residues that are found to interact at the Cav182-136 H1-H2 interface and 
B) Lipid-protein interactions through specific residues between H1 and H2.  This is a 
cartoon representation and the caveolin-1 scaffolding domain (red) and intramembrane 
domain (green) are indicated.  Lipids are indicated with phosphate atoms of the 
headgroups as orange spheres and tails as grey chains.  Both snapshots were taken from 
the 1-μs simulation. 
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Evaluation of the Orientation and Membrane Depth of Cav182-136 in a DMPC 
Bilayer 
The interplay between the hydrophobic length of transmembrane helices and the 
hydrophobic thickness of the lipid bilayer leads to tilting in membrane proteins.  In 
Cav182–136, the helices have the additional complexity of being tethered together at the 
break region, which likely would have a role in determining the overall tilt of the 
caveolin molecule.  Additionally, the two helices diverge in their physiochemical 
properties, therefore the tilts of each independent helix could modulate how the overall 
caveolin molecule tilts with respect to the membrane.  Defining the way the protein tilts 
in the membrane will undoubtedly yield fruitful insight into caveolins structure-function 
relationship in a variety of biological contexts. 
Over the course of the short simulations the tilt of the molecular plane of Cav182–
136 (φ) was examined and fell to an average value of 21  12°, indicating that the protein 
was near vertical with respect to the plane of the bilayer (Figure 3-6).  This again points 
to a non-peripheral conformation of Cav182–136, otherwise much greater φ values 
approaching 90° would have been observed.  This value varied greatly when comparing 
simulation sets, but over the longer time course fell to a more discrete value of 27.5  6°, 
as indicated by the decrease in error in the simulation.  Therefore, this result suggests that 
φ is a slow converging property and requires a longer time scale to obtain a suitable 
disposition in the bilayer, or is highly sensitive to the starting conformational parameters. 
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Figure 3-6.  The population distribution of φ for all systems simulated.  Different 
simulation sets are indicated by color: cav1_45 (red); cav1_55 (green); cav1_65 (blue); 
cav1_75 (magenta); cav1_85 (cyan).  Additionally, the 1 μs simulation is indicated 
(orange) along with the average of all the 100 ns systems (black). 
 
With the overall tilt of Cav182–136 being described, there is still the possibility that 
H1 and H2 can lie somewhat outside the molecular plane of the overall caveolin 
molecule.  This required the determination of individual tilt angles for H1 (α) and H2 (β) 
with respect to the plane of the bilayer (Figure 3-7). 
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Figure 3-7.  The average two-dimensional tilt angle distribution of individual helices 
H1(α) and H2(β) shown as a contour map.  The contour levels are indicated by color 
going from low (black) to high (red) probability.  The one-dimensional distributions of 
each individual helix are shown with each different simulation set distinguished by 
different colors with cav1_45 (red); cav1_55 (green); cav1_65 (blue); cav1_75 
(magenta); cav1_85 (cyan).  Additionally, the 1 μs simulation is indicated (orange) along 
with the average of all the 100 ns systems (black). 
 
The position of α was found to range between 90-120° in nearly all of the short 
simulations, and fell to 99° for the 1 μs simulation, indicating a near vertical orientation 
for H1.  For H2, a much greater tilt was observed having a value between 40-60° in the 
majority of short simulations and rested at 49° for the 1-μs time course.  From a 
physiochemical standpoint these findings make sense with the sequences of H1 and H2.  
The value of 90° represents the minimum amount of coverage of an α-helix would have 
at a given depth within the bilayer.  Examination of the primary sequence of H1 reveals 
that the first 2/3 of the helix are populated with a number of polar uncharged and charged 
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amino acids and does not become markedly hydrophobic until after R101.  It is likely that 
Cav182–136 remains vertical to avoid the energetic penalty of removing the solvation shell 
from charged residues approaching its turn region such as K96 or R101.  On the other 
hand, the second helix contains no charged amino acids and only a few polar uncharged 
amino acids, and is mostly comprised of hydrophobic amino acids that would prefer lipid 
bilayer coverage.  Therefore, α and β strongly reflect the matching of the hydrophobic 
portions of the protein to the thickness of the bilayer. 
The postulation of an intramembrane turn for Cav182–136 has remained a 
controversy as it is not typical for membrane proteins where the N- and C- termini rest 
upon the same side of the membrane.  This is because it would require the breaking of i 
to i+4 hydrogen bonds that are very stable within the bilayer due to a lack of competition 
with water molecules 194.  The simulation results show that the three residue break 
between helices is located within the hydrophobic core in both the short and the 1 μs 
simulation sets (Figure 3-8).  The average Z values for each of the break residues for the 
short and long simulations are -5.1  2.9 Å (G108), -5.4  2.5 Å (I109), and -6.3  3.0 Å 
(P110) and -5.9 1 .7 Å (G108), -6.8  1.6 Å (I109), and -9.3  1.3 Å (P110) respectively 
(Table 3-1).  Clearly, the short simulations are much wider in their distributions and the 
longer simulation allows the protein to fall upon a more discrete depth for the break 
region.  It is also important to note that the break residues are on average found in the 
second leaflet as the starting conditions placed the break randomly from -5 Å to 5 Å.  
This indicates that there is indeed a preference for these residues to be localized within 
the second leaflet and the final position is not biased by the starting position. 
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Figure 3-8.  Distance from the bilayer center (Z) distributions for key residues in the 
Cav182-136 sequence.  Tryptophan residues W85 (black), W98 (red), W115 (green), and 
W128 (blue) as well as break residues G108 (magenta), I109 (purple), and P110 (orange) 
are shown in both A)  Multiple 100 ns simulations and B)  The 1 μs simulation.  The 
distance of the phosphate atoms of the lipid headgroup are indicated by yellow Gaussian 
distributions located at approximately 20 and -20 Å form the bilayer center indicated by 
the dashed line. 
 
The residues are shown to penetrate deeper in the longer simulation and are therefore 
closer to the lipid headgroup of the second leaflet indicating that a distinct depth in the 
membrane may important in stabilizing Cav182–136.  Importantly, in the snapshots taken, 
the backbone atoms of the turn residues were found to hydrogen bond to lipid headgroups 
of the second leaflet, which can be another stabilizing force in controlling the caveolin 
topology.  The break region clearly is shown to be stable in these simulations indicating 
that a membrane buried turn is energetically possible for caveolin. 
 100 
 
The residues in the break region cannot be mutated out without dire consequences 
to the caveolin structure and therefore cannot be probed directly.  However, with such a 
controversial motif, experimental evidence was needed to validate the simulation results.  
The four native tryptophan residues in Cav182–136 can be used to indicate its membrane 
location by examining the emission maximum (λmax) after selectively exciting tryptophan 
by irradiation at 295 nm.  In general, the λmax values are divided into three classes, each 
related to the degree of exposure to water.  Tryptophan residues with λmax in Class I (330-
333 nm) are generally solvent-inaccessible because they are tucked away within the 
bilayer.  Class II (340-344 nm) tryptophan residues are usually found at the 
bilayer/aqueous interface (headgroup region of the bilayer).  A Class III (346-350 nm) 
λmax value is indicative of a tryptophan residue that is fully exposed to high mobile water 
molecules.  Therefore it was desirable to examine the fluorescence emission profiles of 
single tryptophan mutants reconstituted into phospholipid bicelles to see how the polarity 
of the sequence changes along the helices.  This analysis was highly relevant because 
bicelles contain a planar bilayer to mimic the simulation conditions.  Bicelles also scatter 
much less light than vesicles, a property which can lead to spectroscopic artifacts that 
make data interpretation more difficult.  Due to the extreme hydrophobicity of Cav182-136, 
a method was developed to reconstitute the protein into bicelles.  This was accomplished 
using a vesicle to bicelle transition.  This method was developed because direct 
reconstitution of the protein into bicelles by adding bicelles to lyophilized material, or co-
lyophilizing the protein with DMPC followed by a rehydration step with DHPC and 
buffer components was resulting in aggregation of the protein giving very low 
fluorescence signals that were unsuitable for max analysis.  Once the protein had been 
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associated with vesicles by detergent dialysis using the methodologies described in 
Chapter 2 except in place of EYPC, DMPC was used, the reconstitution into bicelles was 
facile and protein loss was minimized.  This process is detailed in Figure 3-9 and 
represents a very novel use the PFOA detergent dialysis method. 
3 dialysis 
exchanges
20 mM Tris pH 
8.0
Removal of 
aggregates, 
10,000 x g, 
Ultracentrifugation 
366,613 x g 
1:700 Protein:Lipid
1:15 Lipid:Detergent  
Figure 3-9.  Procedure for vesicle to bicelle transition technique.  The PFOA detergent 
dialysis technique described in Chapter 2 is used to form vesicles.  These vesicles are 
then spun to remove lipid and protein aggregates using a low centrifugal force.  The 
vesicles are then pelleted using a very high gravitational force and the resulting pellet is 
solubilized using ice-cold buffer containing the rim-forming detergents.  This technique 
was crucial in obtaining high reconstitution yields of Cav182-136 into phospholipid 
bicelles. 
 
Figure 3-10 shows the λmax values from the fluorescence emission spectra of each 
tryptophan after reconstitution into bicelles and are 344.4  2.4 nm (W85), 334.4  0.2 
nm (W98), 330.2  1.0 nm(W115), and 338.2  0.6 nm (W128).  The data indicated that 
W85 is a class II/class III hybrid and is likely found in the headgroup region of the 
bilayer.  The λmax value of W98 is between Classes I and II, placing it below the 
headgroup region and possibly near the aqueous-hydrophobic core interface.  The λmax 
value of W115 is consistent with a class I tryptophan that is in a deeply buried position, 
possibly near the bilayer center.  This tryptophan position is only one helical turn from 
the break region and is likely the best indicator as to the turn’s environment.  The final 
tryptophan, W128, has a λmax value that places it between class I and class II, and 
therefore is probably located in the hydrophobic core of the first leaflet but is getting 
close to the lipid headgroup region. 
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Figure 3-10.  Fluorescence emission spectra for Cav182-136 single tryptophan mutants 
reconstituted into q=0.50 4.0% (w/w) DMPC/CHAPSO bicelles.  Each spectrum indicates 
the identity of the mutant, the raw data is shown as points and the fits are shown as solid 
lines.  The max from fits are indicated for each mutant. 
 
In order to validate that these single tryptophan mutants were not impacting the structure 
and/or dynamics of Cav182-136, an HSQC spectrum was obtained to compare 15N labeled 
Cav182-136 with all four tryptophans and Cav182-136(4F) (a construct where all four 
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tryptophan residues were mutated to phenylalanine).  The spectrum of Cav182-136(4F) had 
good chemical shift dispersion and showed only minor changes in its peaks location 
compared to Cav182-136 (Figure 3-11). 
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Figure 3-11.  Overlay of TROSY-HSQC spectra of Cav182-136 (red) and Cav182-136(4F) 
(blue). 
 
The relationship between the λmax and water exposure was interrogated further by 
looking at the relative percentage of water molecules associated with the indole side 
chain versus the percentage of lipid contacts (Trp-water/(Trp-Water+Trp-lipid)) during 
the course of the simulation.  From lowest exposure of the tryptophan residues to water to 
the highest exposure, the calculated values are, 2  4% (W115), 22  10% (W128), 32  
22% (W98), and 83  14% (W85) for the short simulations and 5  10% (W115), 23  
18% (W128), 42  26% (W98), and 89  8% (W85) for the 1 μs simulation.  The large 
change in water contacts observed between the short and long timescales likely indicates 
that the interplay between hydrophobic coverage and aqueous exposure is a slow 
converging parameter for the Cav182-136 molecule.  The ZCOM values for each tryptophan 
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were also determined and are shown in Figure 3-8.  Akin to the distributions of the break 
residues, the distributions of the tryptophans were broader for the short simulations than 
they were for the long simulations.  The average values for the 100 ns simulations were 
23.4  4.2 Å (W85), 7.5  2.5 Å (W98), -1.1  2.7 Å (W115), and 11.8  2.9 Å (W128).  
For the 1 μs simulation, the values were 23.7  2.2 Å (W85), 6.5  1.8 Å (W98), -4.0  
1.3 Å (W115), and 10.2  2.0 Å (W128).  Interestingly, W85 changed the least when 
comparing the short and long time course showing that its conformational flexibility (not 
in a helix) allows it to find a favorable position sooner than the other tryptophan sites.  
These values are strongly correlated with tryptophan emission measurements, as in the 
simulations W85 is at the top of the first leaflet, W128 is at the interface between the acyl 
chain-headgroup border, W98 is slightly buried within the lipid bilayer, and W115 is 
deeply buried in the hydrophobic core.  Clearly the simulations are yielding relevant 
information as to the actual bilayer depth of the break residues which cannot be probed 
using experimental techniques directly.  A cartoon representation of the protein 
embedded within the DMPC bilayer is shown in figure 3-12.  All values for all 
parameters obtained from the simulations are available in Appendix 3-1. 
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Figure 3-12.  Topological disposition of Cav82-136 in a DMPC bilayer.  Key residues in 
H1 (T91, K96, Y97, and R101), the break region (G108), and H2 (Y118) involved in 
hydrogen bonding and electrostatic interactions with the surrounding lipids are indicated.  
Phosphate atoms that are within 4.5 Å of Cav182-136 are shown in magenta, phosphate 
atoms in the bulk bilayer are shown in orange.  A water bridge between the backbone 
atoms of G108 (cyan spheres) and a lipid headgroup to the bottom leaflet is shown and 
may help stabilize the loss of breaking of H1. 
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CONCLUSIONS 
 
Caveolins are critical to proper caveolae function and appearance, and are 
intricately linked to a variety of diseased states.  For this reason, significant efforts have 
been undertaken to better understand the structure and function of caveolin.  In this 
chapter, significant strides have been made in elucidating the membrane bound structure 
and topology of caveolin-1 residues 82-136, which represents the structural core of the 
membrane interacting portion of the polypeptide. 
Using MD simulations which used NMR secondary structure data of Cav182-136 as 
a starting point, it was demonstrated that a U-shape conformation in the bilayer was 
energetically favorable.  It also was shown that the structure of Cav182-136 was dynamic 
showing fluctuations in its angle between the two helices that were largely due to lipid-
protein interactions.  However, this angle was consistent with a H1-H2 angle that was 
between 40 and 60°.  This analysis rules out caveolin having a transmembrane orientation 
or a fully extended peripheral orientation, as either of these models would require a very 
wide H1-H2 angle (>90°).  This also indicates that caveolin does not likely curve 
membranes by the same mechanism that other membrane curving proteins use (i.e. BAR 
domain proteins which rest on the surface of membranes to mediate curvature); therefore 
the findings presented in this chapter may serve as important advancement in directing 
future hypotheses attempting to elucidate the mechanism of caveolin-1 induced 
membrane curvature. 
Importantly, the break between the two helices was placed within the second 
leaflet of the hydrophobic core, indicating that caveolin does not completely transit the 
bilayer before it makes a dramatic turn.  Although this motif would appear to be 
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unfavorable due to a loss of intra-helical hydrogen bonds, the energetic penalty was likely 
compensated for by hydrogen bonding between the break residue G108 and lipid 
headgroups.  The placement of the break residues in the second leaflet as well as the 
overall depth profile in the simulations was strongly supported using tryptophan 
fluorescence experiments performed in bicelles.  The simulations also revealed that a 
specific orientation of the helices with respect to one another was favored (ρ1=343°, 
ρ2=111°) where residues in and around the break interact via van der Waals forces.  It 
was observed that residues towards the termini of the helices interact with lipids 
intercalated between them through hydrogen bonding.  The sum of these interactions may 
be critical to upholding the U-shaped motif in the membrane. 
It cannot go without mention, however, that these studies were performed in 
DMPC bilayers without the presence of cholesterol, which is a major component of 
caveolae.  Therefore it is critical that the next steps taken probe the possible role that the 
sterol has on these structural parameters.  Furthermore, the construct lacks 70% of the 
total protein, including three sites of cysteine palmitoylation.  Although the core 
membrane interacting segment has been investigated, a longer construct would help 
determine if distant regions of the protein are involved in defining the structural 
parameters that were obtained through the MD simulations.  Finally, it is known that 
caveolin oligomerizes and these simulations were performed using monomeric 
conditions.  Although it is not yet known how the protein oligomerizes, it will be of 
interest to determine how the oligomerization process changes the binding mode of 
caveolin in the bilayer. 
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Appendix 3-1.  Average Values of Parameters for Cav182-136 from MD Simulations 
 
 
 
 
 
 
 
Replicate θ ϕ ρ1 ρ2 Z  
G108[Å] 
Z  
I109[Å] 
Z  
P110[Å] 
α β 
45_1 44°±4° 39°±6° 353°±14° 325°±11° -6.0±2.1 -7.5±2.3 -9.7±2.1 101°±5° 63°±6° 
45_2 63°±11° 14°±7° 334°±17° 116°±10° -6.5±2.0 -7.1±1.9 -8.3±1.9 109°±7° 51°±9° 
45_3 34°±3° 24°±8° 34°±10° 330°±9° 0.7±2.3 -0.4±2.1 2.0±2.2 49°±7° 46°±7° 
45_4 12°±5° 28°±7° 327°±14° 328°±12° -5.4±2.6 -7.7±2.7 -8.8±2.7 76°±6° 66°±5° 
45_5 44°±5° 45°±6° 197°±13° 61°±11° -7.8±1.9 -4.8±1.8 -6.2±1.7 115°±7° 71°±10° 
45_6 62°±6° 6°±4° 324°±23° 137°±20° -6.4±1.9 -7.0±2.0 -8.1±1.8 109°±6° 49°±6° 
45_7 30°±3° 7°±5° 41°±9° 341°±9° -5.0±2.0 -4.7±2.0 -5.1±2.0 64°±6° 60°±6° 
45_8 45°±5° 6°±4° 335°±16° 288°±13° -5.3±2.2 -8.0±2.3 -8.7±2.2 96°±5° 52°±4° 
45_9 47°±9° 14°±6° 347°±15° 111°±12° -5.4±1.9 -6.1±1.8 -8.8±1.8 90°±11° 45°±5° 
45_10 29°±3° 13°±4° 217°±28° 112°±8° -5.5±1.6 -4.7±1.6 -4.5±1.6 73°±6° 68°±6° 
Avg±S.E. 41°±15° 20°±13° 251°±118° 215°±109° -5.3±2.1 -5.8±2.2 -6.6±3.3 88°±21° 57°±9° 
55_1 66°±12° 18°±6° 262°±19° 308°±13° -5.2±2.0 -7.3±1.8 -8.0±1.9 121°±9° 55°±8° 
55_2 27°±5° 22°±5° 318°±10° 17°±11° -8.9±1.9 -6.8±1.9 -7.7±2.0 84°±5° 63°±5° 
55_3 51°±5° 31°±5° 282°±15° 278°±9° -5.8±1.6 -6.3±1.7 -5.5±1.8 120°±6° 73°±7° 
55_4 59°±6° 25°±8° 354°±14° 334°±14° -3.4±2.0 -4.0±1.8 -5.0±1.7 106°±5° 47°±5° 
55_5 59°±7° 26°±9° 204°±16° 76°±25° -9.4±2.3 -7.1±2.4 -7.6±2.2 115°±10° 56°±9° 
55_6 26°±7° 10°±6° 218°±14° 293°±18° -6.9±2.3 -7.1±2.1 -6.2±2.0 80°±9° 55°±8° 
55_7 45°±7° 5°±4° 231°±18° 294°±12° -6.5±2.0 -7.6±2.0 -7.8±2.0 98°±8° 54°±6° 
55_8 61°±8° 23°±5° 191°±16° 103°±15° -7.2±1.8 -5.6±2.2 -6.4±2.3 105°±10° 45°±9° 
55_9 51°±9° 27°±8° 343°±13° 345°±12° -2.8±2.2 -3.6±2.1 -4.7±1.9 96°±7° 45°±6° 
55_10 23°±4° 17°±5° 344°±17° 274°±12° -5.0±1.9 -7.1±2.0 -7.3±2.1 84°±7° 74°±7° 
Avg±S.E. 47°±15° 20°±7° 275°±59° 232°±113° -6.1±2.0 -6.3±1.3 -6.6±1.2 101°±14° 57°±10° 
65_1 67°±6° 19°±7° 331°±13° 121°±10° -6.4±2.0 -7.0±1.8 -9.5±1.9 108°±8° 42°±8° 
65_2 67°±7° 21°±6° 343°±13° 104°±11° -7.7±1.9 -7.3±2.1 -8.5±2.1 132°±8° 65°±5° 
65_3 63°±10° 19°±10° 331°±12° 121°±11° -6.8±2.1 -7.6±2.1 -9.3±1.9 103°±6° 44°±9° 
65_4 84°±8° 13°±6° 202°±13° 76°±12° -5.2±1.7 -3.5±1.7 -5.6±1.6 126°±5° 43°±8 
65_5 47°±6° 7°±5° 344°±14° 108°±11° -3.9±1.8 -4.3±1.6 -6.7±1.6 97°±6° 51°±6° 
65_6 49°±7° 16°±6° 59°±19° 61°±12° -2.8±2.4 -3.7±2.2 -6.9±2.1 92°±12° 43°±11° 
65_7 66°±6° 12°±7° 221°±12° 133°±10° -9.0±2.0 -7.1±2.0 -6.6±1.7 123°±10° 59°±8° 
65_8 45°±7° 21°±8° 182°±18° 112°±15° -5.7±2.6 -2.9±2.6 -3.9±2.3 92°±8° 51°±7° 
65_9 30°±4° 18°±6° 215°±18° 96°±8° -8.8±2.0 -6.5±1.9 -6.2±1.9 99°±10° 82°±6° 
65_10 61°±7° 6°±4° 350°±15° 108°±10° -4.5±1.9 -5.2±1.9 -7.7±1.8 101°±5° 40°±7° 
Avg.±S.E. 58°±14° 15°±5° 257°±93° 104°±20° -6.1±2.0 -5.5±1.7 -7.1±1.6 107°±14° 52°±13° 
75_1 68°±7° 28°±10° 39°±19° 77°±11° -2.9±2.2 -3.3±2.2 -6.4±2.2 107°±8° 39°±6° 
75_2 58°±5° 12°±6° 339°±13° 122°±10° -4.5±2.7 -5.1±2.8 -7.0±2.4 106°±8° 51°±7° 
75_3 58°±7° 15°±8° 229°±12° 108°±12° -8.5±1.7 -6.9±1.8 -7.3±1.8 108°±7° 51°±6° 
75_4 63°±7° 24°±8° 288°±14° 322°±15° -4.6±1.8 -7.0±2.0 -7.6±2.1 120°±7° 57°±6° 
75_5 45°±6° 13°±7° 336°±18° 117°±13° -3.5±1.9 -4.1±2.0 -5.7±1.9 97°±6° 55°±5° 
75_6 65°±8° 65°±7° 323°±13° 340°±21° 3.9±3.1 2.4±2.4 4.1±2.6 105°±14° 41°±15° 
75_7 53°±7° 9°±5° 229°±29° 286°±13° -11.0±2.4 -9.7±2.4 -7.8±2.8 108°±11° 55°±8° 
75_8 57°±10° 19°±6° 337°±18° 120°±14° -5.3±2.2 -5.9±2.0 -7.5±2.0 109°±8° 55°±5° 
75_9 66°±5° 27°±6° 318°±13° 124°±10° -5.3±1.6 -6.7±1.4 -8.8±1.5 104°±6° 42°±5° 
75_10 79°±8° 29°±6° 353°±13° 118°±14° -4.1±2.8 -4.5±2.7 -7.2±2.5 116°±9° 38°±6° 
Avg.±S.E. 61°±9° 24°±15° 279°±90° 173°±95° -4.6±3.7 -5.1±3.0 -6.1±3.5 108°±6° 48°±7° 
85_1 73°±6° 20°±10° 347°±16° 16°±12° -4.5±2.2 -5.3±1.9 -5.8±1.7 100°±7° 27°±4° 
85_2 58°±7° 10°±6° 236°±13° 278°±17° -9.1±2.2 -7.5±2.2 -6.6±2.3 107°±6° 49°±9° 
85_3 68°±9° 10°±5° 350°±16° 111°±13° -4.3±2.2 -4.5±2.0 -6.5±2.2 104°±9° 37°±5° 
85_4 75°±9° 49°±4° 280°±12° 6°±13° 1.3±1.6 -2.4±1.6 -4.1±1.5 126°±6° 52°±9° 
85_5 143°±9° 27°±11° 260°±15° 44°±37° 1.7±2.4 -0.6±2.4 2.1±2.4 145°±6° 6°±5° 
85_6 74°±7° 37°±6° 310°±15° 128°±11° -4.6±2.0 -5.8±1.8 -8.7±1.7 113°±9° 41°±6° 
85_7 61°±5° 8°±5° 350°±18° 121°±10° -3.8±2.7 -3.8±2.3 -5.5±2.1 104°±5° 45°±5° 
85_8 68°±7° 46°±6° 336°±26° 266°±15° 0.2±2.8 2.8±2.2 1.8±1.8 93°±9° 27°±8° 
85_9 33°±4° 13°±7° 358°±14° 316°±15° -8.0±2.1 -9.3±2.1 -10.2±2.0 88°±5° 57°±5° 
85_10 48°±5° 18°±6° 79°±17° 43°±17° -3.5±2.0 -5.6±1.9 -8.6±1.8 80°±10° 35°±8° 
Avg.±S.E. 70°±27° 24°±15° 291°±81° 133°±109° -3.5±3.4 -4.2±3.3 -5.2±4.0 106°±18° 38°±14° 
Total Avg. 55°±20° 21°±12° 271°±92° 171°±109° -5.1±2.9 -5.4±2.5 -6.3±3.0 102°±17° 50°±13° 
1-μs 
Simulation 
53°±5° 27°±6° 331°±22° 124°±12° -5.9±1.7 -6.8±1.6 -9.3±1.3 99°±7° 49°±7° 
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Appendix 3-2.  Sequences of Protein Constructs Utilized 
 
Construct Protein Sequence 
Cav182-136 
 
DGIWKASFTTFTVTKYWYRLLSALFGIPLALIWGIYFAILSFLHI
WAVVPSIKS 
Cav182-136 
(4F) 
DGIFKASFTTFTVTKYFYRLLSALFGIPLALIFGIYFAILSFLHI
FAVVPSIKS 
Cav182-136 
(W85) 
DGIWKASFTTFTVTKYFYRLLSALFGIPLALIFGIYFAILSFLHI
FAVVPSIKS 
Cav182-136 
(W98) 
DGIFKASFTTFTVTKYWYRLLSALFGIPLALIFGIYFAILSFLHI
FAVVPSIKS 
Cav182-136 
(W115) 
DGIFKASFTTFTVTKYFYRLLSALFGIPLALIWGIYFAILSFLHI
FAVVPSIKS 
Cav182-136 
(W128) 
DGIFKASFTTFTVTKYFYRLLSALFGIPLALIFGIYFAILSFLHI
WAVVPSIKS 
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Appendix 3-3.  Mutagenesis Primers Utilized 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Construct Primer Sequence 
F85W 5’-GGATCCATGGACGGTATCTGGAAAGCGTCTTTCACCAC-3’ 
F98W 5’-CACCGTTACCAAATACTGGTTCTACCGTCTGCTGTC-3’ 
F115W 5’-CTGGCGCTGATCTGGGGTATCTACTTCGC-3’ 
F128W 5’-CTTTCCTGCACATCTGGGCGGTTGTTCCGTC-3’ 
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Chapter 4.  Cysteine Scanning Mutagenesis of Full Length Caveolin-1 
Helps to Explain Its Multi-Faceted Interactome 
 
ABSTRACT 
 
Caveolin-1 is critical in modulating the architecture and engineering the functions 
of caveolae.  At the heart of its functional role is the scaffolding domain (CSD, residues 
82-101), which is thought to be involved both signal transduction and cholesterol 
transport.  However, the exact topology of the CSD is unknown, and is unpredictable due 
to its unusual amino acid composition.  Additionally, it is unknown how cholesterol may 
modulate the topology of caveolin-1.  To elucidate the CSD topology with respect to the 
membrane, the accessibilities of single cysteine mutants (spanning residues 82-111) to 
the membrane impermeant reagent biotin-maleimide was probed after reconstituting the 
protein into phospholipid bicelles.  These mutants were confirmed to have not caused 
major perturbations to the wild-type caveolin structure by probing the secondary structure 
of the protein using far UV circular dichroism measurements.  The protein was then 
gently reconstituted in phospholipid bicelles using a native preparation method.  In 
bicelles where the planar region was composed purely of DMPC, it was determined that 
residues 82-87 were in an aqueous exposed region, whereas residues 88-111 were either 
in a dynamic or a membrane buried environment.  Interestingly, the inclusion of a 
cholesterol analog, cholesteryl hemisuccinate (CHS) at a biologically relevant 
concentration modulated the overall topology of the protein by increasing the exposure of 
the 90-95 region.  The findings in this chapter support the multi-faceted nature proposed 
for the CSD in terms of binding signaling molecules and interacting with cholesterol 
simultaneously. 
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INTRODUCTION 
 
The caveolin-1 scaffolding domain is thought to mediate many of the important 
functions of caveolae (Figure 4-1).  In particular, the CSD plays an outsized role as it 
interacts with a number of cell signaling proteins (Src-like kinases, Ha-Ras, endothelial 
nitric-oxide synthase (eNOS), and G protein α-subunits), associates with cholesterol, and 
has been shown to be important for caveolin-1 oligomerization in vivo 16-21.  For example, 
this region has been implicated in the negative regulation of eNOS activity where 
mutations in the CSD resulted in a significant to total loss of inhibitory activity 195.  
Additionally, cholesterol binding is thought to be mediated through residues 94-101 
which contain a cholesterol recognition/interaction amino acid consensus (CRAC) motif 
(sequence VTKYWFYK) 159,196.  Importantly, this stretch of the protein has been 
demonstrated to be necessary and sufficient for membrane binding 72. 
N-Terminal 
Domain
Residues 1-81
(unstructured)
Scaffolding 
Domain 
Residues 82-101
(87-101 helical)
Transmembrane 
Domain
Residues 102-134
(helix-break-helix)
C-Terminal Domain
Residues 135-178
(structurally uncharacterized)
GIP1 87 128 178107 111101 13
5
DGIWKASFTTFTVTKYWFYR
 
Figure 4-1.  Domain map highlighting the sequence of the caveolin-1 scaffolding 
domain.  The amphipathic nature of the sequence (red) makes CSD burial difficult to 
predict. 
 
Despite the diversity in the physiochemical properties of ligands that the CSD is 
purported to interact with, its degree of exposure with respect to the bilayer remains 
unverified, and therefore it is unclear how this region can bind to soluble proteins and 
cholesterol simultaneously.  To date, there have been a number of inquiries into the 
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topological disposition of the CSD.  A study by Epand et al examining the fluorescence 
emission of two tryptophan residues, W85 and W98, within water-soluble CSD based 
peptides (construct caveolin-1 82-103) found that there was little change in their emission 
properties when mixed with multilamellar vesicles, indicating that there was not a strong 
affinity of these peptides to bind to membranes.  In the same study, two-dimensional 1H 
magic angle spinning nuclear Overhauser enhancement spectroscopy (NOESY) 
experiments examined the interaction of these peptides with multilamellar vesicles 159.  
The NOESY experiments supported an interaction between the peptide and the lipid 
headgroups but did not suggest a specific orientation or topology of the peptides with 
respect to the membrane.  A study by Aoki et al employed molecular dynamics 
simulations to compare the topology of two caveolin-1 constructs, one encompassing part 
of the intramembrane domain (residues 103-122) and one encompassing part of the 
scaffolding and intramembrane domains (residues 94-122) 77.  This simulation showed 
that caveolin-1 adopted a U-shape conformation within the bilayer when the CSD portion 
of the polypeptide was included but not in its absence.  This simulation revealed that the 
CSD was critical to the U-shape conformation.  The simulation placed half of the 
residues of the CSD within the headgroup region and the other half within the 
hydrophobic core of the membrane.  A later simulation study examining the same stretch 
of the protein (residues 94-122) embedded in lipid bilayers found that tryptophan residue 
98 was found within 0 ± 2.5 Å of the phosphate headgroup and the depth was dependent 
on the amount of phospholipid unsaturation and the presence of cholesterol 46.  In this 
study it was found that cholesterol changed the topology by giving the protein a more 
interfacial, surface orientation.  Finally, the studies in Chapter 3, which are based on most 
 114 
 
of the CSD being part of a helical region, showed that the CSD enters the membrane in a 
near vertical fashion and that residue 96 is likely where the protein enters the 
hydrophobic core of the membrane.  These studies support the scaffolding domain as 
being the portion of caveolin-1 which first enters the hydrophobic core of the bilayer but 
have not pinpointed a specific residue experimentally.  Although these studies have been 
very insightful most of them have lacked the entire CSD, utilize short caveolin-1 
peptides, and are based on simulations.  Therefore it is still an open question as to the 
topology of the CSD in the context of the full-length caveolin-1 protein, where other 
regions of the protein could have an effect on the burial of this crucial region.  It is also 
unclear as to how the exposure of the protein to cholesterol would modulate the 
accessibility of the CSD. 
To definitively characterize the membrane topology of the CSD, cysteine 
scanning mutagenesis was utilized, which has been used extensively to elucidate the 
topology of membrane proteins 197-202.  Using this approach, single cysteine mutants of a 
full length caveolin-1 construct (mychisCav11-178) scanning the entire scaffolding domain 
(residues 82-101) and a portion of the intramembrane domain (residues 102-111) were 
generated.  Next, fluorescence anisotropy studies were utilized to determine at which q 
value (ratio of DMPC to DHPC) bicelles began to take on properties similar to that of 
pure lipid vesicles (Tm measurements).  Each mutant was then purified into 2.3% (w/v) 
qeff = 1.0, DMPC/DHPC bicelles using nickel affinity chromatography and their 
secondary structure was evaluated using far-UV circular dichroism spectroscopy by 
comparison to the wild-type (cysteine lacking) control to identify any sites which 
disrupted caveolin structure.  For cysteine accessibility studies, the protein was isolated 
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out of E coli membranes to ensure only properly folded and trafficked mutants were 
analyzed 29.  These membranes were then solubilized into 2.3% (w/v) qeff = 1.0, 
DMPC/DHPC bicelles or 2.3% (w/v) qeff = 1.0, DMPC (80%)/cholesteryl hemisuccinate 
(CHS) (20%)/DHPC bicelles.  Using reactivity to a membrane impermeant biotin-
maleimide reagent as a measure of accessibility, it was found that in both bicelle systems 
the accessibility of mychisCav11-178 changed dramatically over the sequence of the CSD.  
This study pinpointed the CSD as being the portion of the polypeptide which first enters 
the hydrophobic core of the bilayer.  Interestingly, it was found that the mychisCav11-178 
construct was more deeply buried in pure DMPC bilayers compared to a more realistic 
environment which contained the CHS.  This result suggested that various factors limit 
the penetration depth of caveolin into the lipid bilayer and this may have implications on 
caveolin’s degree of exposure in vivo. 
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MATERIALS AND METHODS 
 
Determination of gel (liquid ordered) to fluid (liquid disordered) transition 
temperatures for bicellar solutions 
For fluorescence anisotropy experiments, 2.3% (w/w) DMPC–DHPC mixtures 
having qeff values ranging from 0.05 to 1.50 (0.05, 0.30, 0.50, 0.75, 1.00, 1.50) were 
prepared on a 3 gram scale using the following method (For an explanation of qeff see 
Chapter 1).  DMPC in chloroform (50 mg/mL) was added (83, 370, 510, 630, 720, and 
827 μL respectively) to a 2 mL microcentrifuge tube.  After this, 1,6-Diphenyl-1,3,5-
hexatriene (DPH, Sigma Aldrich, St. Louis, MO) dissolved in methanol was added to 
each tube to give a final concentration of 6 μM once resuspended in the final volume.  
The samples were then dried under vacuum overnight.  The samples were then hydrated 
by the addition of 2.78 mL of water, and 75 μL of 40× buffer (400 mM HEPES, 4.0 M 
NaCl pH 7.4).  Finally, DHPC was added as a 25% (w/w) stock (in water) to achieve clear 
homogeneous solutions (250, 196, 169, 146, 129, and 107 μL respectively).  These 
solutions were used directly for anisotropy measurements.  DMPC vesicles were prepared 
by the addition of 16 mg of DMPC in 600 μL of chloroform with DPH dissolved in 
methanol (1:500 DPH to lipid molar ratio).  The sample was then dried under vacuum 
overnight and rehydrated using 2.78 mL of water and 75 μL of 40× buffer (400 mM 
HEPES, 4.0 M NaCl pH 7.4).  This solution was sonicated for 5 minutes using a Branson 
sonifier (Danbury, CT) equipped with a microtip to generate small unilamellar vesicles.  
The solution became translucent and was then centrifuged at 20,000 x g for 5 minutes at 
 117 
 
room temperature to remove titanium particles and non-vesicular lipid aggregates.  The 
supernatant was diluted 4-fold for the fluorescence experiments. 
Fluorescence emission spectra were acquired with magnetic stirring using a 1  1 
cm quartz cuvette on an Agilent Eclipse fluorometer (Santa Clara, CA).  The excitation 
and emission slit widths were both set to 5 nm.  The fluorescence emission intensity was 
measured with excitation (355 nm) and emission (430 nm) with polarizers parallel to 
each other (both oriented at 0° from vertical) and repeated in the perpendicular 
configuration (excitation 0° and emission 90°).  The correction factor for emission 
monochromator transmission efficiency was obtained from the ratio of emission intensity 
at 0° and 90° with the excitation polarizer oriented at 90°.  Melting curves were generated 
for both pure DMPC vesicles and DMPC/DHPC bicelles by examining the change in 
DPH anisotropy as a function of temperature over the range of 2-36 °C. 
 
Cloning and Construction of Caveolin-1 Mutants 
A construct encompassing the full-length caveolin-1 (mychisCav11-178, Appendix 4-
1, underlined portion denotes CSD) was purchased from Genscript (Piscataway, NJ).  
This construct contained three mutations where cysteines 133, 143, and 156 were mutated 
to serine in order to avoid labeling of these positions (Appendix 4-1, bolded).  These 
mutations have been shown to be non-disruptive for caveolin-1 trafficking to caveolae in 
vivo 35.  To the C-terminus, a myc antibody epitope tag and 6× polyhistidine tag were 
included for immuno-detection and affinity purification respectively (Appendix 4-1, myc 
epitope is in blue, histidine tag is in red).  Single cysteine mutants were generated from 
residues 82-111 using the Agilent quick change mutagenesis kit (Santa Clara, CA) for a 
total of 30 mutants (See Appendix 4-1 for full length and mutant constructs).  Primers 
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were designed using the free web-based primerX program, see Appendix 4-2 
(Bioinformatics.org).  See Appendix 2-3 for PCR reaction and cycling conditions.  The 
construct DNA was sub-cloned into the multiple cloning site of the pET 24a vector 
(Novagen, La Jolla, CA) between the NdeI and XhoI restriction sites for expression in E. 
coli (strain BL21DE3).  Transformation protocols are described in Appendix 2-4. 
 
Protein Expression 
Expression of the protein of interest was accomplished using the auto induction 
method developed by Studier et al 147.  Briefly, starter cultures were grown with rapid 
shaking (250 rpm) at 37°C in MDG media supplemented with kanamycin for 24 hours.  
After this time period, a 1:100 dilution of this culture was made into 3 mL of ZYM-5052 
media and the growth was harvested after 12 hours by centrifugation at 20,000 x g for 5 
minutes followed by removal of the supernatant and storage of the bacterial pellet at -
80°C until use.  For large scale growths the procedure was performed exactly the same 
except a 1:1000 dilution of the culture was made into 1 L of ZYM-5052 media.  It was 
determined that growth dynamics were very similar under both conditions. 
 
Non-denaturing Purification of mychisCav11-178 into Phospholipid Bicelles using Mini-
Nickel Spin Column for Circular Dichroism Spectroscopy Measurements 
All steps of the preparation were performed at 4°C.  Cell pellets were resuspended 
into 600 μL of lysis buffer (1 mg/mL lysozyme, 5 mM -mercaptoethanol, 10 mM 
imidazole, 50 mM phosphate pH 8.0, 50 mM Empigen BB®detergent (Sigma Aldrich, St. 
Louis, MO), and 300 mM NaCl).  Next, the suspension was gently mixed over the course 
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of 30 minutes.  This step was followed by disruption of the bacterial membranes using a 
Branson sonifier (Danbury, CT) equipped with a microtip.  The suspension was then spun 
at 20,000 x g for 20 minutes to pellet insoluble cellular debris.  The protein was purified 
using a nickel-NTA spin column (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions.  The wash buffer was composed of 5 mM -mercaptoethanol, 40 mM 
imidazole, 50 mM phosphate pH 8.0, 50 mM Empigen BB® detergent, and 300 mM 
NaCl.  The detergent was then exchanged for bicelles by washing the column with 2.3% 
(w/w) qeff = 1.0 DMPC/DHPC bicelles, 5 mM -mercaptoethanol, 40 mM imidazole, 50 
mM phosphate pH 8.0, and 100 mM NaCl.  The elution buffer was composed of 2.3% 
(w/w) qeff = 1.0 DMPC/DHPC bicelles, 5 mM -mercaptoethanol, 500 mM imidazole, 5 
mM phosphate pH 8.0, and 100 mM NaCl.  Samples were eluted into 100 μL of bicelles 
and imidazole was removed using Zeba® spin desalting columns equilibrated with 7 mM 
DHPC in 10 mM phosphate pH 7.0 supplemented with 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP).  Total protein levels were normalized by determining 
the concentration spectroscopically by measuring the absorbance at the 280 nm 
wavelength and diluting the samples to the same concentration (roughly 20 μM) using a 
bicellar solution. 
 
Circular Dichroism Spectroscopy Measurements 
 Circular dichroism measurements were performed on all mutants using a JASCO 
CD Spectrophotometer (Easton, MD) held at 25°C.  A 0.1 mm path length quartz cuvette 
containing a sample volume of 50 μL was utilized for measurements.  Data were 
collected by scanning every wavelength from 260-190 nm in continuous scan mode at a 
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speed of 200 nm/minute taking 16 accumulations for signal averaging.  A background 
spectrum of 2.3% (w/w) qeff = 1.0 DMPC-DHPC bicelles was used as a blank.  The data 
were converted from machine units () to delta epsilon units (∆ε) using the following 
equation: 
∆ε =  × (0.1 × ܯܴܹ)(ܲ × ܥ) × 3298 
 
 
Here, MRW is the mean residue weight (protein MW/number of residues in the protein), 
P is the pathlength in cm, and C is the protein concentration in mg/mL yielding units of 
M-1cm-1. 
 
Large Scale Preparation of mychisCav11-178 into Phospholipid Bicelles for Analytical 
Ultracentrifugation Experiments 
 Cells from a 1 L growth were harvested by centrifugation at 5,000 x g and were 
washed with 0.9% (w/v) NaCl.  The pellet was then resuspended in 120 mL of a lysis 
buffer containing 50 mM phosphate pH 8.0, 300 mM NaCl, and 2% (v/v) Empigen BB® 
detergent by stirring for 10 minutes at 4℃.  The Sample was then sonicated using a 
Branson sonifier for a period of 15 minutes total, holding the temperature below 8℃.  
After this time period, the supernatant was cleared by centrifugation at 50,000 x g for 1 
hour at 4℃.  The sample was passed through a 0.2 μm syringe filter and was then bound 
to a Ni-Sepharose column.  The bound protein was washed using a gradient going from 
0-50 mM imidazole over a 125 mL volume, with buffer A being composed of 50 mM 
phosphate pH 8, 300 mM NaCl, and 50 mM Empigen BB®, and buffer B being composed 
of 50 mM phosphate pH 8, 300 mM NaCl, 250 mM imidazole, and 50 mM Empigen 
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BB®.  After weakly bound species were removed the protein was eluted in a buffer 
containing 50 mM phosphate pH 8, 300 mM NaCl, 200 mM imidazole, and 50 mM 
Empigen BB®.  The protein-containing fractions were pooled and the sample was 
concentrated to ~ 10 mL using ultrafiltration.  This sample was then filtered through a 0.2 
μm syringe filter and was injected onto a Sephacryl 300 HR 16/60 column (GE 
Healthcare, Piscataway, NJ) equilibrated with a buffer comprised of 50 mM phosphate 
pH 7.4, 150 mM NaCl, 10 mM Empigen BB® and was isolated from other species 
remaining in the sample.  The sample was quantified by examining the absorbance at the 
280 nm wavelength. 
To incorporate mychisCav11-178 into bicelles, an appropriate amount of the gel 
filtration fraction was bound to a Ni-NTA spin column.  The detergent was then 
exchanged for bicelles by washing the column twice with 300 μL of a buffer containing 
2.3% (w/w) qeff = 1.0 DMPC/DHPC bicelles, 250 mM imidazole, 10 mM HEPES pH 7.4, 
and 100 mM NaCl.  The imidazole was removed using Zeba® spin desalting columns 
equilibrated with 7 mM DHPC in 10 mM HEPES pH 7.4, and 100 mM NaCl with D2O at 
71.7% (v/v) (density matched conditions).  The samples were then diluted to 30 ± 2 μM, 
15 ± 2 μM, and 7.5 ± 2 μM for analytical ultracentrifugation experiments by dilution of 
the desalted eluant with a bicellar solution. 
 
Sedimentation Equilibrium Experiments of mychisCav11-178 
 Sedimentation equilibrium experiments were performed at 25°C using a Beckman 
XL-A analytical ultracentrifuge and a 4-hole AnTi-60 rotor.  Samples were loaded into a 
6-channel charcoal-filled epon centerpiece and a reference solution containing only 
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buffer was included.  An equilibration time of 24 hours at 10,000 rpm was given before 
scans were taken.  Equilibrium measurements (280 nm) were taken from 10,000 rpm to 
35,000 rpm with 1000 rpm steps.  The bicellar mychisCav11-178 solution was analyzed at 
three speeds (25,000, 30,000, and 35,000 rpm) and at three concentrations.  These 
experiments were carried out at 25℃.  The data were fit to a single-species model using a 
non-linear least squares approach with the software Heteroanalysis (version 1.1.0.58, 
University of Connecticut Storrs, CT).  The molecular weight, baseline, and reference 
concentrations were allowed to float during the fitting process. 
 
Native Membrane Preparation from E. coli and Reconstitution into qeff = 1.0 Bicelles  
Unless otherwise noted, all steps of the preparation were performed at 4°C.  Cell 
pellets were resuspended into 1000 μL of Tris-Acetate EDTA pH 8.0 buffer 
supplemented with 100 mM β-mercaptoethanol by a briefly vortex mixing.  This step was 
followed by disruption of the bacterial membranes using a Branson sonifier (Danbury, 
CT) equipped with a microtip for 96 seconds in an ice bath.  The suspension was then 
spun at 5,800 x g for 15 minutes to pellet insoluble cellular debris.  The supernatant was 
then spun at 20,000 x g for 2 hours to pellet bacterial membranes.  The supernatant was 
removed and the pelleted membranes were then washed using 100 mM phosphate 
buffered saline (PBS) pH 7.4 supplemented with 0.5 mM TCEP and the previous 
centrifugation step was repeated.  Next, the supernatant was removed and the bacterial 
membranes were solubilized by adding 30 μL of 2.3% (w/w) qeff = 1.0 DMPC-DHPC 
bicelles prepared in 100 mM PBS and 0.15 mM TCEP or the same buffer except 2.3% 
(w/w) qeff = 1.0 DMPC/DHPC bicelles contained 20% CHS (Anatrace, Muamee, OH) in 
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terms of the total lipid mol %.  Solubilization required 2 minutes of vortex mixing.  
Insoluble material was then pelleted by centrifugation of the sample at 20,000 x g for 1 
hour at 25°C.  After this step, 25 μL of the supernatant was removed for analysis. 
Bicelles that contained CHS had to be prepared using a specialized protocol.  
Briefly, the requisite amounts of CHS (10.65 mg, CHS-TRIS salt) and DMPC (47.53 mg) 
for 5 g of 2.3 % (w/w) qeff = 1.0 DMPC/CHS/DHPC bicelles were co-dissolved in a 2:1 
mixture of chloroform (1 mL) and were then dried down under vacuum.  This solution 
was then reconstituted into a buffer containing all the final components, (i.e. 215 μL 25% 
(w/v) DHPC, 500 μL 1 M PBS, 4.22 mL H2O) which was subsequently lyophilized for 24 
hours.  This mixture was then taken into water for a second round of lyophilization before 
use in experiments.   
 
Chemical Accessibility Assays 
After purification, a Western blot was performed by diluting 5μL of the 
reconstituted material five fold into SDS-PAGE sample buffer in order to estimate the 
mychisCav11-178 concentrations using densitometry.  The samples were then diluted to a 
similar level using a bicellar solution before the labeling reaction was performed.  This 
step was performed in order to avoid cysteine labeling rate differences that would come 
from differences in the total level of protein between each single cysteine mutant.  After 
dilution of samples to the same level, 20 μL of a mychisCav11-178 construct was added to a 
tube containing 200 nL of 20 mM Nα-(3-Maleimidylpropionyl)Biocytin (biotin-
maleimide, Invitrogen, Carlsbad, CA) dissolved in dimethylsulfoxide for a final 
concentration of 0.2 mM biotin maleimide.  The sample was briefly mixed and then the 
biotin-maleimide reaction was allowed to continue for 10 minutes at 21℃.  The reaction 
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was quenched by the addition of -mercaptoethanol to a concentration of 100 mM and 
incubation for 10 minutes.  After this time period, the sample was diluted to 100 μL using 
SDS-PAGE sample buffer and was used for Western analysis.  This process was repeated 
three times each for both lipid systems using different membrane preparations to account 
for culture to culture and run to run variability. 
 
SDS-PAGE and Immunoblotting 
Protein samples were resolved on 15% polyacrylamide gels and transferred to a 
PVDF membrane.  The blots were blocked with 0.5% (w/v) casein in TBST, and probed 
using avidin-alkaline phosphatase conjugate (BioRad, Hercules, CA).  Next, the blots 
were stripped, blocked with 5% (w/v) powdered milk in TBST and re-probed using the 
anti-myc primary antibody (Sigma Aldrich, St. Louis, MO) and anti-mouse alkaline-
phosphatase conjugate secondary antibody (Thermofisher Corporation, Rockford, IL).  
Signals were detected using ECL reagent (BioRad, Hercules, CA).   
 
Image and Data Analysis 
Immuno-blots and biotinylation blots were imaged and quantified using a BioRad 
ChemiDoc XRS+ system and Image Lab software (BioRad, Hercules, CA).  
Biotinylation and total protein levels were estimated by densitometry where the % 
Biotinylation of a given mutant was calculated as the Biotin signal/Protein signal.  The 
data set was normalized with respect to the most effectively labeled mutant on the blot 
and the relative biotinylation was plotted versus the cysteine replacement.  Relative 
biotinylation signals for each position were averaged with the maximum number of 
neighbor relative biotinylation signals within ± one residue to generate average relative 
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biotinylation plots.  Igor Pro 6.22A (WaveMetrics, Inc., Lake Oswego, OR) was used to 
fit the data (for both fluorescence anisotropy and relative biotinylation data) to a 
sigmoidal function of the form: 
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RESULTS AND DISCUSSION 
 
Construction of Helix-1 Cysteine Mutants and Chemical Accessibility Assay 
Principle 
The CSD topology is intriguing; there evidence suggesting that there are an 
almost inconceivable number of ligands which are both soluble and membrane bound in 
nature 159,203,204.  The sequence of the CSD is rich with charged and polar uncharged 
amino acids and this makes the prediction of this region’s burial difficult to ascertain.  
There have been a number of inquiries into the exposure of this region but they have been 
inconclusive due to the use of short peptide-based constructs which lack either portions 
or entire domains of caveolin 159,205,206.  To tackle the question of CSD burial to better 
understand how the protein would be able to bind a diverse variety of ligands, the well 
established method of cysteine scanning mutagenesis strategy was utilized 197-202.  In this 
method, constructs are generated which lack native cysteines and have a single cysteine 
replacement site introduced in a one by one fashion along the length of the sequence 
under investigation.  The single cysteine mutant is then subjected to a water soluble 
cysteine reactive probe which can only react with de-protonated (aqueous located) 
cysteines (Figure 4-2).  Advantageously, this approach gives residue by residue 
information on the degree of aqueous exposure and yields information in the broader 
trend in accessibility along the protein sequence.  Therefore, 30 single cysteine mutant 
constructs of full length caveolin were generated replacing every individual amino acid 
within the scaffolding domain and part of the intramembrane domain (82-111) (see 
Appendix 4-1) to examine the exposure along the sequence to a water soluble cysteine 
reactive probe, biotin-maleimide.  Additionally, an anti-myc epitope and 6× 
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polyhistidine tag were added to the C-terminus for immunodetection and nickel affinity 
purification respectively.  It has been shown that the addition of a 6× polyhistidine tag to 
the C-terminus does not affect caveolin’s ability to form caveolae, bolstering the 
argument that the C-terminal tags do not significantly impact caveolin’s native activity29.   
Binding if reaction 
occurs
Signal
No binding if 
reaction doesn’t 
occur
Noise
Biotin-maleimide
Avidin-AP 
Conjugate
-Pi
ECL
ECL
 
Figure 4-2.  Assay principle for cysteine scanning mutagenesis.  Caveolin-1 single 
cysteine mutants (red) that are de-protonated will react with maleimides.  In the aqueous 
environment cysteines have a pKa of ~8.5 and will be de-protonated to a significant 
extent at physiological pH.  The pKa in the hydrophobic core of the bilayer is raised to 
~14 due to the low dielectric of the membrane environment, and therefore these cysteines 
will not be able to react. 
 
Validation of Bicelles using Fluorescence Anisotropy Measurements 
 A key aspect of this experimental strategy is the need for an actual lipid bilayer in 
which the protein can be embedded into natively, which rules out the use of detergent 
micelles.  However, E. coli membranes alone are not ideal because they are comprised 
mainly of phosphatidylethanolamine (PE) (mammalian cells have a roughly equal 
mixture of phosphatidylethanolamine and phosphatidylcholine) and there is no control 
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over the membrane composition (i.e. the introduction of cholesterol).  This can hinder 
studies that examine how different lipids present in the environment play a role in 
modulating membrane protein burial.  Liposomes are also an option but due to the length 
of time that is required to form them by detergent dialysis; they are not viable as cysteine 
oxidation and heterogeneity in the topologies of reconstituted protein can complicate the 
analysis of these studies.  Bicelles, on the other hand, have the advantage of being easy to 
produce, usable in high throughput purification, and also have a bilayered region which 
membrane proteins can bury their hydrophobic portions into natively.  Additionally the 
membrane environment of the bicelles can be modulated with a variety of different lipid 
species 119,120. 
 Bicelles can be prepared at different q ratios, however, it is not clear at which q 
the bicelle begins taking on properties less akin to that of a mixed micelle and more like 
those of a pure bilayer as the physical properties of the bicelle are linked to its size.  
Therefore, the transition temperature of bicelles (Tm) was examined at various qeff values 
(Figure 4-3).  This was achieved by incorporating a small amount of the DPH 
fluorophore into the samples and measuring the anisotropy as a function of temperature.  
It has been well established that DPH anisotropy is quite sensitive to the amount of lipid 
order in a system 207.  When DPH was incorporated into pure DMPC bilayers, the 
anisotropy ranges from 0.340 (highly ordered) at 2°C to 0.085 (low degree of order) at 
36°C.  Importantly, sigmoidal behavior was observed which is indicative of a cooperative 
phase transition of the lipid going through a liquid ordered to liquid disordered transition.  
As one may expect, although the Tm approached that of the pure DMPC bilayer, phase 
transitions did tend to be broader with lower degrees of anisotropy in the gel phase.  This 
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can likely be attributed to the presence of the detergent which will have a finite presence 
in the bilayered region, disrupting gel phase packing of the DMPC.  Analysis of the 
melting curve gave a Tm of 23.10.4°C, in agreement with measurements performed on 
DMPC bilayers using other techniques 121.  These studies were then carried out for 
bicelles for a range of qeff values (0.05-1.5).  For the lowest qeff examined (0.05), the 
anisotropy value ranged from 0.08 at 2°C to 0.03 at 36°C, and the Tm could not be 
evaluated because it was outside of the range of temperatures used in the experiment 
(well below the freezing point of water).  However, it was observed as q increased, the 
phase behavior of the bicelles became more like that of a pure DMPC bilayer.  For 
example, qeff = 1.5 bicelles have a Tm of 24.4 ± 0.2 °C with an anisotropy ranging from 
0.310 to 0.090.  Therefore a q = 1.0 was chosen for these studies because it was the 
lowest q that had a Tm within 1 degree of a pure DMPC bilayer and did not have a 
significant increase in viscosity that would make these solutions difficult to work with.  
Also, it appeared that the anisotropy value was similar in magnitude when pure DMPC 
vesicles and qeff = 1.0 bicelles were around the Tm, suggesting that the detergent levels did 
not significantly alter the degree of disorder for the lipids fluid phase (this was more so 
the case for higher qeff values).  Importantly, this study cautions against the use of bicelles 
with very low q values as they may behave as mixed micelles and will not likely capture 
the essence of a true bilayer.  Low q bicelles will likely subject proteins to detergent 
effects that could disrupt their topological analysis. 
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Figure 4-3.  Left)  Anisotropy for various qeff’s as a function of temperature.  Right)  
The Tm derived from fitting the melting curves to a sigmoidal equation shows that as q 
increases, the Tm approaches the transition temperature for a pure DMPC bilayer 
hyperbolically. 
 
Evaluation of the mychisCav11-178 Oligomeric State in Bicelles 
As caveolin-1 is known to behave as a high order oligomer in vivo, it was desirable to 
know if the protein employed in these studies would have this behavior.  Oligomeric 
activity could influence the interpretation of the accessibility assays by blocking sites that 
would be exposed if not for being part of an aggregate.  However, it had been shown 
previously that caveolin-1 residues 62-178 did not aggregate in vitro, and was in fact 
monomeric 43.  Therefore the protein was expressed and purified on a large scale by 
nickel affinity and gel filtration chromatography, re-bound onto a mini-nickel spin 
column for exchange into bicelles, and then once reconstituted into bicelles, the protein 
was desalted into a buffer containing D2O under a density matched condition for qeff = 1.0 
bicelles (previously determined in the lab of KJG), (Figure 4-4 shows purification traces). 
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Figure 4-4.  Purification traces for large scale expression of mychisCav11-178.  A)  Nickel 
affinity chromatogram.  B)  Gel filtration chromatogram.  Red star denotes peaks that 
were collected. 
 
Using this approach the reconstituted protein was subjected to a sedimentation 
equilibrium study in the AUC.  In a sedimentation equilibrium study, the protein travels 
down the solution column until sedimentation and diffusion are in equilibrium.  Once the 
species has come to equilibrium, absorbance optics measure the concentration profile of 
the protein across the analytical ultracentrifuge sample cell, and this profile gives 
information on the protein’s molecular weight.  The experiment was performed with 
bicelles under a “density matched” condition, which means that the density of the buffer 
and the partial specific volume of the bicelles are the same.  Therefore, bicelles will no 
longer sediment and the concentration profile will allow the extraction of a molecular 
weight of only the protein and not the protein-detergent aggregate.  The molecular weight 
of the protein was analyzed at three different speeds and three different concentrations 
(see methods).  When the data were fit to an ideal single species model, a molecular 
weight of 22,961  103 Da was obtained, which compares nicely to the calculated 
molecular weight of 22,674 Da (Figure 4-5).  Therefore, the protein is behaving as a 
monomer, which greatly reduces the complexity of accessibility analysis in these studies. 
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Figure 4-5.  Sedimentation equilibrium profiles for mychisCav11-178 in bicelles.  Panels A-
C represent a concentration of 30 μM, D-F a concentration of 15 μM, and G-I a 
concentration of 7.5 μM.  Residuals are displayed underneath each equilibrium profile. 
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Evaluation of Single Cysteine Mutants Effect on mychisCav11-178 Secondary Structure 
One of the benefits of cysteine scanning mutagenesis studies is that it requires 
only a single site of cysteine replacement to be introduced, making it a mild way to probe 
protein topology.  However, it is still important to evaluate what effect the mutation will 
have on the proteins structure and function.  Although caveolin-1 is involved in a myriad 
of cellular processes, there is no clear assay to evaluate the correctness of the protein’s 
fold.  Therefore, a comparative study was performed utilizing far UV circular dichroism 
spectroscopy.  In this study the closeness of each single cysteine mutant in terms of its 
secondary structure was compared to that of the cysteine lacking control, which contains 
all the native caveolin-1 residues in the 82-111 stretch. 
For these studies the over-expressed mychisCav11-178 had to be purified away from 
endogenous E. coli proteins which would add a large bias to circular dichroism spectra.  
A non-denaturing strategy was employed using the mild detergent Empigen BB® to bind 
the protein to a mini nickel spin column.  Once the background proteins were eliminated 
by washes with a low concentration of imidazole, mychisCav11-178 was exchanged into 
bicelles and eluted as shown in Figure 4-6. 
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Lysis: 1mg/mL lysozyme, 50 mM 
empigen, 5 mM -ME, 50 mM 
phosphate, 300 mM NaCl pH 8.0 + 
Sonication
Bind to nickel resin
Wash I: 50 mM empigen, 5 mM -ME, 40 mM 
imidazole, 50 mM phosphate, 300 mM NaCl pH 
8.0
Wash II: 2.3 % (w/w) q = 1.0 DMPC-DHPC 
bicelles, 5 mM -ME, 40 mM imidazole, 50 
mM phosphate, 150 mM NaCl pH 8.0
Elution: 2.3 % (w/w) q = 1.0 DMPC-DHPC 
bicelles, 5 mM -ME, 250 mM imidazole, 
50 mM phosphate, 150 mM NaCl pH 8.0
 
Figure 4-6.  Reconstitution strategy for obtaining highly pure mychisCav11-178 in bicelles. 
 
Using this method the protein was purified in high yields.  Examination of each mutant 
using CD spectroscopy by scanning the 190-240 nm region revealed the global secondary 
structure of the single cysteine mutants (Figure 4-7).  Although it has been shown in a 
number of membrane mimetic systems that the caveolin-1 is predominantly α-helical, 
there are no reports of its secondary structure in bicelles.  It appears that in agreement 
with many studies in other detergent systems, the protein has considerable α-helical 
character 68,75,208.  Each mutant overlay shows that no major disruption of the native 
structure was caused by cysteine replacement with each spectrum showing the 
characteristic 190 nm maxima and 208 and 222 nm minima.  Although intensity 
differences were present, it should be noted that the Zeba® desalting columns used to 
remove imidazole lose their effectiveness at high concentrations of salts and may result in 
differences from the bicelle blank that could cause these small variations.  Therefore, 
these data are only to be used qualitatively. 
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Figure 4-7.  Far UV CD spectra of single cysteine mutants (red) compared to the wild-
type protein (dashed). 
 
Analysis of the CSD Topology Using Cysteine Scanning Accessibility Studies 
 To examine the topology of mychisCav11-178, a native preparation strategy was 
utilized which entailed isolating protein from E. coli membranes.  This was undertaken 
because the protein associated with the E. coli plasma membrane would have been 
reconstituted into the membrane by the bacterial translocon, giving it a native fold.  Cryo-
electron microscopy studies have shown that caveolae can be formed in E. coli by the 
 137 
 
expression of caveolin 29.  From these bacterial systems it was also shown that the 
behavior of caveolin was identical to that of the protein in mammalian systems.  For 
instance, the topology was as predicted (N- and C- termini were on the same side of the 
membrane), isoforms that typically cannot form caveolae did not result in heterogeneous 
formation (C. elegans caveolin-1 and caveolin-2), and a S80E mutation, that results in 
Golgi retention of the protein in mammalian cells, was sufficient to disrupt caveolae 
formation 29.  All constructs expressed in this study were found to be localized to the E. 
coli membrane fraction (Figure 4-8).  After isolation of the membranes through a series 
of centrifugation steps and washes, the membrane pellet was flooded with bicelles; 
bicelles do not likely cause disruption of the protein’s topology/fold as they are very 
mild.  Importantly it was found that TCEP had to be present during the purification steps 
to keep the cysteine residues from oxidizing. 
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Figure 4-8.  Western blot showing that mychisCav11-178 single cysteine mutants (residue 
replacement site identified by number under the band) are localized to the membrane 
fraction of E. coli.  Levels of protein were somewhat variant; however, this reflected the 
expression difference and not the difference in trafficking to the membrane.  The band at 
25 kD is a molecular weight marker. 
 
As mentioned, E. coli membranes do not natively contain cholesterol.  This 
approach allowed a comparative study to be undertaken to investigate the impact a 
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cholesterol-like analogue (CHS) would have in determining the protein’s topology once 
reconstituted into the bicelles (Figure 4-9). 
Cholesterol Cholesteryl Hemisuccinate  
Figure 4-9.  Comparison of cholesterol and cholesteryl hemisuccinate.  Cholesteryl 
hemisuccinate has a negative charge at neutral pH whereas cholesterol is neutral. 
 
Cholesterol is not amenable to incorporation into bicelles at ambient temperatures when it 
is at concentrations above 5% by mol.  The cholesterol analog CHS was used because 
bicelles can be prepared with 20% by mol which is the concentration of cholesterol that is 
natively found in mammalian cells.  Therefore the CHS containing bicelles should be a 
very good mimic of caveolae which are mainly composed of saturated phospholipids in a 
cholesterol rich environment 26.  Additionally, CHS confers a negative charge to the 
bicelles and at 20% by mol it would give a similar charge to that of the inner leaflet of the 
plasma membrane which has a phosphatidylserine and phosphatidylinositol concentration 
approaching 15% by mol 210.  This approach also allowed the probing of what role 
cholesterol would have on CSD topology as caveolin is thought to bind cholesterol 
through an interaction with residues 94-101 (VTKYWFR) 140,159. 
Before subjecting the mutants to a reaction with biotin-maleimide, a gel was run 
on the reconstituted material to evaluate the total protein levels.  In these experiments, the 
total protein concentration needed to be similar to avoid rate differences (i.e. if a 
particular mutant was expressed 10 times greater than others, it may appear to get labeled 
to a greater extent but in reality this may result from more reactants being present).  Once 
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the relative amounts were determined, all samples are diluted to a similar concentration 
using bicelles. 
A time course was run to evaluate the degree of background labeling of the wild-
type compared to a construct positioned at the beginning of the CSD (W85C) and a 
construct predicted to be buried in the intramembrane domain (L106C) (Figure 4-10).  
This time course showed low background labeling of the cysteine lacking control and a 
persistent low level of biotinylation for L106C compared to W85C.  For practical 
reasons, the 10 minute time course was chosen as the point to quench the reaction in 
subsequent experiments. 
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Figure 4-10.  Time course evaluation of single cysteine mutants located in the CSD 
(W85C) and intramembrane domain (L106C).  Additionally the cysteine lacking control 
was evaluated.  Legend indicates the time point where the reaction was quenched and 
subsequently analyzed by Western blotting.  Clearly, there is little change in the extent of 
relative biotinylation over the time course investigated.  Low levels of relative 
biotinylation (0-5%) were observed for the cysteine lacking control. 
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After all 30 of the reconstituted mutants were reacted with biotin-maleimide and 
quenched, a gel was run to quantify the degree of biotinylation for each replacement site.  
Mutants that have cysteine residues outside the bilayer (accessible) will show high 
reactivity towards biotin-maleimide, whereas those with their cysteine replacement site 
within the bilayer (inaccessible) will show low reactivity.  Each mutant was evaluated for 
its degree of biotinylation on a per protein basis by Western blot analysis.  Figure 4-11 
shows total protein amounts as indicated by blotting the anti-myc antibody after 
solubilization in membranes and dilution to a similar level based on densitometry for 2.3 
% (w/w) q = 1.0 DMPC/DHPC bicelles  (Panel A) and DMPC/CHS/DHPC bicelles 
(Panel B).  Clearly, all the levels are similar during the reaction, which discounts labeling 
rate enhancements brought on by differentials in the amount of protein (levels were 
within a factor of 10). 
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Figure 4-11.  Representative Western blots for biotinylation experiments of mychisCav11-
178 in bicelles.  A)  Anti-myc (left) and Avidin-AP (right) blots for DMPC/DHPC 
bicelles.  B)  Anti-myc (left) and Avidin-AP (right) for DMPC/DHPC/CHS bicelles.  
Note that in the Avidin-AP blot for DMPC/DHPC bicelles, it appears that residue 95 
would be strongly labeled.  However, if one is to look at the total protein blot, it appears 
that there is more material deposited during Western blotting and therefore, this residue 
has low labeling. 
 
Figure 4-11 also shows blots probing for biotinylation using the avidin-AP 
conjugate for qeff = 1.0 DMPC/DHPC bicelles (Panel A) and DMPC/CHS/DHPC bicelles 
(Panel B).  There is a noticeable difference in the magnitude of the signal between 
cysteines that could be labeled and those that were inaccessible to the reagent.  However, 
these differences must be evaluated on a per protein basis as differences in transfer can be 
a large source of error.  To account for this issue, a plot of relative biotinylation versus 
cysteine replacement site was prepared for both data sets (Figure 4-12).  The data showed 
that for q = 1.0 DMPC/DHPC bicelles there is strong labeling with the biotin-maleimide 
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reagent for residues 82-89.  In the 90-96 region, the labeling appears to be dynamic 
(typically less than 40% of the highest labeled residue on the blot) and is very low for 
residues 97-111 (typically less than 15% of the highest labeled residue on the blot).  
Interestingly, F92C is an outlier where it shows a very high relative accessibility 
compared to surrounding residues.  Due to outliers such as F92C, biotinylation is best 
evaluated as a trend in the accessibility of the CSD by making a plot of the cysteine 
replacement site versus the averaged local accessibility (Figure 4-12, average local 
accessibility denotes the relative biotinylation of the position indicated plus the relative 
biotinylation of the two flanking sites on either side, see methods).  Here a sigmoidal 
function can be fitted to the data and shows that the accessibility changes dramatically 
over the CSD region where residue A87C is the inflection point. 
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Figure 4-12.  A)  Relative biotinylation values for each of the 30 constructs reconstituted 
into DMPC/DHPC bicelles.  Note that the residue with the highest degree of biotinylation 
varied blot to blot, and therefore no individual residue has a value of 1.  Error bars 
represent the average of 3 experiments.  The amount of error in these experiments is large 
(for labeled residues its ~10-20%, for unlabeled residues this error is much lower) but 
there is a statistically significant difference in the regions of high and low degrees of 
labeling.  B)  Averaged relative biotinylation values for each position were used to 
examine the overall trend in accessibility, and helps to interpret how the accessibility of 
mychisCav11-178 changes along the length of the sequence. 
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This position has an averaged accessibility of 0.42 and could represent a position that 
would be exposed and buried an equal amount of the time, giving it a position that could 
be somewhere within the headgroup region of the bilayer.  It appears that the CSD has a 
dichotic position in the membrane where residues from 82-95 would be at least partially 
exposed and residues 96-111 would be buried.  Data from the fluorescence studies 
presented in Chapter three indicated that tryptophan 85 and 98 are located in the 
headgroup (accessible) and the hydrophobic core (inaccessible) regions of the bilayer 
respectively when reconstituted into DMPC/DHPC bicelles and are therefore consistent 
with this analysis of the cysteine scanning mutagenesis study 208.  These accessibility data 
are also in agreement with the molecular dynamics simulation work in chapter three 
indicating that in pure DMPC bilayers residues 91 - 95 are located around and within the 
headgroup region.  Therefore, residues in this stretch may show heterogeneous burial that 
would be somewhere between that of an exposed and that of an unexposed region’s burial 
208. 
Figure 4-11 shows that for q = 1.0 DMPC/CHS/DHPC bicelles there is strong 
labeling for the first 14 residues which drops off starkly at position 96.  These data are 
somewhat different than the data for the pure DMPC bicelles as they show that in the 
presence of CHS, mychisCav11-178 seems to have more even labeling across the CSD and a 
more dramatic drop off in accessibility that occurs between positions 93 and 98 (Figure 
4-13).  Fitting of the averaged relative accessibility data to a sigmoidal function extracts 
an inflection point of T95C, which has an averaged accessibility of 0.35 (Figure 4-13).  
Although in both lipid environments the accessibility to the water soluble probe changes 
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rapidly in the CSD region, pinpointing it as the likely region of membrane entrance, the 
appearance of the averaged relative biotinylation plots are quite different. 
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Figure 4-13.  A)  Relative biotinylation values for each of the 30 constructs reconstituted 
into DMPC/DHPC/CHS bicelles.  As was the case for DMPC/DHPC bicelles, the residue 
with the highest degree of biotinylation varied blot to blot, and therefore no individual 
residue has a value of 1.  Error bars represent the average of 3 experiments.  B)  
Averaged relative biotinylation values for each position were used to examine the overall 
trend in accessibility.  It appears that CHS promoted a more even degree of biotinylation 
across the CSD and a considerably more distinct drop off in accessibility. 
 
Residues 97-111 are poorly accessible in both of the lipid systems.  A deeper look at the 
difference between the two lipid systems by examining which residues were statistically 
different in terms of their relative biotinylation indicated that scaffolding domain residues 
T90, T91, T93, V94, and T95 and the intramembrane domain residue F107 were more 
accessible when CHS was included (Table 4-1).  It should be noted that F107 was an 
outlier compared to residues surrounding it.  Therefore CHS appears to be adjusting the 
exposure of the CSD such that the residues 90-95 are sampling an environment with a 
higher degree of water penetration on average.  This result could be indicating that CHS 
has decreased the depth of bilayer penetration or tilt of the CSD. 
 145 
 
As both lipid systems should be in the gel phase at the temperature employed 
(Tm= 22.000.27℃ for DMPC/DHPC bicelles and sterols broaden the Tm), it appears that 
the sterols presence or the surface charge that CHS imparts on the bicelles could be 
impacting the protein’s topology.  This is in agreement with a number of studies 
investigating the response of caveolin-1 topology to the inclusion of the sterol in bilayers.  
For instance, a molecular dynamics simulation of residues 94-122 embedded in bilayers 
showed that the protein was much deeper in pure DPPC bilayers than it was in 70:30 
DPPC:cholesterol bilayers 46.  Additionally, tryptophan fluorescence quenching studies on 
a caveolin-1 intramembrane peptide (residues 103-122) showed that acrylamide was able 
to quench tryptophan residues within the protein more effectively when reconstituted into 
membranes composed of POPC/DPPC/Cholesterol versus those composed of purely 
POPC suggesting that cholesterol limits the proteins insertion into bilayers. 
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Single Cysteine Position Relative Biotinylation 
DMPC/DHPC 
Relative Biotinylation 
DMPC/DHPC/CHS 
82 0.69  0.28 0.48  0.17 
83 0.67  0.15 0.46  0.20 
84 0.84  0.14 0.58  0.21 
85 0.97  0.05 0.71  0.19 
86 0.53  0.11 0.77  0.29 
87 0.42  0.08 0.53  0.18 
88 0.39  0.14 0.81  0.18 
89 0.31  0.10 0.56  0.25 
90 0.09  0.04 0.44  0.23 
91 0.23  0.08 0.70  0.18 
92 0.69  0.32 0.67  0.11 
93 0.09  0.03 0.42  0.22 
94 0.14  0.11 0.42  0.06 
95 0.20  0.11 0.50  0.12 
96 0.06  0.02 0.14  0.12 
97 0.06  0.03 0.03  0.02 
98 0.05  0.03 0.03  0.01 
99 0.02  0.01 0.02  0.01 
100 0.01  0.01 0.12  0.09 
101 0.01  0.01 0.03  0.05 
102 0.00 0.01 0.01  0.01 
103 0.01  0.01 0.01  0.01 
104 0.02  0.01 0.01  0.01 
105 0.01  0.01 0.05  0.06 
106 0.03  0.02 0.02  0.01 
107 0.06  0.01 0.17  0.06 
108 0.02  0.01 0.04  0.05 
109 0.01  0.01 0.00  0.01 
110 0.01  0.01 0.00  0.01 
111 0.01  0.01 0.01  0.01 
Table 4-1.  Table of relative biotinylation value averages of three trials for both bicelle 
types employed in this study.  Residues that had statistically significant differences in 
accessibility have been highlighted in orange. 
 
The relationship between caveolin-1 and cholesterol is very intimate and 
caveolin-1 is considered to be a cholesterol binding protein 19.  Residues (94-101) in the 
CSD form a putative CRAC motif 159,196.  The disposition of cholesterol within bilayers 
places its hydroxyl moiety in the headgroup region and the sterol portion within the 
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hydrophobic core of the bilayer 210.  The accessibility data show that in the presence of 
CHS, the CRAC motif would be partially exposed and partially buried and could 
facilitate the interaction with both the headgroup and ring regions of cholesterol.  
Interestingly, the CHS seems to cause an increase in the exposure of the CRAC motif 
residues 94 and 95; however, it is unclear how this would enhance the proposed 
interaction between the protein and cholesterol.  Taken together, our accessibility data 
clearly show that the CSD could simultaneously interact with cholesterol and be available 
for binding to soluble proteins.  These studies rationalize how the CSD can interact with 
both signaling proteins and cholesterol simultaneously. 
Using a residue by residue approach, these data have revealed that the CSD 
topology is even more complicated than originally thought and is highly dependent on the 
lipid environment.  To complicate this matter further, there is no consensus as the two 
dimensional structure of the CSD.  Our circular dichroism data suggest that the protein is 
indeed highly α-helical in bicelles.  Bioinformatic and structural studies that have been 
performed have suggested that the stretch of residues in the 82-111 region is composed of 
two α-helices, one amphipathic, and one transmembrane (residues 81-92 and residues 97-
107) 66,68,75.  However, the structural studies performed in Chapter 3 indicated that the 
region is comprised of a single transmembrane α-helix (residues 87-107) 208.  Although 
the former model of two α-helices is difficult to project, the depth of a single α-helix 
ranging from residues 87-111 can be estimated.  A pure DMPC bilayer is roughly 40 Å 
thick, with a single headgroup region having a thickness of ~10 Å 208.  If A87C 
(inflection point of sigmoidal fit in pure DMPC bilayers) is in the center of the headgroup 
region, there is about 5 Å between this residue and the borderline of the hydrophobic 
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core.  If one assumes that the protein does not tilt at all, this helix would extend 31.5 Å 
placing the C-terminus of the helix into the center of the opposing headgroup region.  
However, if that was the case, labeling of F107C-M111C would have been observed, 
therefore it is likely that if this protein was behaving as a single membrane spanning α-
helix, A87C would be above the center of the headgroup region or the protein would be 
tilted to account for the results of this study (Figure 4-14).  This model places the turn 
residues within the second leaflet, near the interface between the headgroup and the 
hydrophobic core regions of the bilayer.  This is consistent with the simulation data 
presented in Chapter 3.  However, due to the nature of these studies (i.e. relative scale), 
the only definitive statement that can be made is between an intramembrane region 
versus an exposed region 211.  The assumption that A87 would be in the center of the 
headgroup region may be incorrect.  Therefore it is unclear how the protein would enter 
the bilayer, although the averaged relative biotinylation data could be consistent with a 
large degree of tilt. 
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Figure 4-14.  Speculative cartoon of the topology of caveolin-1 residues 82-111 in 
DMPC/DHPC bicelles based on biotinylation data.  This analysis is based on residues 87-
107 being α-helical, residues 93-111 being intramembrane (less than 20% relative 
biotinylation), A87 being positioned somewhere within the headgroup region.  The 
ability of arginine 101 (red) to reach the headgroup region of the bilayer to avoid 
desolvation of the positive charge is likely key in determining the degree of tilt.  Gray 
circles are going away from the viewer whereas black circles are coming towards the 
viewer. 
 
The addition of cholesterol to a pure DMPC bilayer at 20% by mol increases the 
bilayer thickness by about 1-2 Å, however, the thickness increase is due to the rigidifying 
of the acyl chains, therefore the headgroup region likely remains a similar thickness 
212,213.  With T95C being buried close to the headgroup-hydrophobic core border, a model 
assuming a single transmembrane α-helix model (residues 87-107) would place F107C 
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~7 Å short of the opposite leaflet’s headgroup region assuming a tilt angle of zero.  This 
model would be consistent with the topological data presented here, however the burial of 
the arginine would likely have to be compensated for by the protein having to tilt 
somewhat to avoid shedding its hydration layer (Figure 4-15). 
When examining the primary sequence of the 82-111 region, it is interesting to 
speculate as to the rationale of why caveolin may prefer cholesterol rich bilayers 
compared to the bulk membrane.  There are a number of charged residues in the CSD, 
two of which are expected to be in inaccessible regions in both lipid systems employed 
that could be key in maintaining the depth of caveolin-1 in the bilayer (K96 is completely 
across species and isoforms and R101 is positive charge conserved).  The more deeply 
buried DMPC model shows that K96 and R101 would have to extend their aliphatic 
chains significantly to secure the charges outside of the bilayer.  In the presence of 
cholesterol the protein is less deeply buried and charged residues would be closer to the 
bilayer surface.  This position could allow snorkeling of these residues out of the 
hydrophobic core to avoid desolvation of the guanidino/lysine moieties more readily.  
This hypothesis will likely need experimental validation to gain stronger support.  
Additionally, it will be worthwhile to examine the trend of labeling in bicelles composed 
of negatively charged lipids to determine if the sterol’s presence changes the topology or 
if the presence of a negative charge on the CHS moiety could bring on topological 
differences (perhaps by electrostatic interactions with K96 and R101).  If the assumption 
that the inflection point is not within the headgroup region, these models become less 
constrictive, nonetheless, it is clear that the 96-111 region seems to be inaccessible and 
these residues would be positioned within the hydrophobic core of the membrane. 
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Figure 4-15.  Speculative cartoon of the topology of caveolin-1 residues 82-111 in a 
DMPC/DHPC/CHS bicelles based on biotinylation data.  This analysis is based on 
residues 87-107 being α-helical, residues 96-111 being intramembrane (less than 10% 
relative biotinylation), T95 being positioned somewhere within the headgroup region.  As 
was the case for caveolin in DMPC/DHPC bicelles, the ability of arginine 101 (red) to 
reach the headgroup region of the bilayer to avoid desolvation of the positive charge will 
likely affect the way the protein tilts.  Gray circles are residues going away from the 
viewer whereas black circles are residues coming towards the viewer. 
 
The data corroborate other studies that probed binding of caveolin-1 to some of its 
partners.  For example, eNOS binding to caveolin-1 has been shown to be dependent on a 
triplet of residues (T90, T91, and F92), which according to the accessibility data, would 
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be exposed and available for binding in cholesterol rich bilayers but less exposed in pure 
DMPC bilayers 195.  Clearly this interaction is occurring outside of the hydrophobic core 
of the bilayer, with the more exposed portion of the CSD.  This is a reasonable location 
for CSD-protein interactions considering that many of the caveolin-1 interaction partners 
such as eNOS, Src kinases, and G proteins are soluble proteins which are held proximal 
to the membrane surface by acylation 17,215.  It seems that cholesterol could optimize the 
CSD interactions with soluble ligands. 
The uniform inaccessibility of residues 96-111 in both cases supports a variety of 
tilts but doesn’t support a horizontal surface orientation (as some models predict 66), as 
this would give an oscillating accessible/non-accessible pattern 215,216.  Therefore, this 
result places the putative loop formed by the intramembrane domain in the hydrophobic 
core as has been suggested by others in the field 66,75-77.  The accessibility data 
corroborate the intramembrane turn location that has been proposed in Chapter 3.  
However, due to the scale being relative, a more concrete experimental metric will likely 
be needed to fully corroborate this assertion. 
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CONCLUSIONS 
 In this chapter, single cysteine mutants of caveolin-1 were reconstituted into 
biologically relevant (in terms of Tm) DMPC/DHPC bicelles and DMPC/CHS/DHPC 
bicelles for secondary structure evaluation using circular dichroism and topological 
evaluation using chemical accessibility assays.  This is the first example of cysteine 
scanning studies employing biotin-maleimide having been performed on over-expressed 
membrane proteins natively reconstituted into bicelles.  The accessibility studies showed 
a clear trend in labeling, where the residues become decreasingly accessible as the 
position of the mutation approaches the putative turn region of caveolin-1 in both 
membrane environments.  This data provides a strong indication that the CSD is likely 
the portion of the protein which first enters the bilayer.  Importantly, the entrance point 
into the hydrophobic core can now be more confidently positioned to residue 96, which is 
buried in both model systems.  The postulation of a membrane embedded turn seems to 
be reasonable as evidenced by the lack of labeling in the 108-110 region, however, one 
must err caution as these residues have been shown to be sensitive to substitution 70.  In 
any case, it appears that the studies employed have lead to a refinement of the topology 
model of caveolin-1.  This study also showed that CHS, which closely resembles 
cholesterol and imparts negative charge, modifies the CSD topology by increasing its 
exposure one helical turn.  Structural data will likely be critical in deciphering how this 
interaction changes caveolins membrane positioning on the molecular level.  In the 
future, the examination of the remainder of the intramembrane domain (residues 112-
134) using the same technique will be important for determining the overall burial and 
exit point from the membrane.  This chapter presents clear topological data which help 
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explain the multi-faceted functionality of the CSD and shed light on the role that the lipid 
environment plays in determining the proteins aqueous exposure. 
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Appendix 4-1.  Sequences of Protein Constructs Utilized 
 
mychisCav11-178  MSGGKYVDSE GHLYTVPIRE QGNIYKPNNK AMADELSEKQ VYDAHTKEID LVNRDPKHLN DDVVKIDFED VIAEPEGTHS 
FDGIWKASFT TFTVTKYWFY RLLSALFGIP MALIWGIYFA 
ILSFLHIWAV VPSIKSFLIE IQSISRVYSI YVHTVSDPLF 
EAVGKIFSNV RINLQKEIEQ KLISEEDLLE HHHHHH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Construct Sequence of 82-111 Portion 
Wild-Type N-DGIWKASFTTFTVTKYWFYRLLSALFGIPM-C 
D82C N-CGIWKASFTTFTVTKYWFYRLLSALFGIPM-C 
G83C N-DCIWKASFTTFTVTKYWFYRLLSALFGIPM-C 
I84C N-DGCWKASFTTFTVTKYWFYRLLSALFGIPM-C 
W85C N-DGICKASFTTFTVTKYWFYRLLSALFGIPM-C 
K86C N-DGIWCASFTTFTVTKYWFYRLLSALFGIPM-C 
A87C N-DGIWKCSFTTFTVTKYWFYRLLSALFGIPM-C 
S88C N-DGIWKACFTTFTVTKYWFYRLLSALFGIPM-C 
F89C N-DGIWKASCTTFTVTKYWFYRLLSALFGIPM-C 
T90C N-DGIWKASFCTFTVTKYWFYRLLSALFGIPM-C 
T91C N-DGIWKASFTCFTVTKYWFYRLLSALFGIPM-C 
F92C N-DGIWKASFTTCTVTKYWFYRLLSALFGIPM-C 
T93C N-DGIWKASFTTFCVTKYWFYRLLSALFGIPM-C 
V94C N-DGIWKASFTTFTCTKYWFYRLLSALFGIPM-C 
T95C N-DGIWKASFTTFTVCKYWFYRLLSALFGIPM-C 
K96C N-DGIWKASFTTFTVTCYWFYRLLSALFGIPM-C 
Y97C N-DGIWKASFTTFTVTKCWFYRLLSALFGIPM-C 
W98C N-DGIWKASFTTFTVTKYCFYRLLSALFGIPM-C 
F99C N-DGIWKASFTTFTVTKYWCYRLLSALFGIPM-C 
Y100C N-DGIWKASFTTFTVTKYWFCRLLSALFGIPM-C 
R101C N-DGIWKASFTTFTVTKYWFYCLLSALFGIPM-C 
L102C N-DGIWKASFTTFTVTKYWFYRCLSALFGIPM-C 
L103C N-DGIWKASFTTFTVTKYWFYRLCSALFGIPM-C 
S104C N-DGIWKASFTTFTVTKYWFYRLLCALFGIPM-C 
A105C N-DGIWKASFTTFTVTKYWFYRLLSCLFGIPM-C 
L106C N-DGIWKASFTTFTVTKYWFYRLLSACFGIPM-C 
F107C N-DGIWKASFTTFTVTKYWFYRLLSALCGIPM-C 
G108C N-DGIWKASFTTFTVTKYWFYRLLSALFCIPM-C 
I109C N-DGIWKASFTTFTVTKYWFYRLLSALFGCPM-C 
P110C N-DGIWKASFTTFTVTKYWFYRLLSALFGICM-C 
M111C N-DGIWKASFTTFTVTKYWFYRLLSALFGIPC-C 
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Appendix 4-1.  Mutagenesis Primers Utilized 
 
Construct Primer Sequence 
D82C 5’-GAAGGTACCCACTCTTTCTGTGGTATCTGGAAAGCGTC-3’ 
G83C 5’-CCCACTCTTTCGACTGTATCTGGAAAGCG-3’ 
I84C 5’-CCACTCTTTCGACGGTTGTTGGAAAGCGTCTTTCAC-3’ 
W85C 5’-CTTTCGACGGTATCTGTAAAGCGTCTTTCACC-3’ 
K86C 5’-CTTTCGACGGTATCTGGTGTGCGTCTTTCACCACCTTC-3’ 
A87C 5’-CTTTCGACGGTATCTGGAAATGTTCTTTCACCACCTTCACCG-
3’ 
S88C 5’-GTATCTGGAAAGCGTGTTTCACCACCTTCAC-3’ 
F89C 5’-GTATCTGGAAAGCGTCTTGTACCACCTTCACCGTTAC-3’ 
T90C 5’-
GTATCTGGAAAGCGTCTTTCTGTACCTTCACCGTTACCAAATAC-
3’ 
T91C 5’-CTGGAAAGCGTCTTTCACCTGTTTCACCGTTACCAAATAC-3’ 
F92C 5’-GCGTCTTTCACCACCTGTACCGTTACCAAATACTG-3’ 
T93C 5’-GCGTCTTTCACCACCTTCTGTGTTACCAAATACTGGTTC-3’ 
V94C 5’-CTTTCACCACCTTCACCTGTACCAAATACTGGTTC-3’ 
T95C 5’-CTTTCACCACCTTCACCGTTTGTAAATACTGGTTCTACCGTC-
3’ 
K96C 5’-CCACCTTCACCGTTACCTGTTACTGGTTCTACCGTC-3’ 
Y97C 5’-CTTCACCGTTACCAAATGTTGGTTCTACCGTCTGC-3’ 
W98C 5’-CGTTACCAAATACTGTTTCTACCGTCTGCTG-3’ 
F99C 5’-CGTTACCAAATACTGGTGTTACCGTCTGCTGTCTG-3’ 
Y100C 5’-CAAATACTGGTTCTGTCGTCTGCTGTCTGCG-3’ 
R101C 5’-CAAATACTGGTTCTACTGTCTGCTGTCTGCGC-3’ 
L102C 5’-
CCAAATACTGGTTCTACCGTTGTCTGTCTGCGCTGTTCGGTATC-
3’ 
L103C 5’-GTTCTACCGTCTGTGTTCTGCGCTGTTC-3’ 
S104C 5’-GTTCTACCGTCTGCTGTGTGCGCTGTTCGGTATC-3’ 
A105C 5’-CTACCGTCTGCTGTCTTGTCTGTTCGGTATCCCG-3’ 
L106C 5’-CGTCTGCTGTCTGCGTGTTTCGGTATCCCGATG-3’ 
F107C 5’-CTGTCTGCGCTGTGTGGTATCCCGATGG-3’ 
G108C 5’-GTCTGCGCTGTTCTGTATCCCGATGG-3’ 
I109C 5’-CTGCGCTGTTCGGTTGTCCGATGGCGCTGATC-3’ 
P110C 5’-GCGCTGTTCGGTATCTGTATGGCGCTGATCTGG-3’ 
M111C 5’-
CTGCGCTGTTCGGTATCCCGTGTGCGCTGATCTGGGGTATCTAC-
3’ 
 
 
 
 
 157 
 
Chapter 5.  The Lipid Environment and Proline at Position 110 
Modulate the Aqueous Exposure of Caveolin-1 
 
ABSTRACT 
The hallmark conformational feature of caveolin-1 is that it has an unusual 
topology where both N- and C- termini are cytoplasmic as a result of a membrane-
embedded turn.  Recent biophysical studies have revealed that a highly conserved proline 
residue located at position 110 (P110) and the protein’s association with cholesterol are 
critical to the structure and topology of caveolin.  Some studies have suggested that the 
protein is dramatically altered and becomes linearized upon the substitution of proline 
110 to alanine, whereas others suggested that there is very little change in the proteins 
conformation.  There have been reports that cholesterol results in secondary structure 
changes to the protein (increased β-strand character) and also causes global topological 
changes.  This work utilizes a functional construct of caveolin-1 (Cav162-178) reconstituted 
into DPC micelles to characterize structural and accessibility changes that occur upon the 
P110A substitution (Cav162-178(P110A)).  Additionally, cholesterol’s effect on 
determining the protein’s exposure was examined by reconstituting the protein in 
micelles composed of both DPC and cholesterol-PEG600.  To unveil global and local 
changes in the environment of the protein upon alanine substitution and the presence of 
cholesterol, four evenly-spaced tryptophan residues native to the caveolin-1 protein were 
utilized as fluorescent reporters.  Near and far UV circular dichroism spectroscopy 
experiments were used to examine changes in aromatic residue packing and global 
secondary structure between constructs.  Next, fluorescence λmax and Stern-Volmer 
quenching analysis were used to examine global (all tryptophan residues present) and 
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local (single tryptophan mutants) accessibility differences.  Fluorescence λmax and Stern-
Volmer quenching analysis revealed that upon mutation and inclusion of cholesterol, 
local changes in tryptophan accessibility occurred.  Additionally, a fluorescence 
resonance energy transfer experiment was used to further examine conformational 
changes that may be occurring in the presence of the cholesterol mimic.  This study 
supports the structural importance of P110 in maintaining a specific caveolin-1 fold, but 
downplays pervious inquiries that suggested an over-arching topological role.  This study 
also indicates that cholesterol may cause small changes in the protein’s fold but large 
changes in the proteins aqueous exposure. 
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INTRODUCTION 
Caveolins are found within cholesterol rich domains in the bilayer called caveolae.  
They all contain a highly conserved 33 amino acid long intramembrane domain (residues 
102-135 in caveolin-1) that has been postulated to form an unusual re-entrant loop within 
the hydrophobic core of the lipid bilayer resulting in a cytoplasmic location for both the 
N- and C- termini 42,66,71,74.  The position of this loop within the intramembrane domain 
of caveolin-1 was suggested to be comprised of four amino acids located at positions 
108-111 based on primary sequence analysis 66. 
In Chapter 3, nuclear magnetic resonance spectroscopy (NMR) experiments 
performed on a caveolin-1 construct containing the entire intramembrane domain and the 
N-terminal flanking region (residues 82-136) revealed that the secondary structure of this 
region was comprised of two helices, each containing ~20 amino acids (residues 87-107 
and residues 111-128) separated by a three residue break in helicity (residues 108-110) 
208.  The three amino acids in the unstructured region are glycine 108, isoleucine 109, and 
proline 110 and are thought to form a re-entrant loop structure.  Mutagenesis experiments 
employing NMR revealed that the identities of the amino acids in this region were critical 
to the caveolin-1 structure 70.  It was found that positions 108 and 109 could only tolerate 
conservative amino acid substitutions and that proline at position 110 appeared to be 
central to maintaining the proper structuring of the protein.  Based on this result, it has 
been postulated that P110 is a critical residue for forming the hallmark intramembrane 
loop configuration.  However, the exact nature of the disruption following P110 mutation 
could not be inferred from analysis of the NMR spectra alone. 
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Interestingly, the degree of α-helical character in the 82-101 region has been disputed.  
Some studies have suggested that there may be a propensity for anti-parallel β-strand 
formation in the 84-94 region of the protein 31.  When residues 76-109 of caveolin-1 were 
examined using Fourier transform infrared spectroscopy, circular dichroism 
spectroscopy, and solid-state NMR, it was shown that substantial portions of the protein 
remained non-helical in the presence of cholesterol 69.  The β-strand character was 
observed specifically in the region of alanine 87 to lysine 96, with the 99-109 region 
showing α-helical character.  However, no insight was given in how this change in the 
secondary structure would play into caveolin’s topology. 
A number of investigations that attempted to shed light on the role of the conserved 
proline on the structure and topology of caveolin-1 have used a proline 110 to alanine 
mutant (P110A).  An in vivo immuno-fluorescence study performed on an N-terminally 
FLAG-tagged caveolin-1 construct showed that wild-type caveolin-1 could not bind 
FLAG-antibodies unless the cells were permeabilized 77.  However, upon the P110A 
mutation, FLAG-antibody binding was observed in non-permeabilized cells.  This study 
indicated that a topological change occurred but, only the location of the N- terminus was 
probed.  Therefore, it was not clear whether this change was due to the linearization of 
the peptide (one long transmembrane helix) or a less dramatic orientation change (N- and 
C- termini both oriented extracellularly).  Interestingly, this study also indicated that the 
P110A impacts the protein functionally as the mutant could not form caveolae.  In the 
same study, the effect of the P110A mutation on a truncated intramembrane construct 
(residues 94-122) embedded in a lipid bilayer was evaluated using molecular dynamics 
simulations and supported a linear conformation for the mutant protein.  A tryptophan 
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fluorescence study that employed truncated wild-type and P110A N- and C-terminally 
lysinated intramembrane-domain constructs (residues 103-122) reconstituted into vesicles 
showed that the mutant was less solvent accessible than the wild-type protein.  However, 
these constructs were soluble in the absence of lipid mimics, did not contain the entire 
intact intramembrane domain, and included more than a single tryptophan.  Therefore the 
data were unable to give conclusive information pertaining to structural and topological 
changes that occurred upon the mutation 75.  Additionally, an in vitro study employing a 
full-length caveolin-1 construct containing two glycosylation sites at both the N- and C-
termini reconstituted into dog pancreas microsomes showed that neither the wild-type or 
the P110A mutant could be glycosylated, pointing to a cytoplasmic disposition for the 
termini 76.  This result showed that wild-type and mutant constructs had the same 
orientation; casting doubt on the over-arching role that proline had been posited to play in 
determining caveolins configuration.  However, the interpretation of these data was based 
on a negative result, and therefore conclusions from these experiments must be taken 
with pause because not all sequences containing a glycosylation epitope are necessarily 
glycosylated.  Clearly, there is still a need to address the role that proline plays in 
modulating the structure and topology of caveolin-1. 
Although chapter 4 indicated that a closely related cholesterol mimic (CHS) increases 
the exposure of the CSD by one helical turn, the results could not differentiate if the 
change was related to the presence of the sterol or the negative charge of the molecule.  
Additionally, the study does not indicate how other portions of the protein that are 
predicted to be membrane embedded (residues 112-134) would change in response to the 
sterol.  There have been attempts to gain insight into how cholesterol may play into 
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caveolin topology.  In a study by Epand et al utilizing small peptidic mimics of residues 
in the 83-101 region reconstituted into POPC or POPC/Cholesterol (1:1) multilamellar 
vesicles, it was found that these peptides showed a deeper position within the membrane 
when cholesterol was present 159.  Conversely, in another study by Aoki et al, a lysinated 
caveolin analogue containing half the intramembrane domain (residues 103-122 flanked 
by four and five lysine residues at the N- and C- termini respectively) reconstituted into 
POPC/DPPC/Cholesterol 1:1:1 vesicles showed higher accessibility to the collisional 
quencher acrylamide compared to when it was reconstituted into vesicles composed 
purely of POPC.  A molecular dynamics study of caveolin-1 residues 94-122 embedded 
in various bilayer types attempted to reconcile the topological difference in response to 
the sterol by providing evidence that the depth of tryptophan residues was more affected 
by the removal of cholesterol from DPPC bilayers than they were from POPC bilayers 46.  
Nonetheless, it remains to be shown how a longer construct of caveolin-1 containing the 
entire intramembrane domain and flanking regions would respond to the presence of the 
sterol. 
The importance of the proline at position 110 and cholesterol represent two key 
topological parameters that haven’t been addressed in the context of a caveolin-1 
construct that accurately captures the essence of the full-length protein.  In this chapter, a 
functional caveolin-1 construct (traffics correctly to caveolae in vivo) containing residues 
62-178 (Cav162-178) was employed to probe structural and accessibility differences 
between the wild-type and the P110A mutant reconstituted into dodecylphosphocholine 
(DPC) micelles and DPC:cholesterol-PEG600 (a cholesterol analog) micelles 145.  
Circular dichroism measurements in the far and near UV regions indicated a preservation 
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of secondary structure but a major change in the tertiary fold between the wild-type and 
mutant construct.  These studies also indicated a possible increase in β-strand character 
when the protein was in DPC:cholesterol-PEG600 micelles.  The fluorescence properties 
of the four native tryptophan residues in caveolin-1 (W85, W98, W115, and W128), 
which are exquisitely evenly spaced throughout the structural core of the protein, were 
used advantageously to shed light on the exposure of the intramembrane domain upon the 
P110A mutation and cholesterol-PEG600 inclusion.  The tryptophan residues in both 
wild-type and the P110A mutant were probed in aggregate by examining tryptophan λmax 
of emission and fluorescence quenching and did not indicate dramatic changes in 
accessibility were occurring upon proline replacement.  In contrast, the inclusion of 
cholesterol-PEG600 into the micelles caused major changes in the accessibility of 
Cav162-178.  To definitively and precisely evaluate the specific modulation of the local 
tryptophan environments by the P110A mutation and inclusion of the sterol into micelles, 
four single tryptophan mutant constructs were generated for both the wild-type and 
P110A Cav162-178 for a total of 8 constructs.  The conformation and secondary structure of 
each was probed using CD spectroscopy in the near and far ultraviolet regions and the 
exposure of each was probed using λmax and Stern-Volmer quenching analysis.  Near and 
far UV circular dichroism experiments on the mutants indicated that there were slight 
changes in the tryptophan packing environment but the secondary structure was largely 
maintained between the wild-type and the P110A single tryptophan mutants.  
Fluorescence studies indicated that modest changes in the local environment of 
tryptophan residues at positions 85, 98, and 115 occurred upon the mutation of P110A, 
with tryptophans within the center of the intramembrane domain becoming more shielded 
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from the aqueous environment.  These findings show that the P110A mutation leads to 
significant alterations in the fold and minor changes in the aqueous accessibility of 
caveolin-1.  On the other hand, the same suite of studies performed on single tryptophan 
mutants (WT and P110A) in the presence of the sterol indicated that minor changes 
occurred in the protein’s fold but major changes were observed in the local accessibility 
of the protein to iodide.  Additionally, a fluorescence resonance energy transfer (FRET) 
experiment looking at how the distance between a dansyl moiety covalently attached at 
position 133 and all four tryptophan residues in aggregate changed in response to the 
sterol.  The FRET study supported the near UV CD studies that indicated cholesterol-
PEG600 causes a minor change in the conformation of caveolin-1. 
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MATERIALS AND METHODS 
 
Protein Expression and Purification 
 DNA for wild-type Cav162-178, was synthesized by Genscript Corporation 
(Piscataway, NJ).  Caveolin-1 has three native cysteines that are palmitoylated in vivo 
(C133, C143, C156), and these residues were shown to be not critical to caveolin-1 
trafficking to caveolae 35.  Therefore, these sites were mutated to serine to avoid 
unwanted disulfide bond formation.  The Cav162-178 gene was cloned, over-expressed, and 
purified according to previously reported protocols (See chapter 2) 146.  After purification 
using high performance liquid chromatography, the identity of the protein was confirmed 
using MALDI-TOF mass spectrometry.  Next, purified Cav162-178 was aliquoted and 
lyophilized using protocols described by Rieth et al 43.  Mutant constructs were prepared 
using the Agilent Quik change mutagenesis kit (Santa Clara, CA) for a total of ten 
constructs (see Appendix 2-3 for PCR conditions).  For labeling of the protein with 
dansyl aziridine which reacts specifically with cysteines, a construct was generated where 
S133 was changed to the native cysteine (Cav162-178(C133)).  Cav162-178 contains four 
tryptophan residues: W85, W98, W115, and W128 that can be used to explore the 
exposure of the protein along the sequence.  For single tryptophan mutants, one of the 
four native tryptophan residues was retained and the other three were mutated to 
phenylalanine to generate the following constructs: Cav162-178(W85), Cav162-178(W98), 
Cav162-178(W115), and Cav162-178(W128).  Additionally proline 110 of Cav162-178 was 
mutated to alanine for wild-type and each of the four single tryptophan mutants to 
generate the following constructs: Cav162-178 P110A, Cav162-178(W85) P110A, Cav162-
178(W98) P110A, Cav162-178(W115) P110A, and Cav162-178(W128) P110A (see 
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Appendices 5-1 and 5-2 for construct sequences and mutagenesis primers respectively).  
Unless otherwise noted, all mutants were expressed and purified according to protocols 
described in Chapter 2. 
 
Labeling of Cav162-178(C133) with Dansyl Aziridine 
 For purification of Cav162-178(C133), the protocol described by Diefenderfer et 
al was employed with some minor differences 146.  Cav162-178(C133) was purified by 
nickel-NTA chromatography by first dissolving the post Triton-X-100 pellet in a binding 
buffer comprised of 8% (w/v) PFOA, 0.5 mM TCEP, 50 mM phosphate pH 8.0, washing 
the bound protein with a buffer comprised of 1% (w/v) PFOA, 0.5 mM TCEP, and 50 
mM phosphate pH 8.0.  The protein was eluted with a buffer comprised of 1% (w/v) 
PFOA, 250 mM imidazole, 0.5 mM TCEP, and 50 mM phosphate pH 8.0.  The eluted 
protein was quantified by measuring the absorbance at 280 nm and then rapidly desalted 
using sephadex G-25 resin equilibrated with a buffer containing 1% PFOA (w/v), 50 mM 
phosphate pH 8.0.  The desalted protein was then treated with a 50 fold molar excess of 
dansyl aziridine (generously synthesized by Dr. Larry Courtney, dissolved in DMOS at 
100 mg/mL).  The solution was then covered in foil and was allowed to react for 18 
hours.  Excess dansyl aziridine was quenched by the addition of β-mercaptoethanol added 
to a concentration of 10 mM.  The protein was then precipitated by dialysis against 20 L 
of 50 mM ammonium sulfate.  The precipitate was then subjected to cyanogen bromide 
cleavage, purified using reverse phase HPLC, and aliquoted out of HFIP 146.  The percent 
labeling of the protein was estimated by measuring the absorbance at 340 nm (dansyl 
peak absorbance) using an extinction coefficient of 3980 M-1cm-1 for dansyl and the 
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absorbance at 280 nm for the protein (22% of the dansyl absorbance at 340 nm was 
subtracted from the absorbance at 280 nm to account for its lower wavelength absorption) 
217,218.  Only 100% labeled material was utilized for fluorescence resonance energy 
transfer experiments.  The protein was reconstituted as described in proceeding sections. 
 
Protein Reconstitution 
To 1.2 mg of lyophilized Cav162-178, 3 mL of ice-cold buffer comprised of 20 mM 
phosphate pH 7.0, 100 mM NaCl, and 50 mM DPC (Anatrace, Maumee, OH) was added 
to reconstitute the protein to a final protein concentration of 30 μM.  After vortex mixing 
until clarification, each sample was filtered using a 0.2 μm filter to remove particulates.  
All mutants were reconstituted in an identical manner. 
For samples containing cholesterol-PEG600 (Sigma Aldrich, St. Louis, MO), Cav162-
178 constructs were first dissolved into HFIP at a concentration of 2 mg/mL.  A 1.2 mg 
quantity of protein was added to a 3 mL solution of 60 mM phosphate pH 7.0, 300 mM 
NaCl, 60 mM cholesterol-PEG600, and 90 mM DPC.  The HFIP concentration was 
adjusted to 50% (v/v) and the solution was lyophilized over night.  The solution was then 
rehydrated and subsequently lyophilized for 15 hours to remove all traces of HFIP.  The 
powder was then taken up into 9 mL of H2O to yield a solution which was 20 mM 
phosphate pH 7.0, 100 mM NaCl, and 20 mM cholesterol-PEG600 and 30 mM DPC for a 
final protein concentration of 30 μM.  This solution was then reconstituted by incubation 
on ice for 1-2 hours with occasional gentle mixing.  The solutions were filtered through a 
0.2 μm filter before use. 
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Far and Near UV Circular Dichroism Spectroscopy 
Circular dichroism experiments were performed using a JASCO circular dichroism 
spectrophotometer (Easton, MD).  The experiments were carried out at 298 K using a 
quartz cuvette with a 0.1 mm path length and a 1 cm path length for far and near UV 
experiments respectively. 
For far UV experiments, spectra were obtained from 260 to 190 nm with a 1 nm data 
point interval in step mode accumulating 16 scans.  For near UV experiments, spectra 
were obtained from 350 to 250 nm with a 0.5 nm data point interval in step mode 
accumulating 16 scans.  In each case, a background spectrum of buffer without 
reconstituted Cav162-178 was subtracted from the protein containing spectra.  Circular 
dichroism experiments were performed for Cav162-178 and Cav162-178(P110A) constructs 
twice.  For far UV experiments, machine units () were converted to mean residue 
ellipticity [] using the following equation: 
[ ] =  × (0.1 × ܯܴܹ)(ܲ × ܥ)  
 
Here, MRW is the mean residue weight (protein MW/number of residues in the protein), 
P is the path length in cm, and C is the protein concentration in mg/mL yielding units of 
deg×cm2×dmol-1.  Far UV spectra were decomposed to reveal their secondary structure 
characteristics using the CDSTR algorithm with basis set 7 (optimized for 240-190 nm 
wavelength range) in dichroweb 224.  For near UV experiments, machine units () were 
converted to mean protein ellipticity [] using the following equation: 
[ ] =  × (0.1 × ܯܹ)(ܲ × ܥ)  
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Here, MW is the molecular weight of the protein, P is the path length in cm, and C is the 
protein concentration in mg/mL yielding units of deg×cm2×dmol-1. 
 
Tryptophan λmax Determination and Fluorescence Quenching 
Steady-state fluorescence emission spectra were acquired at 298 K with an Eclipse 
fluorometer (Agilent, Santa Clara, CA) using a 1  1 quartz cuvette.  The excitation 
wavelength chosen was 295 nm which selectively excites tryptophan residues 127.  Both 
excitation and emission slits were set to 5 nm.  The emission spectrum was measured 
from 315-500 nm with a scan speed of 1 nm/s and 0.5 nm data point increments, 
averaging four scans.  The λmax values for all constructs used in the study were 
determined by fitting the data to a log-normal distribution using Igor Pro 6.22A 
(WaveMetrics, Inc., Lake Oswego, OR) 133.  The error in max values were assigned from 
the average of separate reconstitution experiments and was roughly  1 nm. 
Fluorescence quenching experiments were performed directly after λmax 
determinations utilizing a kinetic mode of data acquisition.  First, freshly prepared 
dithiothreitol was added to a final concentration of 1 mM.  The sample was then 
continuously excited at the 295 nm wavelength and the fluorescence intensity at the λmax 
of emission was monitored at a rate of 1 measurement/s.  Initially the sample’s 
fluorescence intensity was monitored for 3 minutes to ensure the sample was at 
equilibrium and accurately determine the unquenched intensity.  After this time period, 
an 18 μL aliquot of 20 % (w/w) potassium iodide in 1 mM dithiothreitol was added to 
2.58 mL of reconstituted Cav162-178 and the intensity was monitored for one minute 
before the next addition of quencher.  Addition of the quencher was repeated to obtain 
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quenching data in the 10-100 mM range.  Intensity averages at each potassium iodide 
concentration were fit to the modified Stern-Volmer equation to determine tryptophan 
fractional accessibilities 127. 
ܫ0
ܫ0 − ܫ = 1݂ܽ ܭܽ [ܳ] + 1݂ܽ  
 
All fluorescence experiments were repeated three times for the following constructs, 
Cav162-178, Cav162-178(W85), Cav162-178(W98), Cav162-178(W115), Cav162-178(W128), 
Cav162-178(P110A), Cav162-178(P110A/W85), Cav162-178(P110A/W98), Cav162-
178(P110A/W115), and Cav162-178(P110A/W128). 
 
Fluorescence Resonance Energy Transfer Experiments 
 The samples were diluted to the same concentration (~30 μM) using either a 
buffer comprised of 20 mM phosphate pH 7.0, 100 mM NaCl, and 50 mM DPC or 20 
mM phosphate pH 7.0, 100 mM NaCl, and 20 mM cholesterol-PEG600 and 30 mM DPC.  
Steady-state fluorescence emission spectra were acquired at 298 K with an Eclipse 
fluorometer (Agilent, Santa Clara, CA) using a 1  0.1 cm quartz cuvette.  The excitation 
wavelength chosen was 295 nm which selectively excites tryptophan residues 127.  Both 
excitation and emission slits were set to 2.5 nm.  The emission spectrum was measured 
from 315-595 nm with a scan speed of 1 nm/s and 0.5 nm data point increments, 
averaging ten scans.  Three experiments were performed for both micellar environments.  
Intensities at the max were used directly for fluorescence resonance energy transfer 
efficiency determination in equation 1-6: 
ܧ = 1 − ܨܦܣ
ܨܦ
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For the distance calculation, an R0 of 21 Å 127 for the tryptophan-dansyl pair was utilized 
in equation 1-7: 
ܧ = ܴ06
ܴ06 + ݎ6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 172 
 
RESULTS AND DISCUSSION 
 
Construct Design and Protein Reconstitution 
 In order to characterize the structural and accessibility changes occurring upon the 
caveolin-1 P110A mutation, a construct that encompassed residues 62-178 (Cav162-178) 
was chosen.  This portion of the protein was selected because it has been shown to 
capture the behavior of the full-length protein in terms of trafficking to caveolae 145.  
Therefore, the structural core that is critical for the protein’s function is intact in the 
Cav162-178 construct.  In order to exhaustively characterize accessibility changes imparted 
by the P110A mutation along the sequence of the protein, single tryptophan mutants of 
the four native tryptophan residues in caveolin-1 were generated for both the wild-type 
and the mutant construct for a total of 8 mutants.  Importantly, the tryptophan residues 
are reasonably spaced across the intramembrane domain (roughly every 14 amino acids 
from residues 85-128), providing complete coverage of the environment that the 
structural core of the protein experiences.  In each of these constructs, one tryptophan 
was maintained while the others were mutated to phenylalanine.  Phenylalanine was 
chosen because of its similarity to tryptophan in terms of hydrophobicity and size.  All 
constructs were reconstituted in DPC micelles.  DPC micelles were chosen because they 
are native-like and have been widely utilized in biophysical studies of membrane proteins 
(For chemical structure see Figure 1-11) 219-222.  To determine how the protein would 
change conformation in response to the inclusion of cholesterol, a detergent-like 
cholesterol mimic was utilized (cholesterol-PEG600) (Figure 5-1) as pure cholesterol has 
poor micelle solubility.  This molecule was chosen because it can be incorporated at 40% 
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by mol within the micelle, which is the concentration of cholesterol natively found within 
caveolae.  Additionally, this reagent, like cholesterol, is not charged. 
Cholesterol Cholesterol-PEG600
 
Figure 5-1.  Comparison of cholesterol and cholesterol-PEG600.  The PEG moiety 
allows for a high degree of cholesterol incorporation into micelles.  The mass that the 
PEG unit adds to cholesterol is roughly 600D on average. 
 
Far and near UV Circular Dichroism Spectroscopy 
 Circular dichroism spectroscopy was used to compare the secondary and tertiary 
structural changes that occur upon the P110A mutation.  Figure 5-2 shows the far UV 
circular dichroism spectra for Cav162-178 and Cav162-178(P110A) constructs.  When 
reconstituted into DPC, the far UV spectra of both the wild-type and mutant protein had a 
very similar appearance and showed two distinct minima at 208 and 222 nm, which is a 
signature of α-helical secondary structure.  However, a close examination of the spectra 
indicated that there may be a slight increase in helicity upon the P110A mutation (~15%, 
see table 5-1) 223.  This small increase could be due to the turn region becoming helical as 
alanine does not have the helix-breaking properties of proline 224,225.  Therefore, the loss 
of proline does not result in a major change in the secondary structure of caveolin-1, as 
its mutation to alanine only resulted in slight changes to the far UV circular dichroism 
spectra.  All single tryptophan mutants were also examined.  In DPC micelles, the 
secondary structures of the single tryptophan mutants compared nicely to that of the 
constructs where all four tryptophans were present as α-helical character was the major 
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contributor to the secondary structure (Figure 5-2, Table 5-1).  Interestingly, in some of 
the single tryptophan mutants made for the wild-type construct, increased α-helical 
character was observed relative to the wild-type that was of the same magnitude as the 
increase caused by the P110A mutation.  However, it appeared that the increase in 
helicity for the P110A mutant was more consistent, as the percentage of helicity between 
P110A mutants had a much smaller error (60  1%) than that for wild-type mutants (54  
8%). 
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Figure 5-2.  Comparison of far UV circular dichroism spectra of Cav162-178 constructs 
reconstituted in DPC micelles (black) or DPC:cholesterolPEG600 micelles (red) and 
Cav162-178 P110A constructs reconstituted into DPC micelles (blue) or 
DPC:cholesterolPEG600 micelles (green).  Panels A-E represent Cav162-178 constructs 
with all tryptophans present, W85 present, W98 present, W115 present, and W128 
present respectively.  The value [] is calculated for the mean residue ellipticity. 
 
Comparison of the different micelle environments also indicated that there was 
little difference between the protein reconstituted into DPC or DPC:CholesterolPEG600 
micelles.  Morphologically, the CD spectra of cholesterolPEG600 samples always had 
somewhat less defined minima (208 and 222 nm) and maxima (195 nm).  This could be 
due to the appearance of β-strand character which has a minima at 215 nm and a less 
intense maxima at 195.  Analysis of the spectra using dichroweb indicated that there was 
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on average about 19.0  2.0% β-strand character for Cav162-178 constructs reconstituted 
into DPC:CholesterolPEG600 micelles versus 11.0  3.0% β-strand character for Cav162-
178 constructs reconstituted into micelles composed of DPC only.  It appears that there is a 
statistically significant increase in the amount of β-strand character, in agreement with 
studies by others who have suggested that the sterol modifies caveolin’s secondary 
structure.  The increase was also observed when comparing Cav162-178 P110A constructs 
in the different micelle environments (Table 5-1).  Therefore it appears that the 
DPC:cholesterol-PEG600 micelle increases β-sheet character for the constructs used in 
this study.  More data will be required to definitively prove where this increase is 
localized, as dichroweb can only give a very rough estimate of such structural data. 
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Construct and Micelle System 
 
α-Helix  
(%) 
β-Strand  
(%) 
Turns  
(%) 
Disordere
d (%) 
Cav162-178 Wild-Type (DPC) 
 
0.45 0.13 0.17 0.25 
Cav162-178 Wild-Type 
(DPC:Cholesterol-PEG600) 
0.48 0.22 0.12 0.17 
Cav162-178 P110A (DPC) 
 
0.59 0.12 0.18 0.12 
Cav162-178 P110A  
(DPC:Cholesterol-PEG600) 
0.49 0.20 0.12 0.20 
Cav162-178(W85) (DPC) 
 
0.60 0.10 0.14 0.16 
Cav162-178(W85)   
(DPC:Cholesterol-PEG600) 
0.43 0.20 0.17 0.20 
Cav162-178(W85) P110A (DPC) 
 
0.60 0.10 0.16 0.14 
Cav162-178(W85) P110A 
(DPC:Cholesterol-PEG600) 
0.59 0.08 0.21 0.11 
Cav162-178(W98) (DPC) 
 
0.44 0.14 0.2 0.22 
Cav162-178(W98)   
(DPC:Cholesterol-PEG600) 
0.51 0.19 0.13 0.16 
Cav162-178(W98) P110A (DPC) 
 
0.62 0.09 0.14 0.15 
Cav162-178(W98) P110A  
(DPC:Cholesterol-PEG600) 
0.49 0.21 0.14 0.16 
Cav162-178(W115) (DPC) 
 
0.57 0.07 0.21 0.15 
Cav162-178(W115) 
(DPC:Cholesterol-PEG600) 
0.57 0.18 0.11 0.13 
Cav162-178(W115) P110A (DPC) 
 
0.61 0.12 0.15 0.14 
Cav162-178(W115) P110A  
(DPC:Cholesterol-PEG600) 
0.51 0.21 0.15 0.13 
Cav162-178(W128) (DPC) 
  
0.61 0.09 0.15 0.15 
Cav162-178(W128) 
(DPC:Cholesterol-PEG600) 
0.53 0.16 0.15 0.16 
Cav162-178(W128) P110A (DPC) 
 
0.59 0.12 0.14 0.14 
Cav162-178(W128) P110A 
(DPC:Cholesterol-PEG600) 
0.49 0.23 0.13 0.15 
AVG Cav162-178 (DPC) 
 
0.54  0.08 0.11  0.03 0.17  0.03 0.19  0.05 
AVG Cav162-178  
(DPC:Cholesterol-PEG600) 
0.50  0.05 0.19  0.02 0.14 0.02 0.16  0.03 
AVG Cav162-178 P110A (DPC 
) 
0.60  0.01 0.11  0.01 0.15  0.02 0.14  0.03 
AVG Cav162-178 P110A 
(DPC:Cholesterol-PEG600) 
0.51  0.04 0.19  0.06 0.15  0.04 0.15  0.03 
Table 5-1.  Percentages of different secondary structure components for each mutant 
from Dichroweb analysis.  Averaged values show that the secondary structure between 
different mutants is very similar and that the type of micelle is important in determining 
the amount of β-strand character. 
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Near UV circular dichroism, which gives information about the unique 
environment that phenylalanine (255-270 nm), tyrosine (275-282 nm), and tryptophan 
(290-305 nm) are sampling, was used to examine differences in the tertiary fold between 
the wild-type and mutant proteins 126.  When all tryptophans were present in aggregate, 
the appearance of the near UV circular dichroism spectra for wild-type and P110A 
mutant proteins in DPC micelles were very different, especially in the 290-305 nm region 
(Figure 5-3).  There is a large negative peak centered on 298 nm that was not present for 
Cav162-178 but was observed for Cav162-178(P110A).  The spectra also differed somewhat 
in their magnitude but had a similar morphology in the 285-250 nm region.  Although 
tryptophan and tyrosine overlap significantly in this region, there are no mutations to 
tyrosine residues; therefore, the decrease in signal in this region could indicate changes in 
tryptophan packing.  These differences indicate that the structure of the protein has 
changed.  Therefore it is plausible that the mutation of P110A has decreased helical 
packing within the transmembrane region.  Additionally, the appearance of the large 
negative peak in the near UV spectrum of Cav162-178(P110A) is indicative of a dramatic 
environmental change around one or more of the four tryptophan residues.  To try to link 
these changes to a particular tryptophan residue, each single tryptophan mutant was 
examined using near UV circular dichroism. 
Interestingly, when comparing the Cav162-178 and Cav162-178(W85) spectra, it 
appears that W85 contributes strongly to the peak centered on 290 nm, implicating this 
tryptophan in being in a unique fold of the protein.  When examining the single 
tryptophan mutants in which P110 is present the spectra always have a larger signal in the 
295-275 nm region.  The most significant case of this change is in comparing Cav162-
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178(W98) and Cav162-178(W98) P110A.  In the Cav162-178(W98) spectrum the CD signal 
increases over the 290-270 region whereas in the Cav162-178(W98) P110A spectrum the 
CD signal decreases dramatically.  In chapter 3, W98 was observed to be on the face of 
helix-1 that would be involved in helix-helix packing with helix-2.  Therefore, the change 
in the morphology of the Cav162-178(W98) P110A far UV trace could reflect alterations in 
this interaction.  All other single tryptophan mutant traces looked similar in terms of their 
morphology between the wild-type and P110A mutants.  Curiously, the large negative 
peak that appeared at 298 nm in the Cav162-178 P110A spectrum could not be linked to 
any of the single tryptophan mutants.  This observation possibly implicates a unique 
tryptophan-tryptophan interaction within the P110A mutant.  Proline is a special amino 
acid in terms of its structural effect on proteins as it has a narrow range of obtainable Φ 
and Ψ angles on the Ramachandran plot.  Therefore, the replacement of this residue with 
an alanine greatly opens the allowed number of Φ and Ψ angle combinations around the 
turn region.  This less stringent angle around position 110 may result in different 
rotations of either of the helical regions within the structural core of the protein.  A 
change in the rotation of the helical regions would result in a different environment for 
amino acids around and within them, and explains the differences observed in the near 
UV circular dichroism plot.  Regardless of the nature of the structural change, it is 
evident that proline 110 plays an important role in maintaining the proper fold of the 
protein. 
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Figure 5-3.  Comparison of near UV circular dichroism spectra of Cav162-178 constructs 
reconstituted in DPC micelles (black) or DPC:cholesterolPEG600 micelles (red) and 
Cav162-178 P110A constructs reconstituted into DPC micelles (blue) or 
DPC:cholesterolPEG600 micelles (green).  Panels A-E represent Cav162-178 constructs 
with all tryptophans present, W85 present, W98 present, W115 present, and W128 
present respectively.  The value [] is calculated for the mean protein ellipticity. 
 
Examination of the differing micelle environments shows that the inclusion of 
cholesterol-PEG600 caused a decrease in the intensity of the near UV circular dichroism 
spectra but does not significantly change the morphology compared to DPC only micelles 
for both wild-type and P110A spectra when all tryptophan residues are present (Figure 5-
3).  In agreement with the observation that W85 contributes strongly to the signal 
positioned around 290 nm, this peak is very strong in the case of the Cav162-178(W85) 
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spectrum.  This lack of dramatic changes in the near UV spectra leads to the conclusion 
that cholesterol may not change the conformation of caveolin significantly around the 
tryptophan groups.  The lack of appearance of any “new” peaks likely indicates that 
cholesterol would not be locked in place through a specific interaction; such has been 
suggested to occur between cholesterol and the 94-101 region of the protein.  This 
finding corroborates simulation studies which failed to see a specific cholesterol packing 
interface 46.  This also downplays the increased β-strand character in having a role in 
changing the conformation of the protein. 
 
Tryptophan λmax Determination and Fluorescence Quenching: Comparison of 
Cav162-178 and Cav162-178 P110A Constructs 
 The tryptophan residues native to Cav162-178 can act as reporters of solvent 
exposure by analyzing their fluorescence emission maximum (λmax) 133.  Analysis of the 
change in λmax (∆λmax) can be used to compare the degree of aqueous exposure between 
Cav162-178 mutants and different micellar environments (here ∆λmax will be from the 
reference point of going from the wild-type to the P110A mutant, or going from DPC to 
DPC:cholesterol-PEG).  Generally, a blue shift in the λmax value is indicative of greater 
membrane burial or tertiary structure associated shielding from the aqueous environment 
130,134-136.  In these studies, a negative value of ∆λmax will be indicative of a blue shift 
(decrease in accessibility) and a positive value of ∆λmax will be indicative of a red shift 
(increase in accessibility) compared to the reference point.  Steady-state Fluorescence 
emission spectra for all constructs used in the study in both DPC and 
DPC:cholesterolPEG600 micelles are shown in figure 5-4. 
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Figure 5-4.  Steady state tryptophan emission profiles for Cav162-178 and Cav162-178 
P110A constructs in DPC or DPC:cholPEG600 micelles.  Raw data (black) and fits (red) 
are indicated.  Fits were used to obtain max values, hence determining the wavelength 
that would be monitored for fluorescence quenching experiments.  Experiments were 
repeated three times to ensure max values were consistent.  An error of  1 nm was 
assigned to all peaks as this reflected the variance in different preparations. 
 
To further probe accessibility changes upon the P110A mutation of caveolin-1, 
tryptophan fluorescence quenching experiments employing iodide were performed 127.  
Quenching of tryptophan fluorescence by the soluble quencher iodide is greater for 
residues that are exposed to the aqueous environment (large fractional accessibility, fa) 
than for those buried within a membrane.  Modified Stern-Volmer quenching curves for 
all constructs utilized in the study in both DPC and DPC:cholesterol-PEG600 micelles 
are shown in figure 5-5.  Importantly, quenching experiments add a second technique that 
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can compare and contrast with λmax information, which can be subject to influences from 
the local environment of the tryptophan residue (i.e. polarity of neighboring residues, 
degree of hydrogen bonding available in the environment) and not necessarily differences 
in aqueous exposure.  Similar to ∆λmax analysis, ∆fa values can be used to compare 
differences in the exposure due to environment or mutation (Here, ∆fa will be from the 
reference point of going from the wild-type to the P110A mutant, or going from DPC to 
DPC:cholesterol-PEG).  In these studies, a negative ∆fa will be indicative of a more 
shielded environment and a positive ∆fa will be indicative of a less shielded environment 
than the reference point. 
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Figure 5-5.  Representative modified Stern-Volmer quenching curves for all Cav162-178 
constructs.  Plots showed very linear behavior and extrapolation to the y-intercept yielded 
fa values. 
 
Both wild-type and the P110A mutant that contained all tryptophans were probed 
to determine if there were major changes in accessibility between constructs.  Analysis of 
both Cav162-178 and Cav162-178 P110A emission spectra yielded λmax values of 341 nm 
(∆λmax=0), indicating that in aggregate, the tryptophan residues appeared to be sampling a 
similar environment (Figure 5-6).  Next, Cav162-178 and Cav162-178 P110A were quenched 
using iodide and both yielded linear modified Stern-Volmer quenching curves (Figure 5-
5).  Extrapolation of the best fit line in modified Stern-Volmer plots to the y-intercept 
yielded fractional accessibility (fa) values of 0.55 ± 0.02 and 0.54 ± 0.01 respectively 
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(∆fa=0) (Figure 5-7).  The determined λmax and fa values indicate that tryptophan residues 
in Cav162-178 and Cav162-178 P110A do not seem to have appreciably different 
accessibilities.  However, the CD data implicated changes in the tryptophan environment 
upon the P110A mutation (large negative peak at 298 nm).  This result suggested that the 
behavior of the tryptophans in aggregate was masking changes that may be occurring for 
each tryptophan individually (i.e. as one tryptophan becomes more exposed, another 
becomes less exposed).  In order to definitively probe changes that may be occurring 
local to each tryptophan residue, the four single tryptophan mutants generated for both 
Cav162-178 and Cav162-178 P110A were subjected to the same analysis. 
The first tryptophan in the caveolin sequence is at position 85 and is a few amino 
acids prior to the start of the structural core of the protein.  Analysis of the single 
tryptophan mutant spectra for Cav162-178(W85) and Cav162-178(W85) P110A yielded λmax 
values of 334.86 ± 1.0 nm and 341.12 ± 1.0 nm respectively.  Therefore, the ∆λmax going 
from Cav162-178(W85) to Cav162-178(W85) P110A was 6.3 ± 1.4 nm, consistent with a less 
hydrophobic environment for the mutant (Figure 5-6).  Fluorescence quenching analysis 
yielded very linear modified Stern-Volmer plots that had fa values of 0.53 ± 0.01 and 0.59 
± 0.02 for Cav162-178(W85) and Cav162-178(W85) P110A respectively (Figures 5-7).  The 
∆fa value obtained was 0.06 ± 0.01, confirming that W85 became more accessible to 
iodide quenching upon the mutation.  Tryptophan 85 is 25 amino acid residues away 
from position 110 and, remarkably, sensed a different environment when the P110A 
mutation was made.  Therefore, this finding lends extremely strong support to the 
hypothesis that P110 is required for maintenance of the global caveolin fold.  
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The next tryptophan in caveolin is at position 98 is centered within the protein’s 
structural core (helix-break-helix region).  Analysis of the single tryptophan mutant 
spectra for Cav162-178(W98) and Cav162-178(W98) P110A yielded λmax values of 342.78 ± 
1.0 nm and 336.08 ± 1.0 nm respectively.  The ∆λmax value obtained was -6.7 ± 1.4 nm, 
which indicates that the proline replacement results in greater micelle coverage of this 
region of the helix (Figure 5-6).  Modified Stern-Volmer plots for both constructs were 
linear and gave fa values of 0.63 ± 0.02 and 0.58 ± 0.01 for Cav162-178(W98) to Cav162-
178(W98) P110A respectively (Figure 5-7).  The ∆fa value of -0.06 ± 0.02 agrees with λmax 
data, therefore it is clear that the proline substitution resulted in a significantly more 
buried environment for the W98.  Therefore, proline 110 is absolutely critical to 
maintaining a specific depth of caveolin in the micelle. 
The second tryptophan resident to the structural core of the protein is W115.  This 
position should serve as a reporter for the putative turn region as it is located one helical 
turn from position 110.  Analysis of the single tryptophan mutant spectra for Cav162-
178(W115) and Cav162-178(W115) P110A yielded λmax values of 339.33 ± 1.0 nm and 
339.86 ± 1.0 nm respectively.  The ∆λmax value obtained, 0.5 ± 1.40 nm, is small in 
magnitude, which correlates with a relatively miniscule difference between wild-type and 
mutant environments around W115 (Figure 5-6).  Quenching of both wild-type and 
mutant W115 constructs again yielded very linear modified Stern-Volmer plots and gave 
fa values of 0.60 ± 0.01 and 0.52 ± 0.01 for Cav162-178(W115) to Cav162-178(W115) P110A 
respectively (Figure 5-7).  Interestingly, this yields a ∆fa of -0.08 ± 0.01, which is the 
largest fold change in iodide accessibility between any of the single tryptophan mutants 
between WT and P110A single tryptophan mutants.  It appears that the two methods are 
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not in agreement in terms of the effect that the proline replacement causes.  As mentioned 
previously, λmax values are subject to factors other than micelle coverage.  One such 
factor is hydrogen bonding from the indole to the surrounding amino acids or other 
molecules in the local environment of the tryptophan, which causes red shifts in emission 
spectra 226.  Therefore, the lack of blue shift in the spectra of Cav162-178(W115) P110A 
coincident with a decrease in iodide accessibility could be due to the formation of a 
unique hydrogen bond between tryptophan 115 and the surrounding environment.  
Although this is a plausible explanation for the discrepancy between methods, more 
experiments will be needed to confirm this hypothesis. 
The final tryptophan at position 128 is the terminal residue of the second helix 
within the structural core of the protein.  Analysis of the single tryptophan mutant spectra 
for Cav162-178(W128) and Cav162-178(W128) P110A yielded λmax values of 343.65 ± 1.0 
nm and 340.59 ± 1.0 nm respectively.  This gives a small ∆λmax value of -3.1 ± 1.4, 
indicating that W128 was only slightly more buried in the case of the mutant (Figure 5-
6).  Modified Stern-Volmer plots were linear and yielded fa values of 0.57 ± 0.01and 0.55 
± 0.01 for Cav162-178(W128) and Cav162-178(W128) P110A respectively.  Clearly, the 
∆λmax was strongly supported by the small ∆fa value of -0.02 ± 0.02 (Figure 5-7).  
Therefore it can be concluded that the P110A mutation only slightly modifies the depth 
of the C-terminal end of the structural core of the protein. 
With this combined fluorescence data, conclusions as to how the intramembrane 
domain and flanking regions are modulated by the presence of proline at position 110 can 
be drawn.  The decrease in accessibility of tryptophan residues within the intramembrane 
domain points to a role of proline 110 in altering the penetration depth of the protein in 
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micelles.  This effect seems to be more dramatic for residues within the center of the 
intramembrane domain, as the decrease in accessibility was less significant for W128 
than it was for W98 and W115.  Interestingly, it seems that the deeper burial of the 
intramembrane domain within the hydrophobic core of the micelles comes at the cost of 
greater exposure for W85.  Therefore, proline 110 also has a role in orienting regions 
flanking the intramembrane domain.  All data for the single tryptophan mutants are 
reported in tables 5-1 and 5-2. 
 
Figure 5-6.  Comparison of max values obtained from tryptophan emission profile fits. 
 
Tryptophan 
Position 
DPC micelles DPC with Choleserol:PEG600 micelles 
max (nm) max (nm) 
(P110A – 
WT) 
max (nm) max (nm) 
(P110A – 
WT) Cav162-178 
Cav162-178 
P110A Cav162-178 
Cav162-178 
P110A 
W85 334.9 ± 0.8 341.1 ± 0.2 6.3 ± 0.8 340.0 ± 0.2 347.5 ± 0.1 7.5  0.2 
W98 342.8 ± 0.3 336.1 ± 1.0 -6.7 ± 1.0 347.2 ± 0.1 341.2 ± 0.1 -6.0  0.1 
W115 339.2 ± 0.6 339.9 ± 1.5 -0.5 ± 1.6 344.9 ± 0.1 345.0 ± 0.1 0.1  0.1 
W128 343.7 ± 0.3 340.6 ± 1.4 -3.1 ± 1.4 347.2 ± 0.1 347.1 ± 0.2 -0.1 ± 0.2 
Table 5-2.  max and ∆max values obtained for single tryptophan mutants of Cav162-178 
and Cav162-178 P110A. 
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Tryptophan λmax Determination, and Fluorescence Quenching of Cav162-178 
Constructs: a Comparison of Micellar Environments 
 Minor changes in the secondary and tertiary structure of Cav162-178 were observed 
in the near and far ultraviolet regions when the micellar environment was loaded with 
cholesterol-PEG600 at 40% by mol.  Specifically, the amount of β-sheet character 
increased and the appearance of the near UV CD spectra showed a decrease in signal 
intensity.  To evaluate if these changes were also coincident with changes in protein 
accessibility, the changes in λmax (∆λmax) and fa (∆fa) were used to compare the degree of 
aqueous exposure between Cav162-178 in micelles composed purely of DPC and those 
composed of DPC:cholesterol-PEG600. 
First, the Cav162-178 that contained all tryptophans was probed to determine if 
there were major changes in accessibility between micellar environments.  Analysis of 
Cav162-178 reconstituted into either DPC or DPC:cholesterol-PEG600 spectra yielded λmax 
values of 341.1  1.0 nm and 344.5  1.0 nm respectively, indicating that in aggregate, 
the tryptophan residues appeared to be sampling a similar environment as the magnitude 
of the red shift was minor (~3.4 nm, Figure 5-4 and Figure 5-6).  Next, Cav162-178 was 
quenched using iodide and gave linear modified Stern-Volmer quenching curves for both 
micelle types (Figure 5-7).  Extrapolation of the best fit line in modified Stern-Volmer 
plots to the y-intercept yielded fractional accessibility (fa) values of 0.55 ± 0.02 and 0.34 
± 0.01 for Cav162-178 in DPC and Cav162-178 in DPC:CholesterolPEG600 respectively 
(∆fa=-0.21  0.02) (Figure 5-7).  This result was very surprising as there was little 
difference between the emission maxima but a very large decrease in iodide accessibility.  
To better characterize how this change in accessibility translates across the 
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intramembrane domain, the individual tryptophan mutants were examined using the same 
approach. 
Analysis of the single tryptophan mutant spectrum for Cav162-178(W85) 
reconstituted into DPC:cholesterolPEG600 yielded a λmax value of 340.0 ± 1.0 nm.  
Therefore, the ∆λmax going to a cholesterol rich environment from DPC was 5.1 ± 1.4 nm, 
a fairly large red shift (Figure 5-6).  Fluorescence quenching analysis yielded very linear 
modified Stern-Volmer plot and gave a fa value of 0.34 ± 0.01 for Cav162-178(W85) in the 
sterol rich environment (Figures 5-7).  The ∆fa value obtained was -0.26 ± 0.01, 
confirming that the W85 became much less susceptive to iodide quenching upon 
translocation to a cholesterol rich environment.  This is not in agreement with the small 
magnitude in the change of the emission maximum. 
Analysis of the single tryptophan mutant spectrum for Cav162-178(W98) 
reconstituted into DPC:cholesterol-PEG600 yielded a λmax value of 347.2 ± 1.0 nm 
(Figure 5-5).  Going from pure DPC micelles to the DPC:cholesterol-PEG600 micelles 
yields a ∆λmax of 4.4 ± 1.4 nm, indicating a red shift for W98 (Figure 5-6).  The modified 
Stern-Volmer plot gave a fa value of 0.48 (Figure 5-7).  The ∆fa value between DPC 
micelles and those containing cholesterol-PEG600 was -0.15 ± 0.02, again pointing to 
increase shielding of the tryptophan environment from the aqueous milieu due to the 
sterol. 
The next tryptophan examined in DPC:cholesterol-PEG600 micelles, Cav162-
178(W115), gave a λmax value of 344.9 ± 1.0 nm (Figure 5-5).  The ∆λmax value was 5.7 ± 
1.4 nm, revealing a dramatic change in the accessibility or hydrogen bonding 
environment due to the sterol (Figure 5-6).  A significant change in the fa value was again 
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observed, where a modified Stern-Volmer plot yielded an accessibility of 0.50 ± 0.01 (∆fa 
= -0.10  0.02) (Figure 5-7).  Again, the change in the emission maximum (red shift) and 
the change in iodide accessibility were not in strong agreement. 
The final tryptophan site examined in DPC:cholesterol-PEG600 micelles, Cav162-
178(W128), gave a λmax value of 347.2 ± 1.0 nm (Figure 5-5).  Again, there was a red shift 
in the emission maximum compared to that of the protein incorporated into pure DPC 
micelles (∆λmax = 4.2 nm).  However, as has been the case with the other mutants, the 
modified Stern-Volmer plot yielded a fa = 0.38 0.01, giving a ∆fa = -0.20  0.02 which 
again points to the protein being shielded from the aqueous phase to a greater degree 
when in the presence of cholesterol (Figure 5-7).  It is clear that the micelle environment 
is causing drastic changes in the accessibility of the protein in terms of the fraction 
accessible to iodide quenching, where all constructs are less exposed to the aqueous 
environment. 
It appears that the inclusion of cholesterol-PEG600 results in the protein being 
much less accessible to the water soluble quencher iodide without leading to a significant 
blue shift in the observed spectra.  This same trend was observed when comparing 
Cav162-178 P110A constructs reconstituted into the differing micelle environments.  
Therefore, it is likely that the shift in the emission maximum may be the result of 
increased hydrogen bonding between the tryptophan residues and polyethylene glycol 
moieties hanging off the cholesterol molecule.  In the case of this study, the ∆max only 
appears to be useful in comparing different constructs in the same type of micelle as the 
values tracked with the change in the fractional accessibility in a more consistent manner. 
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There were some significant differences when comparing Cav162-178 and Cav162-
178 P110A constructs reconstituted into DPC:CholPEG600 micelles.  The ∆λmax value 
between Cav162-178 and Cav162-178 P110A with all four tryptophan residues in aggregate 
was roughly zero.  The fa values were roughly the same as well (~0.34), yielding a ∆fa of 
zero.  Interestingly, there was a very significant red shift going from Cav162-178(W85) to 
Cav162-178(W85) P110A of 7.5  1.4 nm.  The ∆fa was found to be 0.19  0.02, in 
agreement with the change in the emission maximum, indicating a significant decrease in 
shielding of W85 upon the P110A mutation.  This change was much more dramatic than 
that observed between Cav162-178(W85) to Cav162-178(W85) P110A in pure DPC micelles.  
For Cav162-178(W98) and Cav162-178(W98) P110A, it was found that the ∆λmax and ∆fa 
values were -6.0  1.4 nm and -0.15  0.02 respectively.  This indicates that there was a 
significant increase in shielding from the aqueous environment.  For Cav162-178(W115) 
and Cav162-178(W115) P110A, it was found that the ∆λmax and ∆fa values were -0.1  1.4 
nm and -0.07  0.01 respectively.  This indicates that there was increased shielding of 
W115 in response to the P110A mutation that was not strongly reflected by the change in 
emission maximum.  For Cav162-178(W128) and Cav162-178(W128) P110A, it was found 
that the ∆λmax was -0.1  1.4 nm and the ∆fa was roughly zero.  Therefore, it seems that 
accessibility of W128 remains unchanged.  These data mirrors the changes in the pure 
DPC micelles indicating that P110A mutation alters the accessibility of the caveolin-1 
protein in a predictable way, where W85 is more exposed, W98 and W115 are less 
exposed, and W128 is unaffected (Figure 5-7).  Although three tryptophan residues 
decrease in their accessibility going from wild-type to P110A Cav162-178, the two 
tryptophan residues that are on the N-terminal side are much more affected.  This result 
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could indicate that there is a significant amount of play between the cholesterol-PEG600 
and the protein, and that P110 helps to position the protein for this putative interaction. 
Cholesterol has been suggested in some studies on caveolin to be a factor causing 
aggregation of the protein into 200, 400, and 600 kD oligomers in vivo 74.  Therefore 
protein oligomerization could also be at play in shielding tryptophan residues from 
quenching.  Of course, more conclusive evidence (possibly analytical ultracentrifugation) 
will be needed to support this conclusion.  Therefore, in the context of the construct used 
for these studies, it seems that cholesterol leads to a decreased aqueous accessibility in 
this system.  This result may need visitation in a more relevant system that has a bilayer 
to examine if cholesterol indeed imparts a topological change as these results could be 
artifacts from differential micelle coverage of the protein in the DPC:cholesterol-PEG600 
mixture that may not be related to the protein’s burial.  In contrast to P110A which 
caused changes in the tertiary fold of the protein and does not impart significant changes 
in the secondary structure and only modest alterations to the degree of micelle coverage, 
it appears that cholesterol inclusion causes the opposite, where large changes were 
observed for the degree of burial but slight changes were observed in regards to the 
tertiary fold of the protein. 
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Figure 5-7.  Comparison of fa values obtained from modified Stern-Volmer plots. 
 
Tryptophan 
Position 
DPC micelles DPC with Cholesterol-PEG600 micelles 
fa (%) fa (%) 
(P110A – 
WT) 
fa (%) fa (%) 
(P110A – 
WT) Cav162-178 
Cav162-178 
P110A Cav162-178 
Cav162-178 
P110A 
W85 53 ± 1 59 ± 2 6 ± 1 27 ± 1 46 ± 1 19  1 
W98 63 ± 1 58 ± 1 -5 ± 1 48 ± 1 33 ± 2 -15  2 
W115 60 ± 1 53 ± 1 -7 ± 1 50 ± 1 43 ± 1 -7  1 
W128 57 ± 1 55 ± 1 -2 ± 1 37 ± 1 38 ± 2 1  2 
Table 5-3.  fa and ∆fa values obtained for single tryptophan mutants of Cav162-178 and 
Cav162-178 P110A. 
 
Fluorescence Resonance Energy Transfer Experiments: Comparison of Differing 
Micelle Environments 
 The near UV circular dichroism experiments suggested that there was not 
a major change in tryptophan packing when the protein was reconstituted into 
cholesterol-PEG600 micelles.  However, far UV experiments seemed to suggest a more 
dramatic change in the secondary structure of the protein that could impact the fold.  To 
examine the impact of the sterol on the fold of the intramembrane domain and flanking 
regions, a fluorescence resonance energy transfer experiment was devised.  In this 
experiment, a cysteine native to position 133 was re-introduced and was labeled using 
dansyl-aziridine (Figure 5-8).  Once covalently attached, the dansyl can be excited by 
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tryptophan’s emission and this requires close contact of the fluorophores in space for the 
energy transfer event to occur.  Upon excitation, changes in the tryptophan distances due 
to the micellar environment will be evidenced by increases or decreases in the efficiency 
of the energy transfer (increase in dansyl emission at the cost of a decrease in tryptophan 
emission, (Figure5-9)).  R0, the radius of 50% transfer efficiency is 21 Å for the 
tryptophan-dansyl FRET pair.  This distance would be appropriate to examine changes in 
the average distance of this position from nearby tryptophan residues as W128 is only 5 
residues away from the labeled position and W115 is ~20 Å away from W128 (assuming 
they are within the same helix as suggested in chapter 3).  Assuming a static triangle 
shaped, helix-break-helix motif with an intra-helical angle 53° (see Chapter 3), there would be an average distance of 24 Å between the heads of the helices.  Therefore, the 
dansyl group could also report on changes in the distance to tryptophans W85 and W98. 
Getting the protein labeled to 100% is critical for this experiment because 
unlabeled material will not contribute to the FRET process.  It was found that the protein 
had to be kept completely reduced until moments before the addition of the reagent using 
TCEP because caveolin-1 has a strong disulfide bond forming tendency that results in 
protein dimerization.   
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Figure 5-8.  A)  The dansyl-aziridine moiety is highly reactive due to ring strain and can 
be attached to sulfhydryl groups on proteins at a physiological pH.  B)  FRET assay 
principle.  The hypothesis is that changes in the micelle environment will cause 
differences in the dansyl-tryptophan distance.  The dansyl label is denoted as a star and 
tryptophan residues 85, 98, 115, and 129 are show as circles in black, red, green, and 
blue respectively.  The “fixed” distance between the top of the two helices is based on 
geometric arguments assuming the helices form a co-planar triangle with one helix being 
27 Å and the other being 28.5 Å and the intra-helical angle is 53° based on MD 
simulations (see Chapter 3). 
 
Protein+ Protein
pH = 7.0
A
B
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However, if the TCEP was left in solution, only 50% of the protein was labeled 
on average.  Once the protein was purified by nickel affinity chromatography, it was 
desalted and the reagent was added as fast as possible.  This reaction had to be quenched 
after about 18 hours as incubation times greater than 24 hours resulted in over-labeling.  
This is because the aziridine can react with other nucleophiles on the protein (i.e. lysine).  
Over-labeling is undesirable because it can complicate FRET analysis.  The absorbance 
spectrum of the labeled Cav162-178 is shown in figure 5-9. 
Figure 5-9.  Post HPLC purified Cav162-178 UV-VIS absorbance profile.  The peak 
absorbance at 340 nm is due to the covalently attached dansyl label. 
 
The FRET experiment showed that there were significant differences (~20%) in 
the energy transfer efficiency between the dansyl moiety and the tryptophan groups when 
going from pure DPC micelles to DPC:cholesterol-PEG600 micelles (0.64  0.01 and 
0.43  0.01 respectively) (Figure 5-10).  When using an R0 of 21 Å, the average donor-
acceptor distance translates to 19.04  0.10 Å and 22.00  0.10 Å for Cav162-178(C133) 
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reconstituted in DPC and DPC:cholesterol-PEG600 micelles respectively.  This is in 
agreement with a simulation study which showed that there was an increase the average 
radius of gyration for caveolin residues 94-122 in the presence of cholesterol, suggesting 
that the sterol promotes open conformations of caveolin 46.  This change is very slight in 
terms of intramolecular distance, and agrees with the near UV CD data which pointed to 
very little change in tryptophan packing in micelles composed of DPC:cholesterol-
PEG600.  These data cannot say how the conformation changed, only that there was a 
change in the average distance between the donor and acceptor pair.  For this reason, the 
exact nature of the distance change could not be evaluated.  The use of single tryptophan 
mutants may give more specific information of how each tryptophan environment 
changes when the sterol is included in the micelles, and could clarify the exact nature of 
the change observed.  It is also possible that the distance between the dansyl moiety and 
some of the tryptophan residues would be greater than 2R0, and therefore this would not 
yield any relevant information to changes that are occurring with cholesterol being 
present (E=1.56% at r=2R0).  In this case it may be necessary to label many more sites to 
completely understand how or if the conformation is changing with the inclusion of 
cholesterol. 
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Figure 5-10.  Comparison of dansyl-tryptophan FRET for Cav162-178 reconstituted into 
either DPC micelles (left) or DPC:cholesterol-PEG600 micelles (right).  The unlabeled 
species emission profile is in black and the dansyl-labeled species is in red.  Total 
amounts of protein were the same as assessed by measuring the absorbance at 280 nm 
and diluting each sample using the appropriate micelle blank.  Therefore differences in 
the emission intensity between the unlabeled spectra are due to environmental effects of 
the different types of detergent micelles. 
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CONCLUSIONS 
 Recent biophysical studies revealed that the highly-conserved P110 of caveolin-1 
is critical to its structure and topology.  Importantly, this residue is thought to be vital to 
the appearance of a membrane-embedded helix-break-helix motif that gives caveolin-1 its 
hallmark topology and the loss of this residue is sufficient to disrupt caveolae formation.  
Despite many investigations into the part that P110 plays in caveolin-1 topology, results 
have been inconclusive in determining the exact magnitude of its role in modulating the 
structure and aqueous accessibility of the protein.  In previous NMR studies, high quality 
hetero-nuclear single quantum correlation spectra were not obtainable for the caveolin-1 
P110A mutant, indicative of a poorly structured protein.  In this chapter, the data have 
linked this poor structuring to changes within the tertiary structure rather than the 
secondary structure using near and far circular dichroism spectroscopy 70.  It was found 
that the examination of each tryptophan individually was critical to observe changes in 
the proteins micellar coverage as the behavior of tryptophans in aggregate masked the 
accessibility changes that occurred upon the P110A mutation.  Specifically, the P110A 
mutation slightly decreased the accessibility of tryptophan mutants within the structural 
core of the protein (residues 87-128), confirming that the proline is playing a role in 
modulating the caveolin topology.  However, the magnitudes of these changes were not 
dramatic, therefore the mutation leads to only a modest difference in tryptophan 
accessibility and not major changes (i.e. the translocation of a tryptophan from a fully 
buried to a fully exposed environment.).  The proline also plays a role in determining the 
global fold as W85 showed an increased accessibility upon mutation.  This study lends 
support to in vitro glycosylation studies which failed to see very drastic changes in the 
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topology of caveolin-1 upon proline substitution 76.  To date, this body of work represents 
the most in-depth study of structural and accessibility changes that occur from the 
substitution of caveolin’s critical proline residue.   
 In this study, cholesterol (in the context of a pegylated micellar analogue) was 
shown to result in very slight changes in helical packing, and promoted β-strand 
character.  The FRET experiments showed that there is a slight increase in the average 
distance between a dansyl moiety placed at position 133 and the tryptophan residues 
within the 85-128 region, possibly indicating a more open conformation of the protein.  
On the other hand, quenching data suggested that there is a significant decrease in 
aqueous accessibility of the tryptophans in the presence of the sterol (these data were not 
at all consistent with max data).  These data are at odds with the findings in chapter 4 in 
regards to the sterol’s effect on the burial of the scaffolding domain and reports in the 
literature which indicated that the protein became more accessible in the presence of 
cholesterol.  Interestingly, when the P110A mutant was probed in DPC:cholesterol-
PEG600 micelles, it showed the same trend in accessibility changes that was observed 
between the wild-type and mutant in pure DPC micelles, where residue 85 became more 
exposed and residues 98 and 115 became more buried.  Interestingly, the accessibility of 
the two tryptophan residues that were on the N-terminal side of the P110 residue were 
much more affected by its mutation to alanine.  It was found that shits in max did not 
strongly agree with the degree of quenching when comparing different micelle types.  
However, the max and quenching studies were generally in agreement when comparing 
proteins within the same micellar environment (i.e. blue shift in max was coincident with 
a decrease in the fraction accessible).  Therefore it is with great caution that max should 
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be used alone in comparing the hydrophobic coverage of a protein in different types of 
micelles.  It is difficult to glean topological information in a micellar environment and 
these studies will need to be performed in a bilayered mimic for stronger validation of 
trends observed upon P110A mutation and cholesterol inclusion.  Nonetheless this 
chapter has utilized the most native-like construct to date to try to answer questions of 
how the accessibility of the entire intramembrane domain is linked to the proline at 
position 110 and cholesterol.  Future work will be needed to place these accessibility 
changes into the context of conformational changes within a lipid bilayer.  
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Appendix 5-1.  Sequences of Protein Constructs Utilized 
 
Construct Protein Sequence 
Cav162-178 Wild-
Type 
DVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWYRLLSA
LFGIPLALIWGIYFAILSFLHIWAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 Wild-
Type C133 
DVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWYRLLSA
LFGIPLALIWGIYFAILSFLHIWAVVPCIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178(W85) DVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYFYRLLSA
LFGIPLALIFGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178(W98) DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYWYRLLSA
LFGIPLALIFGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178(W115) DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYFYRLLSA
LFGIPLALIWGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178(W128) DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYFYRLLSA
LFGIPLALIFGIYFAILSFLHIWAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 P110A DVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWYRLLSA
LFGIALALIWGIYFAILSFLHIWAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 
P110A(W85) 
DVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYFYRLLSA
LFGIALALIFGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 
P110A(W98) 
DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYWYRLLSA
LFGIALALIFGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 
P110A(W115) 
DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYFYRLLSA
LFGIALALIWGIYFAILSFLHIFAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
Cav162-178 
P110A(W128) 
DVVKIDFEDVIAEPEGTHSFDGIFKASFTTFTVTKYFYRLLSA
LFGIALALIFGIYFAILSFLHIWAVVPSIKSFLIEIQSISRVY
SIYVHTVSDPLFEAVGKIFSNVRINLQKEI 
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Appendix 5-2.  Mutagenesis Primers Utilized 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Construct Primer Sequence 
F85W 5’-
GGATCCATGGACGGTATCTGGAAAGCGTCTTTCACCA
C-3’ 
F98W 5’-CACCGTTACCAAATACTGGTTCTACCGTCTGCTGTC-
3’ 
 
F115W 5’-CTGGCGCTGATCTGGGGTATCTACTTCGC-3’ 
 
 
F128W 5’-CTTTCCTGCACATCTGGGCGGTTGTTCCGTC-3’ 
 
 
P110A F115F 5’-
CTGTCTGCGCTGTTCGGTATCGCACTGGCGCTGATCTT
CGGTATC-3’ 
P110A F115W 5’-
CTGTCTGCGCTGTTCGGTATCGCACTGGCGCTGATCTG
GGGTATC-3’ 
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Chapter 6.  Applications of Indole-PE:  A Novel Lipid with a 
Tryptophan Headgroup for Use in Quenching Studies 
 
ABSTRACT 
 
Fluorescence quenching studies are routinely employed to estimate the burial of 
tryptophans within the tertiary folds of soluble proteins.  Fluorescence quenching of 
tryptophan residues within membrane proteins embedded in micelles, bicelles, and 
vesicles has also become a standard method to evaluate the protein’s degree of burial.  
The quenching of membrane proteins tends to be more complex because the barrier effect 
of the membrane mimetic on quenchers is not precisely known.  To help with the 
interpretation of quenching studies, a novel lipid with an indole headgroup, dubbed 
“indole-PE”, was synthesized by coupling 3-iodoacetic acid and DMPE via peptide bond 
formation.  This chapter describes the purification and characterization of the 
fluorescence properties of indole-PE.  Additionally, the utility of indole-PE as a 
molecular ruler was examined in two cases.  In the first case it is shown that indole-PE 
can be used to investigate the permeability of commonly used quenchers across lipid 
vesicles.  In the second example, it is shown that indole-PE serves as a tool to help 
interpret fluorescence λmax measurements and iodide fluorescence quenching experiments 
performed on thirteen single tryptophan mutant constructs of caveolin-1 reconstituted 
into phospholipid bicelles. 
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INTRODUCTION 
 
 Tryptophan fluorescence is highly useful in the structural probing of proteins.  For 
instance the max of a residue’s emission can often be linked to different degrees of 
exposure to water and therefore can be an analytical tool to study protein folding or in the 
case of membrane proteins, an estimation of their burial within phospholipid bilayers.  
Additionally, tryptophan can be quenched by a number of different small molecules.  
These molecules can carry different charges or vary in their degree of polarity and 
therefore their usage in combination can yield a rich amount of information about the 
environment of a given residue.  In the study of membrane proteins, soluble probes are 
often used which have limited aces sot the membrane matrix.  To what degree these 
different probes cross or diffuse into bilayers to cause differential quenching is not 
known.  A common technique used is comparing the degree of quenching of the free 
amino acid tryptophan to that of the protein of interest.  This approach can be 
complicated as free tryptophan can interact with membranes and cannot help with finer 
levels of differentiation (i.e. burial at aqueous headgroup interface or within the 
hydrophobic core of the bilayer). 
 In this study, a novel lipid which contains the indole moiety as its headgroup, 
indole-PE, was synthesized to provide a more accurate molecular ruler for comparison in 
max and quenching studies of tryptophan residues.  Herein, the synthetic approach and 
purification of the lipid is described.  The product was confirmed by MALDI-TOF mass 
spectrometry and NMR.  Additionally the fluorescent properties were probed.  It was 
found that indole-PE incorporated into liposomes provides a good marker to determine if 
the polar tryptophan quenching reagents can permeate across bilayers.  It is also shown to 
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be useful in quenching studies when reconstituted into phospholipid bicelles.  
Specifically it was utilized as a metric for a tryptophan scanning mutagenesis study on 
caveolin-1 residues 62-178.  In this study, 13 single tryptophan mutants were generated 
for the protein by mutating all native tryptophans to phenylalanine and then replacing 
aromatic positions or non-conserved positions with tryptophan in the 85-133 region.  It 
was found that these positions were less accessible to iodide quenching than indole-PE 
indicating that this region of the protein is buried beneath the aqueous headgroup 
interface.  
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MATERIALS AND METHODS 
 
HSVFLAGCav162-178 Single Tryptophan Mutant Cloning, Expression, and 
Reconstitution into Bicelles 
 
HSVFLAGCav162-178 was cloned, expressed, and purified according to protocols 
described in chapter 2 and Appendices 2-3 through 2-6.  Cav162–178 contains four 
tryptophan residues: W85, W98, W115, and W128.  The original gene had all four native 
tryptophan residues replaced with phenylalanine.  After this, 13 constructs were 
generated with a single tryptophan re-introduced at a native site (W85, W98, W115, 
W128), a site that contained an aromatic residue (F89, F99, F107, Y118, F124), or a site 
that was not highly conserved across isoforms (L102, M111, I117, C133) (See Appendix 
6-1) using the Quik-change site-directed mutagenesis kit (Agilent, Santa Clara, CA).  
Additionally native cysteines were mutated to serine in order to avoid any biologically 
irrelevant disulfide bond formation and are justified by reasons discussed in previous 
chapters.  Primers were designed using the free web-based primerX program 
(Bioinformatics.org) (See Appendix 6-2).  See Appendix 2-4 for PCR reaction and 
cycling conditions. 
HSVFLAGCav162-178 was reconstituted into 2.5% (w/w) lipid, q= 0.5 DMPC/DHPC 
bicelles at a protein concentration of 30 μM.  To achieve this, HSVFLAGCav162-178 (1.64 mg) 
and DMPC (32.8 mg) were dissolved in 3 mL HFIP.  Next, 2 mL of water was added and 
this solution was rapidly frozen and lyophilized for 24 hours.  The lyophilized mixture 
was then converted to bicelles by adding 166 μL 25% (w/w) DHPC, 300 μL 200 mM 
phosphate pH 7.0, and 2500 μL H2O by vortex mixing.  The bicelles were then 
centrifuged at 10,000 x g for 20 minutes at room temperature to remove aggregates that 
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may have formed during the reconstitution process.  The supernatant was used for 
fluorescence measurements. 
 
Determination of λmax for Single Tryptophan Mutants 
Two separately prepared samples were used to determine λmax for each single 
tryptophan mutant.  Bicelles were used because they scatter very little light, and contain a 
planar DMPC bilayer, which avoids orientation differences associated with vesicles.  
Fluorescence emission spectra were acquired using a 1 × 1 cm quartz cuvette held at 298 
K with an Eclipse fluorometer (Agilent, Santa Clara, CA).  The excitation wavelength 
used was 295 nm to avoid unwanted tyrosine excitation 127.  Both the excitation and 
emission slit widths were set to 5 nm.  The emission spectra were measured from 315 to 
500 nm with a scan speed of 1 nm/s and 0.5 nm data point increments.  Four scans were 
averaged for each construct.  A blank solution containing only bicelles was used to 
subtract background fluorescence.  The λmax values were obtained by fitting the spectra to 
a log-normal distribution using Igor Pro 6.22A software (Wavemetrics, Portland, OR)133. 
 
Synthesis and Purification of Indole-PE 
In a 20 mL glass scintillation vial, 0.573 mmol (100 μL, neat) of N,N-
diisopropylethylamine, 0.044 mmol (7.65 mg, powder) indole-3-acetic acid, 0.20 mmol 
(30.5 mg, powder) 1-hydroxybenzotriazole hydrate, and 0.050 mmol (9.00 mg, powder) 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide were dissolved into 2.5 mL of 
chloroform with stirring.  After 1 hour, 0.022 mmol (13.80 mg, powder) of 1,2-
dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE) was added with stirring and the 
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mixture was allowed to react at room temperature overnight in the dark.  The mixture was 
then transferred to a 50 mL glass conical tube and 5 mL of chloroform was added along 
with 10 mL of 20 mM phosphate pH 7.0 and 9 drops of a saturated NaCl solution.  The 
mixture was vortexed for 5 minutes, and centrifuged at 6000 x g for 10 minutes at 4°C.  
The top layer was disregarded and the bottom layer was washed a second time.  The 
bottom layer was then dried using MgSO4 and the solution was filtered using Whatman 
No. 2 filter paper.  The supernatant was dried under vacuum to a gel.  The resulting gel 
was then taken up into 5 mL of a 50:50 solution of ammonium acetate buffer pH 8.0 and 
methanol by vortexing.  The reconstituted material was then passed through a 0.2 μm 
regenerated cellulose filter.  The sample was then injected onto a 250 x 21.20 mm C4 
reverse phase column with a 15 μm particle packing having a 300 Å pore size at 10 
mL/min.  The lipid was eluted using a 1.25 %/ minute gradient starting at 50 % buffer A 
(ammonium acetate buffer pH 8.0) 50 % buffer B (methanol) and going to 100 % buffer 
B.  After drying down the isolated product, the stock was kept in chloroform at -80°C 
until usage.  The purification gave rise to a well resolved species having an 1H NMR (500 
MHz, CDCl3)δ 0.87(t, 6H), 1.2-1.32(m, 36H), 1.53(m, br, 4H), 2.00(s, 3H), 2.20(q, 3H), 
3.30(br, 2H), 3.60(s, 2H), 3.70(br, 3H), 4.0(q, 1H), 4.2(d, 1H), 5.18(m, 1H), 6.88(t, 1H), 
7.06(t, 1H), 7.1(m, 2H), 7.27(d, 3H), 7.33(d, 1H), 7.5(d, 1H), 9.507(s, 1H).  Additionally, 
MALDI-TOF mass spectrometry was utilized by drying the product down in an 
Eppendorf tube and then resuspension of the film in a solution containing saturated 
sinnipinic acid in 1:1:2 0.1% trifluoroacetic acid:acetonitrile:acetic acid yielding a HR-
MALDI MS for C43H72O9N2P ([M+Na]+) Calcd.: 816.037 D. Found: 815.969 D. 
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Reconstitution of Indole-PE into Vesicles and Bicelles 
For reconstitution into vesicles, 180 μl of a 2.5 mM stock (450 nmol) of indole-
PE in chloroform was co-mixed with 46.62 mg of egg yolk phosphatidylcholine 
dissolved in chloroform at 50 mg/mL.  The mixture was then dried down using N2(g) and 
the resultant film was placed under vacuum for 4 hours.  The film was then dissolved in a 
buffer containing 300 mM PFOA (Oakwood Products, West Columbia, SC), 10 mM 
Tris-HCl pH 8.0 to the egg PC to achieve a final lipid concentration of 20 mM.  The 
mixture was then heated until it became transparent.  The resulting solution was then 
added to a 10 kD MWCO slide-a-lyzer G2 dialysis cassette and was dialyzed against 2 L 
of 10 mM Tris-HCl pH 8.0, 100 mM NaCl.  The mixture was dialyzed for three days with 
exchanges every 24 hours to ensure complete removal of PFOA and resulted in the 
formation of vesicles.  The vesicles were spun at 12,000 x g for 20 minutes to remove any 
aggregated material.  The supernatant was used for fluorescence quenching experiments. 
For reconstitution into bicelles, 36 μl of a 2.5 mM stock (90 nmol) of indole-PE in 
chloroform was co-mixed with 32.8 mg of DMPC dissolved at 50 mg/mL in chloroform.  
This solution was then dried down using N2(g) and the resultant film was hydrated with 
166 μL 25% (w/w) DHPC, 300 μL 200 mM phosphate pH 7.0, and 2500 μL H2O by 
vortex mixing.  Once homogeneous, the solution was frozen and lyophilized for 24 hours.  
The lyophilized material was then reconstituted using 2925 μL H2O to generate 2.5% 
(w/w) q=0.5 DMPC/Indole-PE/DHPC bicelles.  The sample was then utilized in 
fluorescence quenching experiments and max determinations. 
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Measurement of Indole-PE Excitation and Emission Spectra 
 This measurement was performed on indole-PE reconstitute into bicelles.  
Fluorescence excitation and emission spectra were acquired using a 1 × 0.1 cm quartz 
cuvette held at 298 K with an Eclipse fluorometer (Agilent, Santa Clara, CA).  The 
excitation and emission slits were set to 2.5 nm.  First the absorbance spectra was 
evaluated using UV-VIS spectroscopy and it was determined that 280 nm was the peak 
absorption wavelength.  This wavelength was used to excite the indole-PE and the 
emission spectrum was obtained by scanning in the 240-500 nm wavelength range 
acquiring a total of 50 scans using a scan speed of 1 nm/s with 0.5 nm data point 
increments.  After determination of the maximum wavelength of emission, the excitation 
spectrum was obtained by scanning in the 240-330 nm wavelength range acquiring a total 
of 50 scans using a scan speed of 1 nm/s with 0.5 nm data point increments.  The λmax of 
emission was determined by fitting the emission spectrum to a log-normal equation 
132,133.  The Stoke’s shift was calculated by taking the difference of the emission and 
excitation maxima in terms of wavenumbers (cm-1). 
 
Measurement of Bilayer Permeability of Iodide and Acrylamide using Large 
Unilamellar Vesicles with Reconstituted Indole-PE 
The vesicles formed were diluted 12.5 fold into 3 mL to a final concentration of 
12 μM and 1.6 mM for indole-PE and EYPC, respectively, using the dialysis buffer 
supplanted with 1 mM DTT at 25℃.  Using an excitation wavelength of 280 nm, the 
emission intensity was recorded at 343 nm (λmax) for 3 minutes using a 1 s averaging 
time.  To determine if KI can cross the bilayer, 60 μL of 1 M KI dissolved in 1 mM DTT 
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was added with stirring to give a final concentration of 20 mM KI.  After monitoring the 
fluorescence signal for 30 minutes, Triton-X-100 (reduced form) was added to a final 
concentration of 1 % (v/v).  The fluorescence signal was monitored for an additional 20 
minutes.  This addition leads to a signal increase, therefore a control employing only the 
addition of Triton-X-100 determined that the signal increase was due in part to the 
addition of the detergent.  The data is corrected for before and after permeabilization, and 
yields data on the unexposed fraction.  This experiment was repeated using acrylamide 
under the same conditions without DTT. 
 
Fluorescence Quenching of Indole-PE and Single Tryptophan Mutants 
Reconstituted Into DMPC/DHPC Bicelles 
The quenching studies were performed on indole-PE and single tryptophan 
mutants reconstituted into 2.5% (w/w) lipid, q = 0.5 DMPC/DHPC bicelles on a 3 mL 
scale at a concentration of 30 μM.  Fluorescence emission spectra were acquired using a 
1 × 1 cm quartz cuvette held at 298 K with an Eclipse fluorometer (Agilent, Santa Clara, 
CA).  The excitation wavelength used was 295 nm.  Fluorescence emission curves were 
collected and analyzed using a log-normal equation to determine the λmax of emission for 
each mutant 132,133.  The λmax of emission was monitored during the quenching 
experiments.  Both the excitation and emission slit widths were set to 5 nm.  Four scans 
were taken for each point.  An 18 μL aliquot of 20% (w/w) KI in 1 mM DTT was added 
to the cuvette with rapid stirring for the first point allowing 1 minute before measuring 
the intensity at λmax.  After this, 18 μL aliquots of the quencher were added for each point, 
allowing 1 minute of mixing before recording the intensity.  Stern-Volmer quenching 
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curves were generated by a plot of [I-] versus I0/I and the slope was taken as the KSV.  
Modified Stern-Volmer quenching curves were generated by plotting 1/[I-] versus I0/I0-I 
and the y intercept was taken as the fractional accessibility of each single tryptophan 
mutant. 
Indole-PE was used in the case of the bicelle studies so that all quenching 
measurements could be compared to a headgroup located indole group.  
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RESULTS AND DISCUSSION 
 
Synthesis and Purification of Indole-PE 
 The generation of lipids with amino acids as their headgroup is not a new idea.  
This work has been pioneered by Regen and co-workers in his nearest neighbor studies 
212.  However, there is no report of an indole moiety having been coupled to a lipid.  Such 
a molecule could serve as a useful standard in evaluations of tryptophan accessibility in a 
variety of contexts.  Therefore, standard peptide bond formation chemistry using 
HOBt/EDC to couple indole acetic acid and 1,2-dimyristoyl-sn-glycero-3-
phosphoethanolamine was utilized (Reaction Scheme 6.1). 
DIPEA
EDC
HObt
CHCl3
1 hour 25 °C
Overnight
25 °C 
+
 
Reaction Scheme 6-1.  Synthesis of indole-PE. 
 
This approach resulted in a species that could be isolated using reverse phase HPLC to 
homogeneity (Figure 6-1).  The product migrated to a single spot using thin layer 
chromatography and was confirmed to have the correct identity by 1H and 31P NMR and 
MALDI-TOF (Figure 6-1). 
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Figure 6-1.  Purification trace for indole-PE using reverse phase HPLC.  The product is 
denoted by the red star.  B)  High resolution MALDI-TOF spectrum of indole-PE.  The 
molecular ion appeared to be a sodium adduct denoted by the red star.  C)  Proton NMR 
of indole-PE.  For assignments, see methods section.  Resonances in the 1-3 ppm region 
where indicative of the acyl-chain region of the molecule whereas resonances in the 6-8 
ppm region had signatures of the indole moiety.  D)  The presence of the phosphate 
headgroup was shown using 31P NMR. 
 
Bilayer Permeability of Commonly Used Quenchers 
 Fluorescence quenching studies are common place in investigations of the 
aqueous exposure of fluorescent molecules.  In the case of species buried within the lipid 
bilayer, or trapped within vesicles, it is unclear how these quenchers respond to the 
phospholipid barrier.  Prior quenching studies have suggested that potassium iodide and 
acrylamide, which are soluble quenchers commonly employed in topological 
investigations, passively diffuses across lipid bilayers 227.  This study was performed by 
 217 
 
entrapping tryptophan within the vesicles at an expected concentration of 15 mM.  
Tryptophan, although zwitterionic, is small and hydrophobic and could have leaked 
across bilayers causing a false positive for the bilayer crossing of the quenchers.  
Therefore it is still an open question as to the ability of iodide and acrylamide to cross 
bilayers.  The proposition that these quenchers can cross bilayers, if true, complicates 
analysis of quenching studies of proteins within lipid vesicles, and can lead to inaccurate 
data on depth and orientation estimates.  This claimed “leakage” of the quenchers was 
investigated by employing indole-PE incorporated into lipid vesicles formed of roughly 
55 nm in diameter.  Vesicles of this size have roughly equivalent amounts of the indole-
PE distributed in each leaflet (this assumption was based on vesicle size calculations 
from Huang and Mason 156).  Therefore, it would be expected that only 50 % of the 
fluorescence that can be quenched at a given quencher concentration should be available 
under non-permeabilized conditions for our vesicles.  The addition of acrylamide caused 
an intense drop in indole-PE fluorescence directly after the reagent was added.  The 
fluorescence then remained relatively constant over the course of 30 minutes 
(0.05%/minute decrease, Figure 6.2).  After the addition of Triton-X-100, the 
fluorescence signal of the indole-PE was quenched further, consistent with acrylamide 
being able to access the tryptophan headgroup on the inner leaflet of the vesicle under 
permeabilized conditions.  The magnitude of the drop in fluorescence after 
permeabilization was roughly equal to that of the non-permeabilized sample (14% and 
11% of the total signal, respectively).  This result agrees with the expected distribution of 
indole-PE being equal in the inner and outer leaflets.  When added to the external 
environment of the vesicles, iodide also quenched indole-PE fluorescence (Figure 6-2).  
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Interestingly, after a short period of a relatively steady signal, the fluorescence began to 
decay linearly, possibly indicating that the iodide indeed was crossing the bilayer, which 
is consistent with reports in the literature 227.  Addition of Triton-X-100 caused a further 
drop in the intensity.  The drops in intensity before and after permeabilization were again 
consistent with an equal distribution of indole-PE on either side of the bilayer (8% and 
7% of the total signal respectively).  When considering the properties of the two 
quenchers utilized, it is unusual that negatively charged iodide would permeate across the 
bilayer more readily than acrylamide.  Therefore, the smaller size of the iodide ion 
compared to that of the acrylamide molecule could result in iodides enhanced 
permeability into vesicles.  It seems that acrylamide may be a better choice when 
evaluating the distribution of tryptophan groups that are exposed on different sides of the 
bilayer.  Additionally, it was observed that the magnitude of the quencher’s effect on the 
indole-PE fluorescence was different with acrylamide being twice as potent of a quencher 
versus iodide.  This could be explained by the negative charge on indole-PE that would 
repulse other negatively charged species.  This study therefore shows the benefit of using 
quenchers that vary in their properties to obtain as much information on a fluorophores 
location as possible. 
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Figure 6-2.  Acrylamide and iodide were evaluated for their ability to quench indole-PE 
located within different leaflets of vesicles.  The results are consistent with an equal 
distribution of the fluorophore in each leaflet of the large unilamellar vesicles.  The 
smaller ionic quencher, iodide, had enhanced permeability into these vesicles compared 
to the larger polar quencher, acrylamide.  Experiments were repeated twice and showed 
similar results. 
 
Tryptophan Scanning of Caveolin-1 in Bicelles Using Indole-PE as a Molecular 
Ruler 
 One advantage of bicelles in terms of investigating absolute exposure of 
reconstituted membrane proteins using fluorescence quenching is that they do not have an 
interior compartment that can complicate quenching analysis.  However, differences in 
quenching efficiencies that would be observed between tryptophans within the aqueous, 
headgroup, and bilayer regions are not clear for bicelles as there are a limited number of 
reports where the quenching of proteins reconstituted within them has been investigated.  
In particular, it is unclear if tryptophans located within the headgroup and bilayer region 
would show differences in quenching efficiency, due to the increased water penetration 
brought about by the detergent in the bicelle.  Therefore, it seemed necessary to have a 
molecular ruler in order to allow stronger conclusions to be drawn on membrane protein 
quenching experiments performed in bicelles. 
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 First, the excitation and emission spectra were acquired for the indole-PE 
molecule reconstituted into bicelles.  The indole-PE was found to have a max of 
excitation and emission of 280 nm and 343.47 ± 0.93 nm respectively giving a Stoke’s 
shift value of 6389 cm-1.  Next, the indole-PE exposure was probed using iodide (Figure 
6-3). 
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Figure 6-3.  Normalized excitation (black) and emission (red) spectra for indole-PE 
reconstituted into phospholipid bicelles. 
 
Quenching curves were very linear and highly reproducible and were analyzed using both 
Stern-Volmer plots and the modified Stern-Volmer plot in order to obtain both KSV 
(average collisional quenching constant) and the fractional accessibility (Figure 6-4).  
From the slope of the Stern-Volmer plot, the KSV was determined to be 4.40 M-1, which is 
much less accessible than tryptophan in buffer that has a KSV value of ~14.3 M-1, 
characteristic of an indole group that is shielded from the aqueous environment (Figure 6-
4).  The fractional accessibility was determined from the intercept of the modified Stern-
Volmer plot and gave a value of 0.67  0.03 (Figure 6-4).  The value is likely 
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underinflated due to the negative charge on the indole-PE moiety which, due to 
electrostatic repulsion, would decrease the apparent fractional accessibility.  However, 
the max is consistent with an aqueous-headgroup bordering molecule (~343 nm), and 
therefore this value is consistent with a species that would not be completely solvent 
exposed.  This molecular ruler is also valid for this comparative study considering that 
the HSVFLAGCav162-178 molecule has an isoelectric point = 4.21 and would also be 
negatively charged at the pH that these studies were performed at. 
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Figure 6-4.  Quenching of indole-PE with iodide.  A)  Kinetic quenching plot generated 
by monitoring the 343 nm wavelength and adding iodide every minute after an initial 3 
minute incubation period.  B)  Modified Stern-Volmer plot used to obtain the fractional 
accessibility of indole-PE.  C)  Stern-Volmer plot used to obtain the KSV value for indole-
PE to iodide.  Some deviation towards the x-axis was observed at high concentrations of 
iodide. 
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With the accessibility of indole-PE characterized, the quenching of single 
tryptophan mutants was undertaken to determine the positioning of the protein within the 
bicelles.  For these studies, a construct which was flanked by highly charged antibody 
epitopes (HSV and FLAG) at both the N- and C- termini was utilized to facilitate 
reconstitution into bicelles by classical methods.  The addition of charged tags greatly 
decreased the protein’s propensity for aggregation and allowed the time consuming 
vesicle to bicelle transition method presented in chapter 3 to be circumvented.  Thirteen 
mutants in the 85-133 region were analyzed, thereby giving good coverage of the 
proposed membrane interacting domains (the scaffolding domain + the intramembrane 
domain).  Importantly, this will give information about the trend in accessibility and may 
shed light on the burial of the turn region (residues 108-110) as well as the burial of the 
helical regions.  After reconstitution, the mutants were probed by the same methods used 
for the indole-PE.  The max of emission, KSV, and the fractional accessibility values were 
utilized to evaluate the trend in accessibility along the sequence (Table 6.1).  From the 
quenching of the spectra (Figure 6-5 shows un-quenched and partially quenched emission 
spectra for each mutant), it was clear that there were differences in the burial going along 
the sequence. 
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Figure 6-5.  Fluorescence emission spectra for each mutant probed in the presence of 0 
mM iodide (red) and ~110 mM iodide (black). 
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Figure 6-6.  Representative Stern-Volmer quenching curves for each single tryptophan 
mutant used in the study. 
 
Fitting of the max of emission data at different iodide concentrations to Stern-Volmer 
plots (Figure 6-6) showed linear trends with slight curvature towards the x axis, which 
indicates a partially buried fraction.  Modified Stern-Volmer plots were very linear which 
is important for fractional accessibility determination as poorly linear plots tend to have 
very large error due to extrapolation to an infinite quencher concentration (Figure 6-7).  
Each parameter determined from the fluorescence experiments was plotted as a function 
of the position probed to evaluate how the accessibility changes along the length of the 
85-133 region of the protein (Figure 6-8, Table 6-1). 
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Figure 6-7.  Modified Stern-Volmer plot used to evaluate the fractional accessibility of 
the fluorophore population for each single tryptophan mutant used in the study. 
 
Importantly, the plots have are evaluated with respect to the indole-PE moiety which 
represents a headgroup accessible species.  Clearly there is a similar trend among all 
determined parameters where there is decrease in the max, KSV, and fa from residues 85-
107 consistent with greater burial of the protein approaching the turn region.  
Interestingly, in both max and KSV values, there appears to be an upswing in these values 
around position 111.  This could be indicative of the protein having crossed the bilayer 
center and started to enter the aqueous-headgroup region of the second leaflet.  This 
would be in agreement with the simulation data from Chapter 3 which positioned the turn 
residues near the headgroup region of the second leaflet of the bilayer.  After residue 111, 
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the data shows that the accessibility continues to decrease in terms of the max and KSV.  
The values began to increase again after residue 124.  These trends are less pronounced in 
the fractional accessibility data which, due to large error bars show very little difference 
in accessibility in the 99-133 region.  The W-shape of the overall plots is consistent with 
the horseshoe topology as a straight transmembrane helix would show a simple U-shape.  
However, it is likely that more evidence would be needed to fully support this conjecture.  
Importantly, all values probed were significantly lower than that determined for the 
indole-PE molecule.  This indicates that the protein is buried at least as deep as the 
headgroup region from residues 85-133.  These data are in agreement with the data in 
Chapter 3 indicating that the 87-107 region may be overall less buried than the 111-128 
region, as the max and KSV values appear to be on average lower for region after the turn.  
Interestingly, W128 has a relatively red shifted max in comparison to residues 
surrounding it (F124W and C133W).  However if one looks at the KSV and fa values, they 
clearly show accessibilities that are more in line with the surrounding residues (compare 
this to W85 and F89W which have fa and KSV values that reflect the max).  This could be 
an indication that W128 is involved in a hydrogen bonding interaction.  More data will be 
needed to support this conjecture.  It is unlikely that the negatively charged tags would be 
influencing the quenching data as they are far removed from the sites scanned.  The data 
agree nicely with values obtained on the shorter, tag-less caveolin-1 construct used in 
chapter 3 (residues 82-136) – with the major difference being W85 that is 8 nm blue 
shifted in this study.  However, it may be that the truncated construct used in Chapter 3 
results in improper burial as these data are also consistent with the simulation data.  
Although interesting, these mutants will need to be evaluated in terms of their ability to 
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behave like wild-type caveolin in vivo to be sure that they are not significantly altering 
the protein. 
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Figure 6-8.  Examination of parameters (max, KSV, and Fraction accessible) for each 
mutant along the region of the protein scanned.  All plots show similar trends in 
accessibility.  Importantly, parameters determined for indole-PE (red dashed line) give an 
indication that each species is buried beneath the top of the headgroup region of the 
bicelles. 
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Construct λmax (nm) KSV (M-1) fa 
Indole-PE 343.5  0.9 4.40  0.05 0.667  0.030 
W85 338.5  0.1 2.66  0.09 0.497  0.030 
F89W 340.2  0.1 2.74  0.13 0.593  0.017 
W98 335.7  0.1 2.81  0.07 0.511  0.010 
F99W 336.5  0.2 2.21  0.12 0.425  0.060 
L102W 335.6  0.8 1.66  0.11 0.398  0.062 
F107W 334.7  0.1 1.94  0.03 0.447  0.017 
M111W 335.7  0.1 1.96  0.01 0.405  0.027 
W115 332.1  0.1 1.67  0.01 0.395  0.082 
I117W 333.7  0.3 1.42  0.04 0.303  0.065 
Y118W 331.7  0.1 1.36  0.07 0.337  0.033 
F124W 333.14  1.3 1.41  0.01 0.368  0.103 
W128 339.6  0.1 2.14  0.11 0.443  0.029 
C133W 336.7  1.1 2.00  0.01 0.468  0.001 
Table 6-1.  Averaged values of parameters determined for all fluorophores in the study (n 
= 2-3). 
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CONCLUSIONS 
 
 This chapter has provided a number of important findings.  For the first time a 
bonafide indole-based marker for the headgroup region of the bilayer has been 
synthesized, purified to homogeneity, and characterized in terms of its usefulness in 
fluorescence studies of proteins embedded in phospholipid bilayers.  Specifically, it was 
shown that both iodide and acrylamide fluorescence quenchers could be used in 
examinations of membrane protein burial within phospholipid vesicles but iodide may 
have to be used on a faster time scale as it diffuses through bilayers more readily.  
Additionally, the probe helped with interpretation of quenching data in phospholipid 
bicelles.  This is important because, unlike vesicles and micelles, there is a dearth in the 
literature on the amount quenching that would be expected for a membrane protein with a 
tryptophan buried within a bicelle’s bilayered region.  These data showed that for thirteen 
caveolin-1 single tryptophan mutants, each was buried deeper than the top of the 
aqueous-headgroup interface, covering a span of 49 residues.  This result agrees with the 
hydropathy plots which predicted this region to be buried in the 102-135 region.  These 
data cannot differentiate between different degrees of membrane burial, this will likely 
require the synthesis of an indole probe that can be fixed within the center of the bilayer. 
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Appendix 6-1.  Sequences of Protein Constructs Utilized 
 
Construct Protein Sequence 
 
 
HSVFLAGCav162-178 (W85) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIWKASFTTFTVTKYFFYRLLSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (F89W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASWTTFTVTKYFFYRLLSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (W98) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYWFYRLLSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (F99W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFWYRLLSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (L103W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLWSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (F107W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALWG
IPLALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (M111W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPWALIFGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (W115) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIWGIYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (I117W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIFGWYFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
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HSVFLAGCav162-178 (Y118W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIFGIWFAILSFLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (F124W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIFGIYFAILSWLHIFAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (W128) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIFGIYFAILSFLHIWAVVPSIKSFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
 
 
 
HSVFLAGCav162-178 (C133W) 
QPELAPEDPEDDYKDDDDKDVVKIDFEDVIAEP
EGTHSFDGIFKASFTTFTVTKYFFYRLLSALFG
IPLALIFGIYFAILSFLHIFAVVPSIKWFLIEI
QSISRVYSIYVHTVSDPLFEAVGKIFSNVRINL
QKEIDYKDDDDKDGIQPELAPEDPED 
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Appendix 6-2.  Mutagenesis Primers Utilized 
 
Construct Primer Sequence 
W85 5’-CTCTTTCGACGGTATCTGGAAAGCGTCTTTCACCAC-3’ 
F89W 5’-GTATCTTCAAAGCGTCTTGGACCACCTTCACCGTTAC-3’ 
W98 5’-CACCGTTACCAAATACTGGTTCTACCGTCTGCTGTC-3’ 
F99W 5’-CGTTACCAAATACTTCTGGTACCGTCTGCTGTCTG-3’ 
L102W 5’-CAAATACTTCTTCTACCGTTGGCTGTCTGCGCTGTTCGG-3’ 
F107W 5’-GCTGTCTGCGCTGTGGGGTATCCCGCTGG-3’ 
M111W 5’-GCTGTTCGGTATCCCGTGGGCGCTGATCTTCGG-3’ 
W115 5’-CTGGCGCTGATCTGGGGTATCTACTTCGC-3’ 
I117W 5’-GCGCTGATCTTCGGTTGGTACTTCGCGATCCTG-3’ 
Y118W 5’-GCTGATCTTCGGTATCTGGTTCGCGATCCTGTCTTTC-3’ 
F124W 5’-CGCGATCCTGTCTTGGCTGCACATCTTCGC-3’ 
W128 5’-GTCTTTCCTGCACATCTGGGCGGTTGTTCCGTCTATC-3’ 
C133W 5’-CTTCGCGGTTGTTCCGTGGATCAAATCTTTCCTGATC-3’ 
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